Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 'As required' medication regimens for seriously mentally ill people in hospital.1 passage
• (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.1 passage
• (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.1 passage
• (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.1 passage
• 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.1 passage
• 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).1 passage
• 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).1 passage
• A 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcers.1 passage
• A comparison of different antibiotic regimens for the treatment of infective endocarditis.2 passages
• A realist review of which advocacy interventions work for which abused women under what circumstances.1 passage
• A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.1 passage
• AD-8 for detection of dementia across a variety of healthcare settings.1 passage
• Ab interno supraciliary microstent surgery for open-angle glaucoma.1 passage
• Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma.1 passage
• Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma.1 passage
• Ab interno trabecular bypass surgery with Trabectome for open-angle glaucoma.1 passage
• Ab interno trabecular bypass surgery with iStent for open-angle glaucoma.1 passage
• Abdominal drainage to prevent intra-peritoneal abscess after appendectomy for complicated appendicitis.1 passage
• Abdominal drainage to prevent intra-peritoneal abscess after open appendectomy for complicated appendicitis.2 passages
• Abdominal drainage versus no drainage post-gastrectomy for gastric cancer.1 passage
• Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.1 passage
• Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive individuals.1 passage
• Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.1 passage
• Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery.1 passage
• Acetyl-L-carnitine for patients with hepatic encephalopathy.1 passage
• Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.1 passage
• Acetylsalicylic acid (aspirin) for schizophrenia.1 passage
• Action observation for upper limb rehabilitation after stroke.1 passage
• Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.1 passage
• Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults.1 passage
• Active cycle of breathing technique for cystic fibrosis.1 passage
• Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.1 passage
• Active versus expectant management for women in the third stage of labour.2 passages
• Activity monitors for increasing physical activity in adult stroke survivors.1 passage
• Acupuncture and acupressure for premenstrual syndrome.1 passage
• Acupuncture and related interventions for symptoms of chronic kidney disease.1 passage
• Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome.1 passage
• Acupuncture for acute hordeolum.1 passage
• Acupuncture for cancer pain in adults.1 passage
• Acupuncture for chronic hepatitis B.1 passage
• Acupuncture for chronic nonspecific low back pain.1 passage
• Acupuncture for depression.1 passage
• Acupuncture for dysmenorrhoea.1 passage
• Acupuncture for glaucoma.1 passage
• Acupuncture for hip osteoarthritis.1 passage
• Acupuncture for hypertension.1 passage
• Acupuncture for mumps in children.1 passage
• Acupuncture for neck disorders.1 passage
• Acupuncture for neuropathic pain in adults.1 passage
• Acupuncture for polycystic ovarian syndrome.2 passages
• Acupuncture for stroke rehabilitation.1 passage
• Acupuncture for symptomatic gastroparesis.1 passage
• Acupuncture for the prevention of episodic migraine.1 passage
• Acupuncture for the prevention of tension-type headache.1 passage
• Acupuncture or acupressure for induction of labour.1 passage
• Acupuncture or acupressure for pain management during labour.1 passage
• Acute tocolysis for uterine tachysystole or suspected fetal distress.1 passage
• Adalimumab for induction of remission in Crohn's disease.1 passage
• Adalimumab for maintenance of remission in Crohn's disease.1 passage
• Add-back therapy with GnRH analogues for uterine fibroids.1 passage
• Addenbrooke's Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment.1 passage
• Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.1 passage
• Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.1 passage
• Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.2 passages
• Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.1 passage
• Adductor canal blocks for postoperative pain treatment in adults undergoing knee surgery.1 passage
• Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.1 passage
• Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.1 passage
• Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews.1 passage
• Adhesively bonded versus non-bonded amalgam restorations for dental caries.1 passage
• Adhesives for bonded molar tubes during fixed brace treatment.1 passage
• Adhesives for fixed orthodontic bands.1 passage
• Adhesives for fixed orthodontic brackets.1 passage
• Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection.1 passage
• Adjunctive hyperbaric oxygen for necrotizing fasciitis.1 passage
• Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy.1 passage
• Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.1 passage
• Adjunctive systemic antimicrobials for the non-surgical treatment of periodontitis.1 passage
• Adjustable versus non-adjustable sutures for strabismus.1 passage
• Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.1 passage
• Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.1 passage
• Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis.1 passage
• Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women.1 passage
• Adjuvant platinum-based chemotherapy for early stage cervical cancer.1 passage
• Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.1 passage
• Adrenaline and vasopressin for cardiac arrest.1 passage
• Adrenaline with lidocaine for digital nerve blocks.1 passage
• Adult patient access to electronic health records.1 passage
• Advance care planning for adults with heart failure.1 passage
• Advance care planning for haemodialysis patients.1 passage
• Advanced sperm selection techniques for assisted reproduction.1 passage
• Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.1 passage
• Adverse events associated with single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews.1 passage
• Adverse events in people taking macrolide antibiotics versus placebo for any indication.1 passage
• Adverse side effects of dexamethasone in surgical patients.2 passages
• Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well-being of women who experience intimate partner abuse.1 passage
• Aerobic exercise to improve cognitive function in older people without known cognitive impairment.1 passage
• Aerobic exercise training for adults with fibromyalgia.1 passage
• Aerobic physical exercise for adult patients with haematological malignancies.1 passage
• Aflibercept for neovascular age-related macular degeneration.1 passage
• Agricultural and nutritional education interventions for reducing aflatoxin exposure to improve infant and child growth in low- and middle-income countries.1 passage
• Airway clearance techniques for bronchiectasis.1 passage
• Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews.1 passage
• Airway physical examination tests for detection of difficult airway management in apparently normal adult patients.1 passage
• Alarm interventions for nocturnal enuresis in children.1 passage
• Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.1 passage
• Alcohol intake reduction for controlling hypertension.1 passage
• Alcoholics Anonymous and other 12-step programs for alcohol use disorder.1 passage
• Aldosterone antagonists for people with chronic kidney disease requiring dialysis.1 passage
• Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.1 passage
• Alemtuzumab for multiple sclerosis.1 passage
• Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.1 passage
• Alginate dressings for treating pressure ulcers.1 passage
• Alginate dressings for venous leg ulcers.1 passage
• Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery.1 passage
• Alpha-2 adrenergic agonists for the prevention of shivering following general anaesthesia.1 passage
• Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients.1 passage
• Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.1 passage
• Alpha-blockers as medical expulsive therapy for ureteral stones.1 passage
• Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.1 passage
• Alpha₂-adrenergic agonists for the management of opioid withdrawal.1 passage
• Alprazolam for essential tremor.1 passage
• Altered dietary salt intake for people with chronic kidney disease.2 passages
• Altering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumption.1 passage
• Alternating pressure (active) air surfaces for preventing pressure ulcers.1 passage
• Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.1 passage
• Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants.1 passage
• Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers.1 passage
• Alternative versus standard packages of antenatal care for low-risk pregnancy.1 passage
• Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.1 passage
• Alvimopan for recovery of bowel function after radical cystectomy.1 passage
• Ambulatory and short-burst oxygen for interstitial lung disease.1 passage
• Aminophylline for bradyasystolic cardiac arrest in adults.1 passage
• Aminosalicylates for induction of remission or response in Crohn's disease.1 passage
• Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death.1 passage
• Amitriptyline for neuropathic pain in adults.1 passage
• Amniocentesis and chorionic villus sampling for prenatal diagnosis.1 passage
• Amnioinfusion for chorioamnionitis.1 passage
• Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.1 passage
• Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.1 passage
• Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function.1 passage
• Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection.1 passage
• An overview of systematic reviews on mental health promotion, prevention, and treatment of common mental disorders for refugees, asylum seekers, and internally displaced persons.1 passage
• Anabolic steroids for treating pressure ulcers.1 passage
• Anaesthesia for hip fracture surgery in adults.1 passage
• Anaesthesia/analgesia for manual removal of retained placenta.1 passage
• Anaesthetic and sedative agents used for electrical cardioversion.1 passage
• Anaesthetic interventions for prevention of awareness during surgery.1 passage
• Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.1 passage
• Angioplasty versus stenting for iliac artery lesions.2 passages
• Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.1 passage
• Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.1 passage
• Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.1 passage
• Animal-assisted therapy for dementia.1 passage
• Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews.1 passage
• Antenatal breastfeeding education for increasing breastfeeding duration.1 passage
• Antenatal cardiotocography for fetal assessment.1 passage
• Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.2 passages
• Antenatal dietary education and supplementation to increase energy and protein intake.1 passage
• Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.1 passage
• Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews.1 passage
• Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery.1 passage
• Antenatal maternal education for improving postnatal perineal healing for women who have birthed in a hospital setting.1 passage
• Anterior vaginal repair for urinary incontinence in women.1 passage
• Anthelmintic drugs for treating ascariasis.1 passage
• Anthelmintics for people with neurocysticercosis.1 passage
• Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.1 passage
• Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation.1 passage
• Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.2 passages
• Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.1 passage
• Anti-IL-5 therapies for chronic obstructive pulmonary disease.1 passage
• Anti-IL5 therapies for asthma.1 passage
• Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.3 passages
• Anti-TNF agents for paediatric psoriasis.1 passage
• Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility.2 passages
• Anti-angiogenic therapy for high-grade glioma.1 passage
• Anti-cytokine targeted therapies for ANCA-associated vasculitis.1 passage
• Anti-epidermal growth factor receptor therapy for glioblastoma in adults.1 passage
• Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis.1 passage
• Anti-inflammatory medications for obstructive sleep apnoea in children.1 passage
• Anti-inflammatory therapy for preventing stroke and other vascular events after ischaemic stroke or transient ischaemic attack.1 passage
• Anti-inflammatory treatment for carditis in acute rheumatic fever.1 passage
• Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma.1 passage
• Anti-seizure medications for Lennox-Gastaut syndrome.1 passage
• Anti-tuberculous therapy for maintenance of remission in Crohn's disease.1 passage
• Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.1 passage
• Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.2 passages
• Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.1 passage
• Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.1 passage
• Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.1 passage
• Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.2 passages
• Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.1 passage
• Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.1 passage
• Anti-vascular endothelial growth factor for neovascular glaucoma.1 passage
• Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.1 passage
• Antiamoebic drugs for treating amoebic colitis.1 passage
• Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women.1 passage
• Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.2 passages
• Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.1 passage
• Antibiotic lock for the prevention of catheter-related infection in neonates.1 passage
• Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity.2 passages
• Antibiotic prophylaxis for elective hysterectomy.1 passage
• Antibiotic prophylaxis for episiotomy repair following vaginal birth.1 passage
• Antibiotic prophylaxis for operative vaginal delivery.2 passages
• Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures.1 passage
• Antibiotic prophylaxis for prevention of postoperative wound infection in adults undergoing open elective inguinal or femoral hernia repair.1 passage
• Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation.1 passage
• Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis.1 passage
• Antibiotic regimens for early-onset neonatal sepsis.1 passage
• Antibiotic regimens for late-onset neonatal sepsis.1 passage
• Antibiotic regimens for postpartum endometritis.1 passage
• Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.1 passage
• Antibiotic therapy for adults with neurosyphilis.1 passage
• Antibiotic therapy for chronic infection with <I>Burkholderia cepacia</I> complex in people with cystic fibrosis.1 passage
• Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.1 passage
• Antibiotic therapy for pelvic inflammatory disease.2 passages
• Antibiotic therapy for preventing infections in people with acute stroke.1 passage
• Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze.1 passage
• Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.2 passages
• Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.1 passage
• Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.2 passages
• Antibiotic treatment for newborns with congenital syphilis.1 passage
• Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.2 passages
• Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis.1 passage
• Antibiotic treatment for the sexual partners of women with bacterial vaginosis.1 passage
• Antibiotic use for irreversible pulpitis.2 passages
• Antibiotics and antiseptics for pressure ulcers.1 passage
• Antibiotics and antiseptics for surgical wounds healing by secondary intention.1 passage
• Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants.1 passage
• Antibiotics for acute bronchitis.1 passage
• Antibiotics for acute laryngitis in adults.1 passage
• Antibiotics for acute otitis media in children.1 passage
• Antibiotics for acute rhinosinusitis in adults.1 passage
• Antibiotics for asymptomatic bacteriuria in kidney transplant recipients.1 passage
• Antibiotics for asymptomatic bacteriuria in pregnancy.2 passages
• Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.1 passage
• Antibiotics for exacerbations of asthma.1 passage
• Antibiotics for exacerbations of chronic obstructive pulmonary disease.1 passage
• Antibiotics for hospital-acquired pneumonia in neonates and children.1 passage
• Antibiotics for induction and maintenance of remission in Crohn's disease.1 passage
• Antibiotics for infection prevention after excision of the cervical transformation zone.1 passage
• Antibiotics for neonates born through meconium-stained amniotic fluid.1 passage
• Antibiotics for otitis media with effusion in children.1 passage
• Antibiotics for persistent cough or wheeze following acute bronchiolitis in children.1 passage
• Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.1 passage
• Antibiotics for preventing recurrent sore throat.1 passage
• Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age.1 passage
• Antibiotics for prolonged wet cough in children.1 passage
• Antibiotics for secondary prevention of coronary heart disease.1 passage
• Antibiotics for the neurological complications of Lyme disease.1 passage
• Antibiotics for the treatment of COVID-19.1 passage
• Antibiotics for trachoma.1 passage
• Antibiotics for treating acute chest syndrome in people with sickle cell disease.2 passages
• Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.1 passage
• Antibiotics for treating gonorrhoea in pregnancy.1 passage
• Antibiotics for treating osteomyelitis in people with sickle cell disease.2 passages
• Antibiotics for treating scrub typhus.1 passage
• Antibiotics for treating septic abortion.1 passage
• Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.1 passage
• Antibiotics for treatment of sore throat in children and adults.1 passage
• Antibiotics for ventilator-associated pneumonia.1 passage
• Antibiotics to prevent complications following tooth extractions.1 passage
• Antibiotics versus no treatment for toxoplasma retinochoroiditis.1 passage
• Antibiotics versus topical antiseptics for chronic suppurative otitis media.1 passage
• Antibody tests for identification of current and past infection with SARS-CoV-2.1 passage
• Antibody therapies for lymphoma in children.1 passage
• Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.1 passage
• Anticholinergic medication for antipsychotic-induced tardive dyskinesia.1 passage
• Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.1 passage
• Anticoagulant treatment for subsegmental pulmonary embolism.2 passages
• Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.1 passage
• Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.1 passage
• Anticoagulants for acute ischaemic stroke.2 passages
• Anticoagulation for people with cancer and central venous catheters.1 passage
• Anticoagulation for perioperative thromboprophylaxis in people with cancer.1 passage
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.2 passages
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.1 passage
• Anticoagulation versus placebo for heart failure in sinus rhythm.1 passage
• Anticonvulsants for cocaine dependence.1 passage
• Antidepressant treatment for postnatal depression.1 passage
• Antidepressants for chronic non-cancer pain in children and adolescents.1 passage
• Antidepressants for depression in adults with HIV infection.1 passage
• Antidepressants for functional abdominal pain disorders in children and adolescents.1 passage
• Antidepressants for insomnia in adults.1 passage
• Antidepressants for people with epilepsy and depression.1 passage
• Antidepressants for preventing postnatal depression.1 passage
• Antidepressants for smoking cessation.1 passage
• Antidepressants for the treatment of depression in people with cancer.2 passages
• Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.1 passage
• Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.1 passage
• Antidepressants for treating depression in dementia.1 passage
• Antidepressants plus benzodiazepines for adults with major depression.1 passage
• Antidepressants versus placebo for panic disorder in adults.1 passage
• Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.1 passage
• Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.1 passage
• Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.2 passages
• Antiepileptic drugs as prophylaxis for post-craniotomy seizures.1 passage
• Antiepileptic drugs as prophylaxis for postcraniotomy seizures.2 passages
• Antiepileptic drugs for chronic non-cancer pain in children and adolescents.1 passage
• Antiepileptic drugs for seizure control in people with neurocysticercosis.3 passages
• Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis.1 passage
• Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis.1 passage
• Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy.2 passages
• Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease.1 passage
• Antifibrinolytic drugs for acute traumatic injury.1 passage
• Antifibrinolytic drugs for treating primary postpartum haemorrhage.1 passage
• Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.2 passages
• Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.1 passage
• Antifibrinolytic therapy to reduce haemoptysis from any cause.1 passage
• Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.1 passage
• Antifibrinolytics for heavy menstrual bleeding.1 passage
• Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.1 passage
• Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.1 passage
• Antigen-specific active immunotherapy for ovarian cancer.1 passage
• Antiglucocorticoid and related treatments for psychosis.1 passage
• Antihelminthics in helminth-endemic areas: effects on HIV disease progression.1 passage
• Antihistamines for the common cold.1 passage
• Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.1 passage
• Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals.1 passage
• Antihypertensive withdrawal for the prevention of cognitive decline.1 passage
• Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction.1 passage
• Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.1 passage
• Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy.1 passage
• Antimicrobial dressings for the prevention of catheter-related infections in newborn infants with central venous catheters.1 passage
• Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis.1 passage
• Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them.1 passage
• Antimicrobial mouthwashes (gargling) and nasal sprays to protect healthcare workers when undertaking aerosol-generating procedures (AGPs) on patients without suspected or confirmed COVID-19 infection.1 passage
• Antimicrobial-impregnated central venous catheters for prevention of catheter-related bloodstream infection in newborn infants.1 passage
• Antioxidant supplementation for lung disease in cystic fibrosis.1 passage
• Antioxidant treatments for schizophrenia.1 passage
• Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.1 passage
• Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.1 passage
• Antioxidants for female subfertility.2 passages
• Antioxidants for male subfertility.1 passage
• Antioxidants for preventing and reducing muscle soreness after exercise.1 passage
• Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.1 passage
• Antiplatelet agents for preventing pre-eclampsia and its complications.1 passage
• Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.1 passage
• Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.1 passage
• Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.2 passages
• Antipsychotic combinations for schizophrenia.1 passage
• Antipsychotic medications for cocaine dependence.1 passage
• Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.1 passage
• Antipsychotics for fibromyalgia in adults.1 passage
• Antipsychotics for treatment of delirium in hospitalised non-ICU patients.1 passage
• Antiretroviral resistance testing in HIV-positive people.1 passage
• Antiseptics for burns.1 passage
• Antistreptococcal interventions for guttate and chronic plaque psoriasis.1 passage
• Antithrombin III for critically ill patients.1 passage
• Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants.1 passage
• Antithrombotic treatment after stroke due to intracerebral haemorrhage.1 passage
• Antiviral agents for infectious mononucleosis (glandular fever).1 passage
• Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.1 passage
• Antiviral treatment for Bell's palsy (idiopathic facial paralysis).3 passages
• Appendectomy versus antibiotic treatment for acute appendicitis.1 passage
• Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer).1 passage
• Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.1 passage
• Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.1 passage
• Aquatic exercise for the treatment of knee and hip osteoarthritis.1 passage
• Aqueous shunts for glaucoma.1 passage
• Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma.1 passage
• Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.1 passage
• Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation).1 passage
• Aripiprazole for autism spectrum disorders (ASD).1 passage
• Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.1 passage
• Aromatase inhibitors for short stature in male children and adolescents.1 passage
• Aromatherapy for dementia.1 passage
• Aromatherapy for treatment of postoperative nausea and vomiting.1 passage
• Art therapy for people with dementia.1 passage
• Artemether for severe malaria.1 passage
• Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria.1 passage
• Artificial corneas versus donor corneas for repeat corneal transplants.1 passage
• As required versus fixed schedule analgesic administration for postoperative pain in children.1 passage
• Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.1 passage
• Asenapine versus placebo for schizophrenia.1 passage
• Aspirin (single dose) for perineal pain in the early postpartum period.2 passages
• Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.1 passage
• Aspirin for acute treatment of episodic tension-type headache in adults.1 passage
• Aspirin for in vitro fertilisation.1 passage
• Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.1 passage
• Assessment and support during early labour for improving birth outcomes.1 passage
• Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI)).1 passage
• Assisted reproductive technologies for male subfertility.1 passage
• Assisted reproductive technology: an overview of Cochrane Reviews.2 passages
• Assisted standing for Duchenne muscular dystrophy.1 passage
• Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and improve function after hip arthroplasty.1 passage
• Assistive technology for children and young people with low vision.1 passage
• Assistive technology for memory support in dementia.1 passage
• Asthma education for school staff.1 passage
• Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.1 passage
• Atherectomy for peripheral arterial disease.1 passage
• Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.1 passage
• Atraumatic restorative treatment versus conventional restorative treatment for managing dental caries.1 passage
• Atypical antipsychotics for disruptive behaviour disorders in children and youths.1 passage
• Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.1 passage
• Aural toilet (ear cleaning) for chronic suppurative otitis media.1 passage
• Autogenic drainage for airway clearance in cystic fibrosis.1 passage
• Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain.1 passage
• Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.1 passage
• Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas.1 passage
• Autologous platelet concentrates for treating periodontal infrabony defects.1 passage
• Autologous platelet-rich plasma for treating chronic wounds.1 passage
• Autologous serum eye drops for dry eye.1 passage
• Automated mandatory bolus versus basal infusion for maintenance of epidural analgesia in labour.1 passage
• Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.1 passage
• Automated telephone communication systems for preventive healthcare and management of long-term conditions.1 passage
• Avatar Therapy for people with schizophrenia or related disorders.1 passage
• Avoidance of bottles during the establishment of breast feeds in preterm infants.1 passage
• Avoidance of bottles during the establishment of breastfeeds in preterm infants.1 passage
• Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.1 passage
• Axillary treatment for operable primary breast cancer.1 passage
• Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.1 passage
• Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.1 passage
• Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.1 passage
• Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.1 passage
• Azithromycin for acute lower respiratory tract infections.1 passage
• BIS monitoring versus clinical assessment for sedation in mechanically ventilated adults in the intensive care unit and its impact on clinical outcomes and resource utilization.1 passage
• Back Schools for chronic non-specific low back pain.1 passage
• Back schools for acute and subacute non-specific low-back pain.1 passage
• Baclofen for alcohol use disorder.1 passage
• Baclofen for alcohol withdrawal.3 passages
• Balneotherapy (or spa therapy) for rheumatoid arthritis.1 passage
• Balneotherapy for chronic venous insufficiency.1 passage
• Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.1 passage
• Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.1 passage
• Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.1 passage
• Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.1 passage
• Banked preterm versus banked term human milk to promote growth and development in very low birth weight infants.1 passage
• Barrier agents for adhesion prevention after gynaecological surgery.2 passages
• Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis.1 passage
• Barriers and facilitators to the implementation of doctor-nurse substitution strategies in primary care: a qualitative evidence synthesis.1 passage
• Bed rest for pressure ulcer healing in wheelchair users.1 passage
• Bed rest in singleton pregnancies for preventing preterm birth.1 passage
• Bed rest with and without hospitalisation in multiple pregnancy for improving perinatal outcomes.1 passage
• Bed sharing versus no bed sharing for healthy term neonates.1 passage
• Beds, overlays and mattresses for preventing and treating pressure ulcers: an overview of Cochrane Reviews and network meta-analysis.1 passage
• Beds, overlays and mattresses for treating pressure ulcers.1 passage
• Beginning reading interventions for children and adolescents with intellectual disability.1 passage
• Behavioral interventions for improving contraceptive use among women living with HIV.1 passage
• Behavioural activation therapy for depression in adults with non-communicable diseases.1 passage
• Behavioural activation therapy for depression in adults.1 passage
• Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).1 passage
• Behavioural and cognitive-behavioural interventions for outwardly-directed aggressive behaviour in people with intellectual disabilities.1 passage
• Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population.1 passage
• Behavioural interventions for smoking cessation: an overview and network meta-analysis.1 passage
• Behavioural interventions to promote workers' use of respiratory protective equipment.1 passage
• Belimumab for systemic lupus erythematosus.1 passage
• Benzodiazepines for antipsychotic-induced tardive dyskinesia.1 passage
• Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses.1 passage
• Benzodiazepines for restless legs syndrome.1 passage
• Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.1 passage
• Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit.1 passage
• Benzodiazepines versus placebo for panic disorder in adults.1 passage
• Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery.1 passage
• Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.2 passages
• Beta-blockers for congestive heart failure in children.2 passages
• Beta-blockers for hypertension.1 passage
• Beta-blockers for preventing aortic dissection in Marfan syndrome.1 passage
• Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.1 passage
• Beta-blockers for suspected or diagnosed acute myocardial infarction.1 passage
• Beta-blockers in patients without heart failure after myocardial infarction.1 passage
• Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.1 passage
• Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis.1 passage
• Betahistine for symptoms of vertigo.1 passage
• Bicarbonate- versus lactate-buffered solutions for acute continuous haemodiafiltration or haemofiltration.1 passage
• Bifeprunox versus placebo for schizophrenia.1 passage
• Bilateral versus unilateral hearing aids for bilateral hearing impairment in adults.1 passage
• Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.1 passage
• Bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction.1 passage
• Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.1 passage
• Biocompatible dialysis fluids for peritoneal dialysis.1 passage
• Biofeedback for treatment of irritable bowel syndrome.1 passage
• Bioidentical hormones for women with vasomotor symptoms.1 passage
• Biologic interventions for fatigue in rheumatoid arthritis.1 passage
• Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).1 passage
• Biologics for chronic rhinosinusitis.2 passages
• Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.1 passage
• Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.1 passage
• Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.1 passage
• Biomarkers for diagnosis of Wilson's disease.1 passage
• Biomedical risk assessment as an aid for smoking cessation.1 passage
• Biopsy versus resection for high-grade glioma.1 passage
• Biopsy versus resection for the management of low-grade gliomas.1 passage
• Biphasic versus monophasic waveforms for transthoracic defibrillation in out-of-hospital cardiac arrest.1 passage
• Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.1 passage
• Birth and death notification via mobile devices: a mixed methods systematic review.1 passage
• Bispectral index for improving intraoperative awareness and early postoperative recovery in adults.1 passage
• Bisphosphonate therapy for osteogenesis imperfecta.1 passage
• Bisphosphonate use in children with cerebral palsy.1 passage
• Bisphosphonates and other bone agents for breast cancer.1 passage
• Bisphosphonates for Paget's disease of bone in adults.1 passage
• Bisphosphonates for advanced prostate cancer.1 passage
• Bisphosphonates for steroid-induced osteoporosis.1 passage
• Bisphosphonates in multiple myeloma: an updated network meta-analysis.1 passage
• Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.1 passage
• Bladder neck needle suspension for urinary incontinence in women.1 passage
• Blood CEA levels for detecting recurrent colorectal cancer.1 passage
• Blood biomarkers for the non-invasive diagnosis of endometriosis.1 passage
• Blood pressure control for diabetic retinopathy.1 passage
• Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.1 passage
• Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.1 passage
• Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.1 passage
• Blood pressure lowering efficacy of renin inhibitors for primary hypertension.1 passage
• Blood pressure targets for hypertension in older adults.1 passage
• Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.3 passages
• Blood pressure targets in adults with hypertension.1 passage
• Blood pressure-lowering efficacy of loop diuretics for primary hypertension.1 passage
• Blood pressure-lowering efficacy of reserpine for primary hypertension.1 passage
• Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack.1 passage
• Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.2 passages
• Blood transfusions for treating acute chest syndrome in people with sickle cell disease.2 passages
• Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.1 passage
• Blue-light filtering intraocular lenses (IOLs) for protecting macular health.1 passage
• Body positioning for spontaneously breathing preterm infants with apnoea.1 passage
• Body weight management in overweight and obese breast cancer survivors.1 passage
• Booster dose vaccination for preventing hepatitis B.1 passage
• Bortezomib for the treatment of multiple myeloma.1 passage
• Botulinum toxin for motor and phonic tics in Tourette's syndrome.1 passage
• Botulinum toxin for the treatment of strabismus.1 passage
• Botulinum toxin type A for facial wrinkles.1 passage
• Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.1 passage
• Botulinum toxin type A therapy for blepharospasm.1 passage
• Botulinum toxin type A therapy for cervical dystonia.2 passages
• Botulinum toxin type A therapy for hemifacial spasm.1 passage
• Botulinum toxin type A versus anticholinergics for cervical dystonia.1 passage
• Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.1 passage
• Botulinum toxin type B for cervical dystonia.1 passage
• Botulinum toxins for the prevention of migraine in adults.1 passage
• Braces and orthoses for treating osteoarthritis of the knee.1 passage
• Braces for idiopathic scoliosis in adolescents.1 passage
• Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates.1 passage
• Branched-chain amino acids for people with hepatic encephalopathy.3 passages
• Breast surgery for metastatic breast cancer.1 passage
• Breastfeeding education and support for women with twins or higher order multiples.1 passage
• Breastfeeding for procedural pain in infants beyond the neonatal period.1 passage
• Breastfeeding or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour.1 passage
• Breathing exercises for adults with asthma.1 passage
• Breathing exercises for children with asthma.1 passage
• Brief educational strategies for improving contraception use in young people.1 passage
• Brief school-based interventions and behavioural outcomes for substance-using adolescents.1 passage
• Brivaracetam add-on therapy for drug-resistant epilepsy.1 passage
• Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD.1 passage
• Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.1 passage
• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease.1 passage
• Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.2 passages
• Budesonide for induction of remission in Crohn's disease.1 passage
• Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children.1 passage
• Buflomedil for acute ischaemic stroke.1 passage
• Buprenorphine for managing opioid withdrawal.1 passage
• Buprenorphine for neuropathic pain in adults.1 passage
• Buprenorphine for treating cancer pain.1 passage
• Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.1 passage
• Bypass surgery for chronic lower limb ischaemia.1 passage
• Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.1 passage
• C-reactive protein for diagnosing late-onset infection in newborn infants.1 passage
• CHIVA method for the treatment of chronic venous insufficiency.2 passages
• COVID-19 and its cardiovascular effects: a systematic review of prevalence studies.1 passage
• CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).1 passage
• Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.1 passage
• Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.1 passage
• Calcium and phosphorus supplementation of human milk for preterm infants.1 passage
• Calcium antagonists for acute ischemic stroke.1 passage
• Calcium channel blockers for antipsychotic-induced tardive dyskinesia.1 passage
• Calcium channel blockers for people with chronic kidney disease requiring dialysis.1 passage
• Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.1 passage
• Calcium channel blockers for primary Raynaud's phenomenon.1 passage
• Calcium channel blockers for primary and secondary Raynaud's phenomenon.1 passage
• Calcium channel blockers for pulmonary arterial hypertension.1 passage
• Calcium channel blockers versus other classes of drugs for hypertension.1 passage
• Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes.1 passage
• Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy.1 passage
• Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.1 passage
• Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.1 passage
• Calcium supplementation for prevention of primary hypertension.2 passages
• Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism.1 passage
• Can Cochrane Reviews inform decisions to improve indigenous people's health?1 passage
• Cannabinoids for fibromyalgia.1 passage
• Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.1 passage
• Cannabinoids for the treatment of dementia.1 passage
• Cannabis for the treatment of Crohn's disease.1 passage
• Cannabis for the treatment of ulcerative colitis.1 passage
• Cannabis-based medicines for chronic neuropathic pain in adults.1 passage
• Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.1 passage
• Capnography versus standard monitoring for emergency department procedural sedation and analgesia.1 passage
• Capsaicin for non-allergic rhinitis.1 passage
• Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.3 passages
• Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.3 passages
• Carbohydrate supplementation of human milk to promote growth in preterm infants.2 passages
• Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing.1 passage
• Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review.1 passage
• Care delivery and self management strategies for adults with epilepsy.1 passage
• Care delivery and self management strategies for children with epilepsy.1 passage
• Care delivery and self-management strategies for children with epilepsy.1 passage
• Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.1 passage
• Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors.1 passage
• Caregiver-mediated exercises for improving outcomes after stroke.1 passage
• Carisbamate add-on therapy for drug-resistant focal epilepsy.1 passage
• Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis.1 passage
• Carotid endarterectomy for symptomatic carotid stenosis.2 passages
• Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.1 passage
• Case management approaches to home support for people with dementia.1 passage
• Caseworker-assigned discharge plans to prevent hospital readmission for acute exacerbations in children with chronic respiratory illness.1 passage
• Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.1 passage
• Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients.1 passage
• Celecoxib for osteoarthritis.1 passage
• Celecoxib for rheumatoid arthritis.1 passage
• Cell salvage in emergency trauma surgery.1 passage
• Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.2 passages
• Central venous catheter (CVC) removal for patients of all ages with candidaemia.1 passage
• Cerebral near-infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults.1 passage
• Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants.1 passage
• Cerebrolysin for acute ischaemic stroke.4 passages
• Cerebrolysin for vascular dementia.1 passage
• Cerivastatin for lowering lipids.1 passage
• Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.1 passage
• Certolizumab pegol for induction of remission in Crohn's disease.1 passage
• Cervical assessment by ultrasound for preventing preterm delivery.1 passage
• Cervical ripening before first trimester surgical evacuation for non-viable pregnancy.1 passage
• Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy.1 passage
• Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies.1 passage
• Chelation for autism spectrum disorder (ASD).1 passage
• Chelation therapy for atherosclerotic cardiovascular disease.1 passage
• Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.1 passage
• Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.1 passage
• Chemotherapy and radiotherapy for advanced pancreatic cancer.1 passage
• Chemotherapy for advanced gastric cancer.1 passage
• Chemotherapy for advanced non-small cell lung cancer in the elderly population.1 passage
• Chemotherapy for children with medulloblastoma.1 passage
• Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.1 passage
• Chemotherapy for second-stage human African trypanosomiasis: drugs in use.1 passage
• Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.2 passages
• Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.1 passage
• Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.1 passage
• Chest physiotherapy for pneumonia in children.1 passage
• Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy.1 passage
• Chest ultrasonography versus supine chest radiography for diagnosis of pneumothorax in trauma patients in the emergency department.1 passage
• Chewing gum for enhancing early recovery of bowel function after caesarean section.1 passage
• Chewing gum for postoperative recovery of gastrointestinal function.1 passage
• Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.1 passage
• Chinese herbal medicine for menopausal symptoms.1 passage
• Chinese herbal medicine for oesophageal cancer.1 passage
• Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.2 passages
• Chinese herbal medicine for treating recurrent urinary tract infections in women.1 passage
• Chinese herbal medicines for hypothyroidism.1 passage
• Chinese herbal medicines for unexplained recurrent miscarriage.1 passage
• Chinese medicinal herbs for mumps.1 passage
• Chloral hydrate as a sedating agent for neurodiagnostic procedures in children.2 passages
• Chlorhexidine bathing of the critically ill for the prevention of hospital-acquired infection.1 passage
• Chlorhexidine mouthrinse as an adjunctive treatment for gingival health.1 passage
• Chlorhexidine skin or cord care for prevention of mortality and infections in neonates.1 passage
• Chlorhexidine treatment for the prevention of dental caries in children and adolescents.1 passage
• Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.1 passage
• Chlorpromazine dose for people with schizophrenia.1 passage
• Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.1 passage
• Chlorpromazine versus clotiapine for schizophrenia.1 passage
• Chlorpromazine versus metiapine for schizophrenia.1 passage
• Chlorpromazine versus penfluridol for schizophrenia.1 passage
• Chlorpromazine versus piperacetazine for schizophrenia.1 passage
• Chlorpromazine versus reserpine for schizophrenia.1 passage
• Cholinergic medication for antipsychotic-induced tardive dyskinesia.1 passage
• Cholinesterase inhibitors for rarer dementias associated with neurological conditions.1 passage
• Cholinesterase inhibitors for the treatment of delirium in non-ICU settings.1 passage
• Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.1 passage
• Chondroitin for osteoarthritis.1 passage
• Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum.1 passage
• Chronic disease management programmes for adults with asthma.1 passage
• Chronic non-invasive ventilation for chronic obstructive pulmonary disease.1 passage
• Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.1 passage
• Cilostazol for intermittent claudication.1 passage
• Circuit class therapy for improving mobility after stroke.1 passage
• Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.1 passage
• Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions.1 passage
• Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.1 passage
• Citicoline for treating people with acute ischemic stroke.1 passage
• Citrate salts for preventing and treating calcium containing kidney stones in adults.1 passage
• Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology.1 passage
• Client feedback in psychological therapy for children and adolescents with mental health problems.1 passage
• Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.1 passage
• Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people.1 passage
• Clinically-indicated replacement versus routine replacement of peripheral venous catheters.2 passages
• Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.1 passage
• Clobazam add-on therapy for drug-resistant epilepsy.1 passage
• Clobazam monotherapy for focal or generalized seizures.1 passage
• Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome.1 passage
• Clonazepam add-on therapy for drug-resistant epilepsy.1 passage
• Clonazepam add-on therapy for refractory epilepsy in adults and children.1 passage
• Clonazepam monotherapy for treating people with newly diagnosed epilepsy.1 passage
• Clonidine for pain in non-ventilated infants.1 passage
• Clonidine for sedation and analgesia for neonates receiving mechanical ventilation.1 passage
• Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.1 passage
• Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.1 passage
• Closure methods for laparotomy incisions for preventing incisional hernias and other wound complications.1 passage
• Closure methods of the appendix stump for complications during laparoscopic appendectomy.1 passage
• Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.1 passage
• Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.1 passage
• Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.1 passage
• Clozapine dose for schizophrenia.1 passage
• Clozapine for psychotic disorders in adults with intellectual disabilities.1 passage
• Co-bedding in neonatal nursery for promoting growth and neurodevelopment in stable preterm twins.1 passage
• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.1 passage
• Coblation versus other surgical techniques for tonsillectomy.1 passage
• Codeine versus placebo for chronic cough in children.1 passage
• Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents.1 passage
• Cognitive behavioural therapy (brief versus standard duration) for schizophrenia.1 passage
• Cognitive behavioural therapy for anxiety disorders in children and adolescents.2 passages
• Cognitive behavioural therapy for tinnitus.1 passage
• Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.1 passage
• Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia.1 passage
• Cognitive rehabilitation for attention deficits following stroke.1 passage
• Cognitive training for people with mild to moderate dementia.1 passage
• Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.1 passage
• Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.1 passage
• Cognitive-behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour.1 passage
• Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.1 passage
• Cognitive-behavioural treatment for subacute and chronic neck pain.1 passage
• Colchicine for acute gout.1 passage
• Colchicine for prevention of cardiovascular events.1 passage
• Colchicine for the treatment of COVID-19.1 passage
• Collaborative writing applications in healthcare: effects on professional practice and healthcare outcomes.1 passage
• Colloids versus crystalloids for fluid resuscitation in critically ill people.1 passage
• Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.1 passage
• Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.3 passages
• Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.1 passage
• Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.1 passage
• Combination of the non-invasive tests for the diagnosis of endometriosis.1 passage
• Combination pharmacotherapy for the treatment of fibromyalgia in adults.1 passage
• Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).1 passage
• Combined diet and exercise interventions for preventing gestational diabetes mellitus.1 passage
• Combined hormonal contraceptives for heavy menstrual bleeding.1 passage
• Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.1 passage
• Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.1 passage
• Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.1 passage
• Combined pharmacotherapy and behavioural interventions for smoking cessation.1 passage
• Combined proximal descending aortic endografting plus distal bare metal stenting (PETTICOAT technique) versus conventional proximal descending aortic stent graft repair for complicated type B aortic dissections.1 passage
• Combined spinal-epidural versus spinal anaesthesia for caesarean section.1 passage
• Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma.1 passage
• Communication interventions for autism spectrum disorder in minimally verbal children.1 passage
• Communication skills training for healthcare professionals working with people who have cancer.1 passage
• Communication skills training for mental health professionals working with people with severe mental illness.1 passage
• Community coalition-driven interventions to reduce health disparities among racial and ethnic minority populations.1 passage
• Community first responders for out-of-hospital cardiac arrest in adults and children.1 passage
• Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.1 passage
• Community pharmacy personnel interventions for smoking cessation.1 passage
• Community screening for visual impairment in older people.1 passage
• Community wide interventions for increasing physical activity.1 passage
• Community-based antibiotic delivery for possible serious bacterial infections in neonates in low- and middle-income countries.1 passage
• Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes.1 passage
• Community-based maternal and newborn educational care packages for improving neonatal health and survival in low- and middle-income countries.1 passage
• Community-based supplementary feeding for food insecure, vulnerable and malnourished populations - an overview of systematic reviews.1 passage
• Community-level interventions for improving access to food in low- and middle-income countries.1 passage
• Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.1 passage
• Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.1 passage
• Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.1 passage
• Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.1 passage
• Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.1 passage
• Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.1 passage
• Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.1 passage
• Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.1 passage
• Comparison of different protein concentrations of human milk fortifier for promoting growth and neurological development in preterm infants.1 passage
• Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.1 passage
• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.1 passage
• Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.1 passage
• Competitions for smoking cessation.1 passage
• Complementary and alternative therapies for post-caesarean pain.1 passage
• Complementary therapies for acne vulgaris.1 passage
• Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.1 passage
• Complex interventions for preventing diabetic foot ulceration.1 passage
• Comprehensive geriatric assessment for older adults admitted to hospital.1 passage
• Comprehensive geriatric assessment for older people admitted to a surgical service.1 passage
• Compression bandages or stockings versus no compression for treating venous leg ulcers.1 passage
• Compression stockings for preventing deep vein thrombosis in airline passengers.1 passage
• Compression therapy for prevention of post-thrombotic syndrome.1 passage
• Compression therapy for treating post-thrombotic syndrome.1 passage
• Compulsory community and involuntary outpatient treatment for people with severe mental disorders.1 passage
• Computed tomography for diagnosis of acute appendicitis in adults.1 passage
• Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.1 passage
• Computed tomography versus magnetic resonance imaging versus bone scintigraphy for clinically suspected scaphoid fractures in patients with negative plain radiographs.1 passage
• Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.1 passage
• Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia.1 passage
• Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults.1 passage
• Computer-based versus in-person interventions for preventing and reducing stress in workers.1 passage
• Computer-generated reminders delivered on paper to healthcare professionals: effects on professional practice and healthcare outcomes.1 passage
• Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.1 passage
• Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life.1 passage
• Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife.1 passage
• Computerised cognitive training for preventing dementia in people with mild cognitive impairment.1 passage
• Concomitant atrial fibrillation surgery for people undergoing cardiac surgery.1 passage
• Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.1 passage
• Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.2 passages
• Conjunctival autograft for pterygium.1 passage
• Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy.1 passage
• Conservative interventions for treating functional daytime urinary incontinence in children.1 passage
• Conservative interventions for treating middle third clavicle fractures in adolescents and adults.1 passage
• Conservative management following closed reduction of traumatic anterior dislocation of the shoulder.1 passage
• Conservative management for postprostatectomy urinary incontinence.1 passage
• Conservative management of oesophageal soft food bolus impaction.1 passage
• Constraint-induced movement therapy for upper extremities in people with stroke.1 passage
• Constraint-induced movement therapy in children with unilateral cerebral palsy.1 passage
• Consultation liaison in primary care for people with mental disorders.1 passage
• Contact tracing strategies in household and congregate environments to identify cases of tuberculosis in low- and moderate-incidence populations.1 passage
• Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.1 passage
• Continuing education meetings and workshops: effects on professional practice and healthcare outcomes.1 passage
• Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour.1 passage
• Continuous chest compression versus interrupted chest compression for cardiopulmonary resuscitation of non-asphyxial out-of-hospital cardiac arrest.1 passage
• Continuous distending pressure for respiratory distress in preterm infants.1 passage
• Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.1 passage
• Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.1 passage
• Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes.1 passage
• Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults.1 passage
• Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery.1 passage
• Continuous local anaesthetic wound infusion for postoperative pain after midline laparotomy for colorectal resection in adults.1 passage
• Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams.1 passage
• Continuous positive airway pressure (CPAP) for acute bronchiolitis in children.2 passages
• Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.1 passage
• Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.1 passage
• Continuous support for women during childbirth.1 passage
• Continuous veno-venous hemofiltration for severe acute pancreatitis.1 passage
• Continuous versus bolus intermittent intragastric tube feeding for preterm and low birth weight infants with gastro-oesophageal reflux disease.1 passage
• Continuous versus intermittent antibiotics for bronchiectasis.1 passage
• Contracting out to improve the use of clinical health services and health outcomes in low- and middle-income countries.1 passage
• Controlled cord traction for the third stage of labour.1 passage
• Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm.2 passages
• Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.3 passages
• Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.1 passage
• Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia.1 passage
• Conventional occlusion versus pharmacologic penalization for amblyopia.1 passage
• Cooling for cerebral protection during brain surgery.1 passage
• Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.1 passage
• Corneal collagen cross-linking for bacterial infectious keratitis.1 passage
• Corneal collagen cross-linking for treating keratoconus.1 passage
• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).1 passage
• Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.1 passage
• Corticosteroid implants for chronic non-infectious uveitis.1 passage
• Corticosteroid therapy for nephrotic syndrome in children.1 passage
• Corticosteroids as adjunctive therapy in the treatment of influenza.2 passages
• Corticosteroids as adjuvant therapy for ocular toxoplasmosis.1 passage
• Corticosteroids as standalone or add-on treatment for sore throat.1 passage
• Corticosteroids for Bell's palsy (idiopathic facial paralysis).1 passage
• Corticosteroids for Guillain-Barré syndrome.1 passage
• Corticosteroids for acute bacterial meningitis.1 passage
• Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery).1 passage
• Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.2 passages
• Corticosteroids for managing tuberculous meningitis.1 passage
• Corticosteroids for parasitic eosinophilic meningitis.1 passage
• Corticosteroids for periorbital and orbital cellulitis.1 passage
• Corticosteroids for pneumonia.1 passage
• Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term.1 passage
• Corticosteroids for septic arthritis in children.1 passage
• Corticosteroids for the common cold.1 passage
• Corticosteroids for the management of cancer-related pain in adults.1 passage
• Corticosteroids for the treatment of Duchenne muscular dystrophy.1 passage
• Corticosteroids for the treatment of Kawasaki disease in children.1 passage
• Corticosteroids for treating nerve damage in leprosy.1 passage
• Corticosteroids for treating optic neuritis.1 passage
• Corticosteroids for treating sepsis in children and adults.1 passage
• Corticosteroids for treating sepsis.1 passage
• Corticosteroids for tuberculous pleurisy.1 passage
• Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms.1 passage
• Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation.1 passage
• Cough augmentation techniques for people with chronic neuromuscular disorders.1 passage
• Couple and family therapies for post-traumatic stress disorder (PTSD).1 passage
• Couple therapy for depression.1 passage
• Crisis intervention for people with severe mental illnesses.1 passage
• Cromolyn sodium for the prevention of chronic lung disease in preterm infants.1 passage
• Cryotherapy for liver metastases.1 passage
• Cuffed versus uncuffed endotracheal tubes for general anaesthesia in children aged eight years and under.1 passage
• Culture media for human pre-implantation embryos in assisted reproductive technology cycles.1 passage
• Culture-specific programs for children and adults from minority groups who have asthma.1 passage
• Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed.1 passage
• Cyanoacrylate microbial sealants for skin preparation prior to surgery.1 passage
• Cyclamen europaeum extract for acute sinusitis.1 passage
• Cycle regimens for frozen-thawed embryo transfer.1 passage
• Cycled light in the intensive care unit for preterm and low birth weight infants.1 passage
• Cyclical progestogens for heavy menstrual bleeding.1 passage
• Cycling infrastructure for reducing cycling injuries in cyclists.1 passage
• Cyclo-oxygenase (COX) inhibitors for treating preterm labour.1 passage
• Cyclodestructive procedures for non-refractory glaucoma.1 passage
• Cyclodestructive procedures for refractory glaucoma.1 passage
• Cyclophosphamide for connective tissue disease-associated interstitial lung disease.1 passage
• Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.1 passage
• Cytology versus HPV testing for cervical cancer screening in the general population.1 passage
• D-dimer test for excluding the diagnosis of pulmonary embolism.1 passage
• Daikenchuto for reducing postoperative ileus in patients undergoing elective abdominal surgery.1 passage
• Daily iron supplementation for improving anaemia, iron status and health in menstruating women.1 passage
• Daily oral iron supplementation during pregnancy.1 passage
• Dance movement therapy for dementia.1 passage
• Dance movement therapy for depression.1 passage
• Dance/movement therapy for improving psychological and physical outcomes in cancer patients.1 passage
• Day care as a strategy for drowning prevention in children under 6 years of age in low- and middle-income countries.1 passage
• Day care versus in-patient surgery for age-related cataract.1 passage
• Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection.1 passage
• De-escalation techniques for managing non-psychosis induced aggression in adults.1 passage
• De-escalation techniques for psychosis-induced aggression or agitation.1 passage
• De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.1 passage
• Death audits and reviews for reducing maternal, perinatal and child mortality.1 passage
• Debridement for venous leg ulcers.1 passage
• Debriefing interventions for the prevention of psychological trauma in women following childbirth.1 passage
• Decision aids for people considering taking part in clinical trials.1 passage
• Decision aids for people facing health treatment or screening decisions.1 passage
• Decision coaching for people making healthcare decisions.1 passage
• Decision-support tools via mobile devices to improve quality of care in primary healthcare settings.1 passage
• Decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury.1 passage
• Deep brain and cortical stimulation for epilepsy.1 passage
• Deep brain stimulation for dystonia.1 passage
• Deferasirox for managing iron overload in people with thalassaemia.1 passage
• Degarelix for treating advanced hormone-sensitive prostate cancer.1 passage
• Dehydroepiandrosterone for women in the peri- or postmenopausal phase.1 passage
• Delayed antibiotic prescriptions for respiratory infections.1 passage
• Deliberate hypotension with propofol under anaesthesia for functional endoscopic sinus surgery (FESS).1 passage
• Delivery arrangements for health systems in low-income countries: an overview of systematic reviews.1 passage
• Dental cavity liners for Class I and Class II resin-based composite restorations.2 passages
• Deprescribing versus continuation of chronic proton pump inhibitor use in adults.1 passage
• Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.1 passage
• Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure.1 passage
• Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders.2 passages
• Desmopressin for treating nocturia in men.1 passage
• Desmopressin use for minimising perioperative blood transfusion.1 passage
• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.1 passage
• Device-modified trabeculectomy for glaucoma.1 passage
• Devices and dressings to secure peripheral venous catheters to prevent complications.1 passage
• Devices for preventing percutaneous exposure injuries caused by needles in healthcare personnel.1 passage
• Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance.1 passage
• Dexamethasone as an adjuvant to peripheral nerve block.1 passage
• Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer.1 passage
• Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.1 passage
• Diagnostic test accuracy of jolt accentuation for headache in acute meningitis in the emergency setting.1 passage
• Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment.1 passage
• Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.2 passages
• Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis.1 passage
• Diaphragm-triggered non-invasive respiratory support in preterm infants.1 passage
• Diet and exercise interventions for preventing gestational diabetes mellitus.1 passage
• Diet or exercise, or both, for preventing excessive weight gain in pregnancy.1 passage
• Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.1 passage
• Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.1 passage
• Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.1 passage
• Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years.1 passage
• Dietary advice for people with schizophrenia.1 passage
• Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus.1 passage
• Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas.1 passage
• Dietary fibre for the primary prevention of cardiovascular disease.1 passage
• Dietary interventions for adult cancer survivors.1 passage
• Dietary interventions for adults with chronic kidney disease.1 passage
• Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.1 passage
• Dietary interventions for mineral and bone disorder in people with chronic kidney disease.1 passage
• Dietary interventions for multiple sclerosis-related outcomes.1 passage
• Dietary interventions for phenylketonuria.1 passage
• Dietary interventions for recurrent abdominal pain in childhood.1 passage
• Dietary modifications for infantile colic.1 passage
• Dietary supplements for chronic gout.1 passage
• Dietary supplements for dysmenorrhoea.1 passage
• Different antibiotic treatments for group A streptococcal pharyngitis.1 passage
• Different classes of antibiotics given to women routinely for preventing infection at caesarean section.1 passage
• Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders.1 passage
• Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy.1 passage
• Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.1 passage
• Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.1 passage
• Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.1 passage
• Different infusion durations for preventing platinum-induced hearing loss in children with cancer.3 passages
• Different insulin types and regimens for pregnant women with pre-existing diabetes.1 passage
• Different intensities of glycaemic control for pregnant women with pre-existing diabetes.1 passage
• Different intensities of glycaemic control for women with gestational diabetes mellitus.1 passage
• Different lasers and techniques for proliferative diabetic retinopathy.1 passage
• Different methods and settings for glucose monitoring for gestational diabetes during pregnancy.1 passage
• Different oral corticosteroid regimens for acute asthma.1 passage
• Different strategies for diagnosing gestational diabetes to improve maternal and infant health.2 passages
• Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour.1 passage
• Different types of dietary advice for women with gestational diabetes mellitus.1 passage
• Different types of implants for reconstructive breast surgery.1 passage
• Different types of intranasal steroids for chronic rhinosinusitis.1 passage
• Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization.1 passage
• Different-sized incisions for phacoemulsification in age-related cataract.1 passage
• Digital contact tracing technologies in epidemics: a rapid review.1 passage
• Digital interventions for the management of chronic obstructive pulmonary disease.1 passage
• Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders.1 passage
• Dilute versus full-strength formula in exclusively formula-fed preterm or low birth weight infants.1 passage
• Dimercaptosuccinic acid scan or ultrasound in screening for vesicoureteral reflux among children with urinary tract infections.1 passage
• Dimethyl fumarate for multiple sclerosis.1 passage
• Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.1 passage
• Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.1 passage
• Direct composite resin fillings versus amalgam fillings for permanent posterior teeth.1 passage
• Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.1 passage
• Direct-acting antivirals for chronic hepatitis C.2 passages
• Directed preconception health programs and interventions for improving pregnancy outcomes for women who are overweight or obese.1 passage
• Directly observed therapy for treating tuberculosis.1 passage
• Discharge planning from hospital.1 passage
• Discontinuation of intravenous oxytocin in the active phase of induced labour.1 passage
• Disease management interventions for heart failure.1 passage
• Disease-modifying treatments for primary autoimmune haemolytic anaemia.1 passage
• Disposable surgical face masks for preventing surgical wound infection in clean surgery.1 passage
• Diuretics for transient tachypnoea of the newborn.1 passage
• Doctors or mid-level providers for abortion.1 passage
• Donepezil for dementia due to Alzheimer's disease.1 passage
• Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history.1 passage
• Dopamine agonists for preventing ovarian hyperstimulation syndrome.2 passages
• Dopamine agonists for the treatment of cocaine dependence.1 passage
• Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.1 passage
• Dornase alfa for cystic fibrosis.3 passages
• Double versus single intrauterine insemination (IUI) in stimulated cycles for subfertile couples.1 passage
• Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.1 passage
• Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.1 passage
• Dressings and securement devices for central venous catheters (CVC).1 passage
• Dressings and topical agents for arterial leg ulcers.2 passages
• Dressings and topical agents for preventing pressure ulcers.1 passage
• Dressings and topical agents for treating pressure ulcers.1 passage
• Dressings and topical agents for treating venous leg ulcers.1 passage
• Dressings for the prevention of surgical site infection.1 passage
• Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews.1 passage
• Droperidol for psychosis-induced aggression or agitation.1 passage
• Drug interventions for the treatment of obesity in children and adolescents.1 passage
• Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.1 passage
• Drug therapies for reducing gastric acidity in people with cystic fibrosis.2 passages
• Drug therapy for chronic idiopathic axonal polyneuropathy.1 passage
• Drug therapy for delirium in terminally ill adults.1 passage
• Drug therapy for symptoms associated with anxiety in adult palliative care patients.1 passage
• Drug therapy for treating post-dural puncture headache.1 passage
• Drug treatment for spinal muscular atrophy type I.1 passage
• Drug treatment for spinal muscular atrophy types II and III.1 passage
• Drug treatments for managing cystic fibrosis-related diabetes.1 passage
• Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.1 passage
• Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.1 passage
• Drug-eluting stents versus bare-metal stents for acute coronary syndrome.1 passage
• Drugs for discoid lupus erythematosus.1 passage
• Drugs for preventing lung cancer in healthy people.1 passage
• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.1 passage
• Drugs for preventing red blood cell dehydration in people with sickle cell disease.2 passages
• Drugs for the acute treatment of migraine in children and adolescents.1 passage
• Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.1 passage
• Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).1 passage
• Dual antibiotics for bronchiectasis.1 passage
• Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.1 passage
• Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitis.1 passage
• Duration of intravenous antibiotic therapy in people with cystic fibrosis.1 passage
• Duration of treatment for asymptomatic bacteriuria during pregnancy.1 passage
• E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions.1 passage
• E-learning for health professionals.1 passage
• EEG for children with complex febrile seizures.3 passages
• Ear drops for the removal of ear wax.1 passage
• Early (&lt; 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.1 passage
• Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.1 passage
• Early additional food and fluids for healthy breastfed full-term infants.1 passage
• Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.1 passage
• Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.1 passage
• Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.1 passage
• Early discharge hospital at home.1 passage
• Early discharge with home support of gavage feeding for stable preterm infants who have not established full oral feeds.1 passage
• Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.1 passage
• Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without supplemental parenteral nutrition in critically ill adults.1 passage
• Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.1 passage
• Early erythropoiesis-stimulating agents in preterm or low birth weight infants.2 passages
• Early fortification of human milk versus late fortification to promote growth in preterm infants.1 passage
• Early full enteral feeding for preterm or low birth weight infants.1 passage
• Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD).1 passage
• Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit.1 passage
• Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.1 passage
• Early palliative care for adults with advanced cancer.1 passage
• Early planned removal of umbilical venous catheters to prevent infection in newborn infants.1 passage
• Early planned removal versus expectant management of peripherally inserted central catheters to prevent infection in newborn infants.1 passage
• Early postnatal discharge from hospital for healthy mothers and term infants.1 passage
• Early removal versus expectant management of central venous catheters in neonates with bloodstream infection.1 passage
• Early skin-to-skin contact for mothers and their healthy newborn infants.1 passage
• Early supported discharge services for people with acute stroke.1 passage
• Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.1 passage
• Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.1 passage
• Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.1 passage
• Early versus delayed appendicectomy for appendiceal phlegmon or abscess.1 passage
• Early versus delayed continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.1 passage
• Early versus delayed dressing removal after primary closure of clean and clean-contaminated surgical wounds.1 passage
• Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.1 passage
• Early versus delayed post-operative bathing or showering to prevent wound complications.1 passage
• Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.2 passages
• Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.1 passage
• Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.1 passage
• Early versus late parenteral nutrition for critically ill term and late preterm infants.1 passage
• Early versus late removal of the laryngeal mask airway (LMA) for general anaesthesia.1 passage
• Early versus late tracheostomy for critically ill patients.1 passage
• Early versus late ureteric stent removal after kidney transplantation.1 passage
• Early warning systems and rapid response systems for the prevention of patient deterioration on acute adult hospital wards.1 passage
• Education and training for preventing and minimizing workplace aggression directed toward healthcare workers.1 passage
• Education and training for preventing sharps injuries and splash exposures in healthcare workers.1 passage
• Education for contraceptive use by women after childbirth.1 passage
• Education of family members to support weaning to solids and nutrition in infants born preterm.1 passage
• Education of family members to support weaning to solids and nutrition in later infancy in term-born infants.1 passage
• Education of healthcare professionals for preventing pressure ulcers.1 passage
• Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.1 passage
• Educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under.1 passage
• Educational interventions for the management of cancer-related fatigue in adults.1 passage
• Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.1 passage
• Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.1 passage
• Effect of administration of antihelminthics for soil-transmitted helminths during pregnancy.1 passage
• Effect of alcohol on blood pressure.1 passage
• Effect of atorvastatin on testosterone levels.1 passage
• Effect of cocoa on blood pressure.1 passage
• Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy.1 passage
• Effect of partograph use on outcomes for women in spontaneous labour at term and their babies.1 passage
• Effect of restricted pacifier use in breastfeeding term infants for increasing duration of breastfeeding.1 passage
• Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.1 passage
• Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.1 passage
• Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.2 passages
• Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.1 passage
• Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.1 passage
• Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation.1 passage
• Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.1 passage
• Effectiveness of brief alcohol interventions in primary care populations.1 passage
• Effectiveness of posterior decompression techniques compared with conventional laminectomy for lumbar stenosis.1 passage
• Effectiveness of provision of animal-source foods for supporting optimal growth and development in children 6 to 59 months of age.1 passage
• Effectiveness of psychosocial interventions for reducing parental substance misuse.1 passage
• Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia.1 passage
• Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer.1 passage
• Effects and safety of periconceptional oral folate supplementation for preventing birth defects.1 passage
• Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)).1 passage
• Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation.1 passage
• Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.2 passages
• Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.1 passage
• Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age.1 passage
• Effects of peri-operative nonsteroidal anti-inflammatory drugs on post-operative kidney function for adults with normal kidney function.1 passage
• Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes.1 passage
• Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants.1 passage
• Effects of total fat intake on body fatness in adults.1 passage
• Effects of total fat intake on body weight.1 passage
• Effects of total fat intake on bodyweight in children.2 passages
• Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.1 passage
• Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat.1 passage
• Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.1 passage
• Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.1 passage
• Elective repeat caesarean section versus induction of labour for women with a previous caesarean birth.1 passage
• Electrical conductance for the detection of dental caries.1 passage
• Electrical stimulation for treating pressure ulcers.1 passage
• Electrical stimulation with non-implanted devices for stress urinary incontinence in women.1 passage
• Electrical stimulation with non-implanted electrodes for overactive bladder in adults.2 passages
• Electrocoagulation for liver metastases.1 passage
• Electroconvulsive therapy for treatment-resistant schizophrenia.1 passage
• Electromagnetic therapy for treating pressure ulcers.1 passage
• Electromagnetic therapy for treating venous leg ulcers.1 passage
• Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke.2 passages
• Electromechanical-assisted training for walking after stroke.2 passages
• Electronic cigarettes for smoking cessation.3 passages
• Electrotherapy modalities for rotator cuff disease.1 passage
• Elevation of the head during intensive care management in people with severe traumatic brain injury.1 passage
• Eliciting adverse effects data from participants in clinical trials.1 passage
• Email for clinical communication between healthcare professionals.1 passage
• Embolisation for pulmonary arteriovenous malformation.2 passages
• Emergency ultrasound-based algorithms for diagnosing blunt abdominal trauma.1 passage
• Emollients and moisturisers for eczema.1 passage
• Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.1 passage
• End-of-life care pathways for improving outcomes in caring for the dying.1 passage
• Endodontic procedures for retreatment of periapical lesions.1 passage
• Endoluminal interventions versus surgical interventions for stenosis in vein grafts following infrainguinal bypass.1 passage
• Endometrial biomarkers for the non-invasive diagnosis of endometriosis.1 passage
• Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction.1 passage
• Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination.2 passages
• Endometrial injury in women undergoing assisted reproductive techniques.1 passage
• Endometrial injury in women undergoing in vitro fertilisation (IVF).1 passage
• Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes.1 passage
• Endometrial resection and ablation techniques for heavy menstrual bleeding.1 passage
• Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.2 passages
• Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction.1 passage
• Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure.1 passage
• Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension.1 passage
• Endoscopic or surgical intervention for painful obstructive chronic pancreatitis.1 passage
• Endoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones.1 passage
• Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.1 passage
• Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.1 passage
• Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH).1 passage
• Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones.1 passage
• Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants.1 passage
• Endothelin receptor antagonists for pulmonary arterial hypertension.1 passage
• Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage.1 passage
• Endovascular repair versus open repair for inflammatory abdominal aortic aneurysms.1 passage
• Endovascular revascularisation versus conservative management for intermittent claudication.1 passage
• Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.1 passage
• Endovascular thrombectomy and intra-arterial interventions for acute ischaemic stroke.1 passage
• Endovascular treatment for ruptured abdominal aortic aneurysm.1 passage
• Endovascular versus open repair of asymptomatic popliteal artery aneurysm.1 passage
• Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins.1 passage
• Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgery.1 passage
• Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery.2 passages
• Enhancing partner support to improve smoking cessation.1 passage
• Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates.1 passage
• Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.2 passages
• Enteral nutrition for maintenance of remission in Crohn's disease.1 passage
• Enteral nutrition formulations for acute pancreatitis.1 passage
• Enteral nutritional therapy for induction of remission in Crohn's disease.1 passage
• Enteral tube feeding for cystic fibrosis.2 passages
• Enteral tube feeding for people with severe dementia.1 passage
• Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for adults in the intensive care unit.1 passage
• Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.1 passage
• Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment.1 passage
• Environmental and behavioural modifications for improving food and fluid intake in people with dementia.1 passage
• Environmental enrichment for stroke and other non-progressive brain injury.1 passage
• Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health.1 passage
• Enzyme replacement and substrate reduction therapy for Gaucher disease.1 passage
• Enzyme replacement therapy for Anderson-Fabry disease.1 passage
• Enzyme replacement therapy for infantile-onset Pompe disease.1 passage
• Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI.2 passages
• Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome).1 passage
• Enzyme replacement therapy with laronidase (Aldurazyme1 passage
• Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.1 passage
• Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.1 passage
• Epidermal growth factor receptor blockers for the treatment of ovarian cancer.1 passage
• Epidural analgesia for adults undergoing cardiac surgery with or without cardiopulmonary bypass.1 passage
• Epidural analgesia versus patient-controlled intravenous analgesia for pain following intra-abdominal surgery in adults.1 passage
• Epidural corticosteroid injections for lumbosacral radicular pain.1 passage
• Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery.1 passage
• Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery.1 passage
• Epidural therapy for the treatment of severe pre-eclampsia in non labouring women.1 passage
• Epidural versus non-epidural or no analgesia for pain management in labour.1 passage
• Epinephrine for transient tachypnea of the newborn.1 passage
• Eplerenone for hypertension.1 passage
• Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.1 passage
• Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.2 passages
• Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.1 passage
• Ergonomic interventions for preventing musculoskeletal disorders in dental care practitioners.1 passage
• Ergonomic interventions for preventing work-related musculoskeletal disorders of the upper limb and neck among office workers.1 passage
• Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.1 passage
• Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.1 passage
• Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy.1 passage
• Eszopiclone for insomnia.1 passage
• Ethanol for preventing preterm birth in threatened preterm labor.1 passage
• Ethical case interventions for adult patients.1 passage
• Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.3 passages
• Etrolizumab for induction of remission in ulcerative colitis.1 passage
• Exercise for cancer cachexia in adults.1 passage
• Exercise for dysmenorrhoea.1 passage
• Exercise for haemophilia.1 passage
• Exercise for hand osteoarthritis.1 passage
• Exercise for improving outcomes after osteoporotic vertebral fracture.1 passage
• Exercise for intermittent claudication.1 passage
• Exercise for osteoarthritis of the knee.1 passage
• Exercise for pregnant women with gestational diabetes for improving maternal and fetal outcomes.1 passage
• Exercise for pregnant women with pre-existing diabetes for improving maternal and fetal outcomes.1 passage
• Exercise for preventing falls in older people living in the community.1 passage
• Exercise for reducing falls in people living with and beyond cancer.1 passage
• Exercise for rheumatoid arthritis of the hand.1 passage
• Exercise for treating patellofemoral pain syndrome.1 passage
• Exercise for women receiving adjuvant therapy for breast cancer.1 passage
• Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.1 passage
• Exercise interventions for cerebral palsy.1 passage
• Exercise interventions for people undergoing multimodal cancer treatment that includes surgery.1 passage
• Exercise interventions for smoking cessation.1 passage
• Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults.1 passage
• Exercise programmes for ankylosing spondylitis.1 passage
• Exercise programs for people with dementia.1 passage
• Exercise rehabilitation following intensive care unit discharge for recovery from critical illness.1 passage
• Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.1 passage
• Exercise therapy for chronic fatigue syndrome.2 passages
• Exercise therapy for chronic low back pain.1 passage
• Exercise therapy for fatigue in multiple sclerosis.1 passage
• Exercise training for adult lung transplant recipients.1 passage
• Exercise training for advanced lung cancer.1 passage
• Exercise training for bronchiectasis.1 passage
• Exercise training to improve exercise capacity and quality of life in people with non-malignant dust-related respiratory diseases.1 passage
• Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer.1 passage
• Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections.1 passage
• Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections.1 passage
• Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator.1 passage
• Exercise-based cardiac rehabilitation for adults after heart valve surgery.2 passages
• Exercise-based cardiac rehabilitation for adults with atrial fibrillation.1 passage
• Exercise-based cardiac rehabilitation for adults with heart failure.1 passage
• Exercise-based cardiac rehabilitation for adults with stable angina.1 passage
• Exercise-based cardiac rehabilitation for coronary heart disease.2 passages
• Exercise-based cardiac rehabilitation for people with implantable ventricular assist devices.1 passage
• Exercise-based cardiac rehabilitation in heart transplant recipients.1 passage
• Exercise-based rehabilitation programmes for pulmonary hypertension.1 passage
• Exercises for mechanical neck disorders.1 passage
• Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.1 passage
• Exhaled nitric oxide levels to guide treatment for children with asthma.1 passage
• Expedited versus conservative approaches for vaginal delivery in breech presentation.1 passage
• Exposure to the smell and taste of milk to accelerate feeding in preterm infants.1 passage
• Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma.1 passage
• Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.1 passage
• Extended-field radiotherapy for locally advanced cervical cancer.1 passage
• Extent of lymph node dissection for adenocarcinoma of the stomach.1 passage
• External beam radiation dose escalation for high grade glioma.2 passages
• External beam radiotherapy for unresectable hepatocellular carcinoma.1 passage
• External cephalic version for breech presentation at term.1 passage
• External cephalic version for breech presentation before term.1 passage
• External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults.1 passage
• External inspection of compliance with standards for improved healthcare outcomes.1 passage
• Extracorporeal membrane oxygenation for critically ill adults.1 passage
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.1 passage
• Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.1 passage
• Extracorporeal shock wave therapy for the healing and management of venous leg ulcers.1 passage
• Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.1 passage
• Face washing promotion for preventing active trachoma.1 passage
• Face-to-face interventions for informing or educating parents about early childhood vaccination.1 passage
• Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.1 passage
• Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative evidence synthesis.1 passage
• Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.1 passage
• Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence-synthesis.1 passage
• Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.1 passage
• Factors that influence the provision of intrapartum and postnatal care by skilled birth attendants in low- and middle-income countries: a qualitative evidence synthesis.1 passage
• Families and Schools Together (FAST) for improving outcomes for children and their families.1 passage
• Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke.1 passage
• Family therapy approaches for anorexia nervosa.2 passages
• Family therapy for autism spectrum disorders.1 passage
• Family-based prevention programmes for alcohol use in young people.1 passage
• Family-based programmes for preventing smoking by children and adolescents.1 passage
• Fasting for haemostasis in children with gastrointestinal bleeding.1 passage
• Fat supplementation of human milk for promoting growth in preterm infants.2 passages
• Fecal transplantation for treatment of inflammatory bowel disease.1 passage
• Feed thickener for infants up to six months of age with gastro-oesophageal reflux.1 passage
• Felbamate add-on therapy for drug-resistant focal epilepsy.1 passage
• Felbamate as an add-on therapy for refractory partial epilepsy.1 passage
• Fentanyl for neuropathic pain in adults.1 passage
• Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia.1 passage
• Fetal and umbilical Doppler ultrasound in high-risk pregnancies.1 passage
• Fetal and umbilical Doppler ultrasound in normal pregnancy.1 passage
• Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health.1 passage
• Fetal electrocardiogram (ECG) for fetal monitoring during labour.1 passage
• Fetal fibronectin testing for reducing the risk of preterm birth.1 passage
• Fetal movement counting for assessment of fetal wellbeing.1 passage
• Fibrates for primary prevention of cardiovascular disease events.1 passage
• Fibrates for secondary prevention of cardiovascular disease and stroke.1 passage
• Fibrin glue for pilonidal sinus disease.1 passage
• Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery.1 passage
• Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery.3 passages
• Final-impression techniques and materials for making complete and removable partial dentures.1 passage
• Financial arrangements for health systems in low-income countries: an overview of systematic reviews.1 passage
• Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality.1 passage
• Fingolimod for relapsing-remitting multiple sclerosis.1 passage
• First aid glucose administration routes for symptomatic hypoglycaemia.1 passage
• First aid interventions by laypeople for acute oral poisoning.1 passage
• First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.1 passage
• First rank symptoms for schizophrenia.1 passage
• First trimester serum tests for Down's syndrome screening.1 passage
• First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.1 passage
• First-line chemotherapy in low-risk gestational trophoblastic neoplasia.1 passage
• First-line combination therapy versus first-line monotherapy for primary hypertension.2 passages
• First-line drugs for hypertension.1 passage
• First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.2 passages
• First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.2 passages
• Fish oil for kidney transplant recipients.1 passage
• Fitness training for cardiorespiratory conditioning after traumatic brain injury.1 passage
• Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.1 passage
• Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.1 passage
• Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis.1 passage
• Flexibility exercise training for adults with fibromyalgia.1 passage
• Fludrocortisone for orthostatic hypotension.1 passage
• Fluid and pharmacological agents for adhesion prevention after gynaecological surgery.1 passage
• Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.2 passages
• Fluid restriction for treatment of preterm infants with chronic lung disease.1 passage
• Fluid restriction in the management of transient tachypnea of the newborn.1 passage
• Fluid supplementation for neonatal unconjugated hyperbilirubinaemia.1 passage
• Fluid therapy for acute bacterial meningitis.1 passage
• Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.2 passages
• Fluorescence devices for the detection of dental caries.1 passage
• Fluoridated milk for preventing dental caries.1 passage
• Fluoride gels for preventing dental caries in children and adolescents.1 passage
• Fluoride mouthrinses for preventing dental caries in children and adolescents.1 passage
• Fluoride supplementation (with tablets, drops, lozenges or chewing gum) in pregnant women for preventing dental caries in the primary teeth of their children.1 passage
• Fluoride toothpastes of different concentrations for preventing dental caries.1 passage
• Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment.1 passage
• Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.1 passage
• Fluoxetine for adults who are overweight or obese.1 passage
• Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.1 passage
• Fluphenazine (oral) versus placebo for schizophrenia.1 passage
• Fluphenazine decanoate (depot) and enanthate for schizophrenia.1 passage
• Fluvastatin for lowering lipids.1 passage
• Fly control to prevent diarrhoea in children.1 passage
• Foam dressings for treating pressure ulcers.1 passage
• Foam surfaces for preventing pressure ulcers.1 passage
• Focal laser treatment in addition to chemotherapy for retinoblastoma.1 passage
• Folate supplementation in people with sickle cell disease.2 passages
• Follicular flushing during oocyte retrieval in assisted reproductive techniques.1 passage
• Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors.1 passage
• Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.1 passage
• Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.1 passage
• Follow-up strategies for patients treated for non-metastatic colorectal cancer.2 passages
• Follow-up strategies for women treated for early breast cancer.1 passage
• Food fortification with multiple micronutrients: impact on health outcomes in general population.1 passage
• Food supplementation for improving the physical and psychosocial health of socio-economically disadvantaged children aged three months to five years.1 passage
• Formula versus donor breast milk for feeding preterm or low birth weight infants.2 passages
• Formula versus maternal breast milk for feeding preterm or low birth weight infants.1 passage
• Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.2 passages
• Fortification of maize flour with iron for controlling anaemia and iron deficiency in populations.1 passage
• Fortification of rice with vitamins and minerals for addressing micronutrient malnutrition.1 passage
• Fortification of staple foods with vitamin A for vitamin A deficiency.1 passage
• Fortification of staple foods with zinc for improving zinc status and other health outcomes in the general population.1 passage
• Fortification of wheat and maize flour with folic acid for population health outcomes.1 passage
• Fraction size in radiation therapy for breast conservation in early breast cancer.1 passage
• Frenotomy for tongue-tie in newborn infants.1 passage
• Frequency of dressing changes for central venous access devices on catheter-related infections.1 passage
• Frequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newborns.1 passage
• Fresh frozen plasma for cardiovascular surgery.1 passage
• Fresh versus frozen embryo transfers in assisted reproduction.2 passages
• Full publication of results initially presented in abstracts.1 passage
• Full-mouth treatment modalities (within 24 hours) for chronic periodontitis in adults.1 passage
• Fulvestrant for hormone-sensitive metastatic breast cancer.1 passage
• Fundal pressure during the second stage of labour.1 passage
• GLP-1 receptor agonists for Parkinson's disease.1 passage
• GM-CSF (granulocyte macrophage colony-stimulating factor) supplementation in culture media for women undergoing assisted reproduction.1 passage
• Gabapentin add-on treatment for drug-resistant focal epilepsy.2 passages
• Gabapentin for chronic neuropathic pain in adults.1 passage
• Gabapentin for fibromyalgia pain in adults.1 passage
• Galactomannan detection for invasive aspergillosis in immunocompromised patients.1 passage
• Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.1 passage
• Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.1 passage
• Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.2 passages
• Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.1 passage
• Ganoderma lucidum (Reishi mushroom) for cancer treatment.1 passage
• Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors.1 passage
• Gases for establishing pneumoperitoneum during laparoscopic abdominal surgery.1 passage
• Gefitinib for advanced non-small cell lung cancer.1 passage
• Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.1 passage
• Gene therapy for haemophilia.2 passages
• Gene therapy for peripheral arterial disease.1 passage
• Gene therapy for sickle cell disease.3 passages
• General health checks in adults for reducing morbidity and mortality from disease.1 passage
• Genetic testing for prevention of severe drug-induced skin rash.1 passage
• Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.1 passage
• Ghrelin for the management of cachexia associated with cancer.1 passage
• Ginseng for erectile dysfunction.1 passage
• Giving women their own case notes to carry during pregnancy.1 passage
• Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.1 passage
• Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.1 passage
• Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI.1 passage
• Glucocorticoid with cyclophosphamide for oral paraquat poisoning.1 passage
• Glucocorticoids for croup in children.1 passage
• Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.2 passages
• Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy.1 passage
• Glucocorticosteroids for people with alcoholic hepatitis.2 passages
• Glucose targets for preventing diabetic kidney disease and its progression.1 passage
• Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.2 passages
• Glutamine for induction of remission in Crohn's disease.1 passage
• Glutamine supplementation to prevent morbidity and mortality in preterm infants.1 passage
• Glycerin laxatives for prevention or treatment of feeding intolerance in very low birth weight infants.1 passage
• Goal setting and strategies to enhance goal pursuit for adults with acquired disability participating in rehabilitation.1 passage
• Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.1 passage
• Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.1 passage
• Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.1 passage
• Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.1 passage
• Governance arrangements for health systems in low-income countries: an overview of systematic reviews.1 passage
• Government regulation of private health insurance.1 passage
• Graduated compression stockings for prevention of deep vein thrombosis.1 passage
• Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration.1 passage
• Graft interposition for preventing Frey's syndrome in patients undergoing parotidectomy.1 passage
• Graft type for femoro-popliteal bypass surgery.1 passage
• Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes.1 passage
• Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction.1 passage
• Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction.1 passage
• Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction.1 passage
• Green tea (Camellia sinensis) for the prevention of cancer.1 passage
• Grommets (ventilation tubes) for recurrent acute otitis media in children.1 passage
• Group behaviour therapy programmes for smoking cessation.1 passage
• Group versus conventional antenatal care for women.1 passage
• Group-based parent training programmes for improving emotional and behavioural adjustment in young children.1 passage
• Growth factors for angiogenesis in peripheral arterial disease.1 passage
• Growth factors for treating diabetic foot ulcers.1 passage
• Growth hormone for in vitro fertilisation (IVF).1 passage
• Growth hormone therapy for people with thalassaemia.2 passages
• Guanylate cyclase stimulators for pulmonary hypertension.1 passage
• Guided imagery for treating hypertension in pregnancy.1 passage
• HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.1 passage
• Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.1 passage
• Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.1 passage
• Haemostatic therapies for acute spontaneous intracerebral haemorrhage.1 passage
• Haloperidol discontinuation for people with schizophrenia.1 passage
• Haloperidol for long-term aggression in psychosis.1 passage
• Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).1 passage
• Haloperidol for the treatment of nausea and vomiting in palliative care patients.1 passage
• Haloperidol plus promethazine for psychosis-induced aggression.1 passage
• Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.1 passage
• Hand cleaning with ash for reducing the spread of viral and bacterial infections: a rapid review.1 passage
• Hand hygiene for the prevention of infections in neonates.2 passages
• Hand washing promotion for preventing diarrhoea.1 passage
• Hand-washing promotion for preventing diarrhoea.1 passage
• Harms of off-label erythropoiesis-stimulating agents for critically ill people.1 passage
• Head midline position for preventing the occurrence or extension of germinal matrix-intraventricular haemorrhage in preterm infants.1 passage
• Head midline position for preventing the occurrence or extension of germinal matrix-intraventricular hemorrhage in preterm infants.1 passage
• Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.1 passage
• Head-to-head trials of antibiotics for bronchiectasis.1 passage
• Health education interventions to promote early presentation and referral for women with symptoms of endometrial cancer.1 passage
• Health system and community level interventions for improving antenatal care coverage and health outcomes.1 passage
• Health workers' perceptions and experiences of using mHealth technologies to deliver primary healthcare services: a qualitative evidence synthesis.1 passage
• Health-improving interventions for obtaining employment in unemployed job seekers.1 passage
• Healthcare financing systems for increasing the use of tobacco dependence treatment.1 passage
• Healthcare stakeholders' perceptions and experiences of factors affecting the implementation of critical care telemedicine (CCT): qualitative evidence synthesis.1 passage
• Healthcare workers' perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis.1 passage
• Hearing aids for mild to moderate hearing loss in adults.1 passage
• Heat and moisture exchangers versus heated humidifiers for mechanically ventilated adults and children.1 passage
• Heated insufflation with or without humidification for laparoscopic abdominal surgery.1 passage
• Heated, humidified air for the common cold.1 passage
• Helicobacter pylori eradication for the prevention of gastric neoplasia.2 passages
• Helicopter emergency medical services for adults with major trauma.1 passage
• Heliox for croup in children.2 passages
• Heliox inhalation therapy for bronchiolitis in infants.1 passage
• Hematopoietic stem cell transplantation for Gaucher disease.1 passage
• Hematopoietic stem cell transplantation for people with sickle cell disease.2 passages
• Hematopoietic stem cell transplantation for people with ß-thalassaemia major.1 passage
• Hematopoietic stem cell transplantation for people with β-thalassaemia.1 passage
• Hemodialysis for lithium poisoning.1 passage
• Heparin for the prevention of intraventricular haemorrhage in preterm infants.1 passage
• Heparin for the treatment of thrombosis in neonates.1 passage
• Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children.1 passage
• Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.1 passage
• Hepatic late adverse effects after antineoplastic treatment for childhood cancer.1 passage
• Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.1 passage
• Herbal medicinal products or preparations for neuropathic pain.1 passage
• High feedback versus low feedback of prenatal ultrasound for reducing maternal anxiety and improving maternal health behaviour in pregnancy.1 passage
• High flow nasal cannula for respiratory support in preterm infants.1 passage
• High frequency jet ventilation versus high frequency oscillatory ventilation for pulmonary dysfunction in preterm infants.1 passage
• High initial concentration versus low initial concentration sevoflurane for inhalational induction of anaesthesia.1 passage
• High versus low medium chain triglyceride content of formula for promoting short-term growth of preterm infants.1 passage
• High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome.1 passage
• High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants.1 passage
• High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.1 passage
• High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.1 passage
• High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma.1 passage
• High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma.1 passage
• High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews.1 passage
• High-flow nasal cannulae for respiratory support in adult intensive care patients.2 passages
• High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome.1 passage
• High-frequency ultrasound for diagnosing skin cancer in adults.1 passage
• High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis.1 passage
• High-volume haemofiltration for sepsis in adults.1 passage
• Higher versus lower amino acid intake in parenteral nutrition for newborn infants.1 passage
• Higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit.1 passage
• Higher versus lower protein intake in formula-fed low birth weight infants.1 passage
• Histologic scoring indices for evaluation of disease activity in Crohn's disease.1 passage
• Histologic scoring indices for evaluation of disease activity in ulcerative colitis.1 passage
• Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age.1 passage
• Home or foster home care versus institutional long-term care for functionally dependent older people.1 passage
• Home parenteral nutrition for people with inoperable malignant bowel obstruction.1 passage
• Home telemonitoring and remote feedback between clinic visits for asthma.1 passage
• Home use of interdental cleaning devices, in addition to toothbrushing, for preventing and controlling periodontal diseases and dental caries.1 passage
• Home uterine monitoring for detecting preterm labour.2 passages
• Home versus hospital intravenous antibiotic therapy for cystic fibrosis.1 passage
• Home versus in-patient treatment for deep vein thrombosis.1 passage
• Home versus inpatient induction of labour for improving birth outcomes.1 passage
• Home-based chemically-induced whitening (bleaching) of teeth in adults.1 passage
• Home-based multidimensional survivorship programmes for breast cancer survivors.1 passage
• Home-based versus centre-based cardiac rehabilitation.2 passages
• Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections.1 passage
• Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness.1 passage
• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children.2 passages
• Homeopathy for treatment of irritable bowel syndrome.1 passage
• Homocysteine-lowering interventions for preventing cardiovascular events.2 passages
• Honey as a topical treatment for wounds.1 passage
• Honey for acute cough in children.1 passage
• Hormonal and intrauterine methods for contraception for women aged 25 years and younger.1 passage
• Hormonal contraceptives for contraception in overweight or obese women.1 passage
• Hormone replacement therapy after surgery for epithelial ovarian cancer.1 passage
• Hormone replacement therapy for women previously treated for endometrial cancer.1 passage
• Hormone therapy for preventing cardiovascular disease in post-menopausal women.1 passage
• Hospital at home: home-based end-of-life care.2 passages
• Hospital nurse-staffing models and patient- and staff-related outcomes.1 passage
• Hospitalisation in short-stay units for adults with internal medicine diseases and conditions.1 passage
• House dust mite reduction and avoidance measures for treating eczema.1 passage
• House modifications for preventing malaria.2 passages
• Household interventions for preventing domestic lead exposure in children.1 passage
• Household interventions for secondary prevention of domestic lead exposure in children.1 passage
• Human albumin infusion for treating oedema in people with nephrotic syndrome.1 passage
• Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation.1 passage
• Human milk-derived fortifier versus bovine milk-derived fortifier for prevention of mortality and morbidity in preterm neonates.1 passage
• Human resource management training of supervisors for improving health and well-being of employees.1 passage
• Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace.1 passage
• Humour-based interventions for people with schizophrenia.1 passage
• Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle.1 passage
• Hyaluronic acid in embryo transfer media for assisted reproductive technologies.1 passage
• Hybrid repair versus conventional open repair for aortic arch dissection.1 passage
• Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms.1 passage
• Hydrogel dressings for treating pressure ulcers.1 passage
• Hydromorphone for cancer pain.2 passages
• Hydromorphone for neuropathic pain in adults.1 passage
• Hydrosurgical debridement versus conventional surgical debridement for acute partial-thickness burns.1 passage
• Hydroxyurea (hydroxycarbamide) for sickle cell disease.1 passage
• Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia.1 passage
• Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.1 passage
• Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings.1 passage
• Hyperbaric oxygen therapy for acute coronary syndrome.1 passage
• Hyperbaric oxygen therapy for chronic wounds.1 passage
• Hyperbaric oxygen therapy for late radiation tissue injury.1 passage
• Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD).1 passage
• Hyperbaric oxygenation for tumour sensitisation to radiotherapy.1 passage
• Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.2 passages
• Hypertonic salt solution for peri-operative fluid management.1 passage
• Hypnosis for pain management during labour and childbirth.1 passage
• Hypnotherapy for smoking cessation.1 passage
• Hypofractionation for clinically localized prostate cancer.1 passage
• Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.2 passages
• Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation.1 passage
• Hypothermia for traumatic brain injury.1 passage
• Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.1 passage
• Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.1 passage
• Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.2 passages
• Ibuprofen for acute treatment of episodic tension-type headache in adults.1 passage
• Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.2 passages
• Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.3 passages
• Image-guided glucocorticoid injection versus injection without image guidance for shoulder pain.1 passage
• Imaging for the exclusion of pulmonary embolism in pregnancy.1 passage
• Imaging modalities for characterising focal pancreatic lesions.1 passage
• Imaging modalities for the detection of posterior pelvic floor disorders in women with obstructed defaecation syndrome.1 passage
• Imaging modalities for the non-invasive diagnosis of endometriosis.1 passage
• Imaging modalities to inform the detection and diagnosis of early caries.1 passage
• Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.2 passages
• Immediate postpartum insertion of intrauterine device for contraception.1 passage
• Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.1 passage
• Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.1 passage
• Immediate versus delayed postpartum insertion of contraceptive implant for contraception.1 passage
• Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.1 passage
• Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.1 passage
• Immersion in water during labour and birth.1 passage
• Immunoglobulin for alloimmune hemolytic disease in neonates.1 passage
• Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.1 passage
• Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.1 passage
• Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.1 passage
• Immunonutrition for acute respiratory distress syndrome (ARDS) in adults.1 passage
• Immunonutrition for patients undergoing surgery for head and neck cancer.1 passage
• Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.1 passage
• Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.1 passage
• Immunosuppressive agents for treating IgA nephropathy.2 passages
• Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis.2 passages
• Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.1 passage
• Immunosuppressive treatment for proliferative lupus nephritis.1 passage
• Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.2 passages
• Immunotherapy (oral and sublingual) for food allergy to fruits.1 passage
• Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.1 passage
• Immunotherapy for diabetic amyotrophy.1 passage
• Immunotherapy for metastatic renal cell carcinoma.1 passage
• Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes.1 passage
• Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.1 passage
• Impact of institutional smoking bans on reducing harms and secondhand smoke exposure.1 passage
• Impact of medication reconciliation for improving transitions of care.1 passage
• Impact of public release of performance data on the behaviour of healthcare consumers and providers.1 passage
• Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.1 passage
• Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.1 passage
• Implantable defibrillators versus medical therapy for cardiac channelopathies.1 passage
• Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope.1 passage
• Implantable miniature telescope (IMT) for vision loss due to end-stage age-related macular degeneration.1 passage
• Implanted spinal neuromodulation interventions for chronic pain in adults.1 passage
• Implementation interventions to promote the uptake of evidence-based practices in stroke rehabilitation.1 passage
• Implementation of treatment guidelines for specialist mental health care.1 passage
• Implementation strategies for health systems in low-income countries: an overview of systematic reviews.1 passage
• Improving adherence to Standard Precautions for the control of health care-associated infections.1 passage
• Improving vaccination uptake among adolescents.1 passage
• In defence of reviews of small trials: underpinning the generation of evidence to inform practice.1 passage
• In vitro fertilisation for unexplained subfertility.1 passage
• In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.1 passage
• In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.1 passage
• In-service training for health professionals to improve care of seriously ill newborns and children in low-income countries.1 passage
• Incentives and enablers to improve adherence in tuberculosis.1 passage
• Incentives for increasing prenatal care use by women in order to improve maternal and neonatal outcomes.1 passage
• Incentives for preventing smoking in children and adolescents.1 passage
• Incentives for smoking cessation.2 passages
• Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.1 passage
• Increasing antipsychotic dose for non response in schizophrenia.1 passage
• Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia.1 passage
• Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.1 passage
• Individual behavioural counselling for smoking cessation.1 passage
• Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa.1 passage
• Individual recovery expectations and prognosis of outcomes in non-specific low back pain: prognostic factor review.1 passage
• Individual-, family-, and school-level interventions targeting multiple risk behaviours in young people.1 passage
• Individual-level interventions to reduce personal exposure to outdoor air pollution and their effects on people with long-term respiratory conditions.1 passage
• Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).1 passage
• Individualized versus standard diet fortification for growth and development in preterm infants receiving human milk.1 passage
• Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction.1 passage
• Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults.1 passage
• Indomethacin for symptomatic patent ductus arteriosus in preterm infants.1 passage
• Indoor residual spraying for preventing malaria in communities using insecticide-treated nets.1 passage
• Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis.1 passage
• Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.1 passage
• Induction of labour at or beyond 37 weeks' gestation.1 passage
• Induction of labour at or near term for suspected fetal macrosomia.1 passage
• Induction of labour for improving birth outcomes for women at or beyond term.1 passage
• Industry sponsorship and research outcome.1 passage
• Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.1 passage
• Infant formulas containing hydrolysed protein for prevention of allergic disease.1 passage
• Infant pacifiers for reduction in risk of sudden infant death syndrome.1 passage
• Infant position in neonates receiving mechanical ventilation.1 passage
• Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions.1 passage
• Influenza vaccine for chronic obstructive pulmonary disease (COPD).1 passage
• Influenza vaccines for preventing acute otitis media in infants and children.2 passages
• Influenza vaccines for preventing cardiovascular disease.1 passage
• Influenza vaccines in immunosuppressed adults with cancer.1 passage
• Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a general practice (primary care) setting.1 passage
• Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting.1 passage
• Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations.1 passage
• Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting.1 passage
• Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early detection of dementia across a variety of healthcare settings.1 passage
• Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings.1 passage
• Information or education interventions for adult intensive care unit (ICU) patients and their carers.1 passage
• Information provision for people with multiple sclerosis.1 passage
• Information provision for stroke survivors and their carers.1 passage
• Infraorbital nerve block for postoperative pain following cleft lip repair in children.1 passage
• Infusion techniques for peripheral arterial thrombolysis.1 passage
• Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.1 passage
• Inhaled corticosteroids for bronchiectasis.1 passage
• Inhaled corticosteroids for cystic fibrosis.2 passages
• Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth.1 passage
• Inhaled corticosteroids with combination inhaled long-acting beta1 passage
• Inhaled magnesium sulfate in the treatment of acute asthma.1 passage
• Inhaled mannitol for cystic fibrosis.3 passages
• Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.1 passage
• Inhaled nitric oxide for respiratory failure in preterm infants.1 passage
• Inhaled nitric oxide for treating pain crises in people with sickle cell disease.1 passage
• Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis.1 passage
• Inhaled steroids with and without regular formoterol for asthma: serious adverse events.1 passage
• Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.1 passage
• Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.1 passage
• Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.1 passage
• Initial arch wires used in orthodontic treatment with fixed appliances.1 passage
• Injectable local anaesthetic agents for dental anaesthesia.1 passage
• Injected corticosteroids for treating plantar heel pain in adults.1 passage
• Injection sclerotherapy for varicose veins.1 passage
• Injection therapies for Achilles tendinopathy.1 passage
• Inositol for subfertile women with polycystic ovary syndrome.1 passage
• Inositol in preterm infants at risk for or having respiratory distress syndrome.2 passages
• Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.2 passages
• Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders.1 passage
• Insecticide space spraying for preventing malaria transmission.1 passage
• Insecticide-treated nets for preventing malaria.1 passage
• Instruments for assessing readiness to commence suck feeds in preterm infants: effects on time to establish full oral feeding and duration of hospitalisation.1 passage
• Instruments for assisted vaginal birth.1 passage
• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.1 passage
• Insulin and oral agents for managing cystic fibrosis-related diabetes.1 passage
• Insulin for the treatment of women with gestational diabetes.1 passage
• Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.1 passage
• Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.1 passage
• Integrated community case management of childhood illness in low- and middle-income countries.1 passage
• Integrated disease management interventions for patients with chronic obstructive pulmonary disease.1 passage
• Integrated management of childhood illness (IMCI) strategy for children under five.1 passage
• Integrated versus non-integrated orbital implants for treating anophthalmic sockets.1 passage
• Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.1 passage
• Intensity of continuous renal replacement therapy for acute kidney injury.1 passage
• Intensive case management for severe mental illness.1 passage
• Intensive versus conventional glycaemic control for treating diabetic foot ulcers.1 passage
• Interactive telemedicine: effects on professional practice and health care outcomes.1 passage
• Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes.1 passage
• Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.1 passage
• Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.2 passages
• Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.1 passage
• Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.1 passage
• Interleukin-6 blocking agents for treating COVID-19: a living systematic review.1 passage
• Intermittent auscultation (IA) of fetal heart rate in labour for fetal well-being.1 passage
• Intermittent catheter techniques, strategies and designs for managing long-term bladder conditions.1 passage
• Intermittent fasting for the prevention of cardiovascular disease.1 passage
• Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults.1 passage
• Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women.1 passage
• Intermittent oral iron supplementation during pregnancy.1 passage
• Intermittent preventive antimalarial treatment for children with anaemia.1 passage
• Intermittent preventive treatment for malaria in infants.2 passages
• Internal dressings for healing perianal abscess cavities.1 passage
• Internal fixation implants for intracapsular hip fractures in older adults.1 passage
• Internal iliac artery revascularisation versus internal iliac artery occlusion for endovascular treatment of aorto-iliac aneurysms.1 passage
• International travel-related control measures to contain the COVID-19 pandemic: a rapid review.1 passage
• Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adults.2 passages
• Internet-based interventions for smoking cessation.1 passage
• Internet-based interventions for the secondary prevention of coronary heart disease.1 passage
• Interprofessional collaboration to improve professional practice and healthcare outcomes.1 passage
• Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.1 passage
• Interval brain imaging for adults with cerebral glioma.1 passage
• Interval debulking surgery for advanced epithelial ovarian cancer.1 passage
• Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation.1 passage
• Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews.1 passage
• Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews.1 passage
• Interventions for American cutaneous and mucocutaneous leishmaniasis.1 passage
• Interventions for Old World cutaneous leishmaniasis.1 passage
• Interventions for acne scars.1 passage
• Interventions for altering blood pressure in people with acute subarachnoid haemorrhage.1 passage
• Interventions for atypical haemolytic uraemic syndrome.1 passage
• Interventions for autumn exacerbations of asthma in children.1 passage
• Interventions for bacterial folliculitis and boils (furuncles and carbuncles).1 passage
• Interventions for basal cell carcinoma of the skin.1 passage
• Interventions for bronchiectasis: an overview of Cochrane systematic reviews.1 passage
• Interventions for central serous chorioretinopathy: a network meta-analysis.1 passage
• Interventions for childhood apraxia of speech.1 passage
• Interventions for children with ear discharge occurring at least two weeks following grommet (ventilation tube) insertion.1 passage
• Interventions for chronic kidney disease in people with sickle cell disease.1 passage
• Interventions for chronic kidney disease-associated restless legs syndrome.1 passage
• Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.1 passage
• Interventions for chronic palmoplantar pustulosis.1 passage
• Interventions for chronic pruritus of unknown origin.1 passage
• Interventions for congenital talipes equinovarus (clubfoot).1 passage
• Interventions for convergence insufficiency: a network meta-analysis.1 passage
• Interventions for cutaneous disease in systemic lupus erythematosus.1 passage
• Interventions for cutaneous molluscum contagiosum.1 passage
• Interventions for dialysis patients with hepatitis C virus (HCV) infection.1 passage
• Interventions for dissociated vertical deviation.1 passage
• Interventions for drug-using offenders with co-occurring mental health problems.1 passage
• Interventions for drug-using offenders with co-occurring mental illness.1 passage
• Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury.1 passage
• Interventions for dysphagia in long-term, progressive muscle disease.1 passage
• Interventions for emergency contraception.2 passages
• Interventions for enhancing adherence to treatment in adults with bronchiectasis.1 passage
• Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.1 passage
• Interventions for eye movement disorders due to acquired brain injury.1 passage
• Interventions for fatigue in Parkinson's disease.1 passage
• Interventions for fatigue in inflammatory bowel disease.1 passage
• Interventions for fear of childbirth including tocophobia.1 passage
• Interventions for female drug-using offenders.2 passages
• Interventions for female pattern hair loss.1 passage
• Interventions for frostbite injuries.1 passage
• Interventions for great saphenous vein incompetence.1 passage
• Interventions for hand eczema.1 passage
• Interventions for heartburn in pregnancy.1 passage
• Interventions for helping people adhere to compression treatments for venous leg ulceration.1 passage
• Interventions for helping to turn term breech babies to head first presentation when using external cephalic version.1 passage
• Interventions for hereditary haemochromatosis: an attempted network meta-analysis.1 passage
• Interventions for hidradenitis suppurativa.1 passage
• Interventions for hirsutism (excluding laser and photoepilation therapy alone).1 passage
• Interventions for idiopathic intracranial hypertension.1 passage
• Interventions for idiopathic steroid-resistant nephrotic syndrome in children.2 passages
• Interventions for idiopathic toe walking.1 passage
• Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.1 passage
• Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.2 passages
• Interventions for improving community ambulation in individuals with stroke.1 passage
• Interventions for improving coverage of childhood immunisation in low- and middle-income countries.1 passage
• Interventions for improving employment outcomes for workers with HIV.1 passage
• Interventions for improving medical students' interpersonal communication in medical consultations.1 passage
• Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications.1 passage
• Interventions for improving modifiable risk factor control in the secondary prevention of stroke.1 passage
• Interventions for improving oral health in people after stroke.1 passage
• Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.2 passages
• Interventions for improving sleep quality in people with chronic kidney disease.1 passage
• Interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment.1 passage
• Interventions for increasing fruit and vegetable consumption in children aged five years and under.5 passages
• Interventions for increasing the proportion of health professionals practising in rural and other underserved areas.1 passage
• Interventions for increasing the use of shared decision making by healthcare professionals.1 passage
• Interventions for infantile haemangiomas of the skin.1 passage
• Interventions for infantile seborrhoeic dermatitis (including cradle cap).1 passage
• Interventions for intermittent exotropia.1 passage
• Interventions for intra-operative pain relief during postpartum mini-laparotomy tubal ligation.1 passage
• Interventions for investigating and identifying the causes of stillbirth.1 passage
• Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations.1 passage
• Interventions for itch in people with advanced chronic kidney disease.1 passage
• Interventions for leg cramps in pregnancy.2 passages
• Interventions for lowering plasma homocysteine levels in dialysis patients.1 passage
• Interventions for lowering plasma homocysteine levels in kidney transplant recipients.1 passage
• Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.1 passage
• Interventions for managing halitosis.1 passage
• Interventions for managing medication-related osteonecrosis of the jaw.1 passage
• Interventions for managing skeletal muscle spasticity following traumatic brain injury.1 passage
• Interventions for managing taste disturbances.1 passage
• Interventions for men and women with their first episode of genital herpes.1 passage
• Interventions for metabolic bone disease in children with chronic kidney disease.1 passage
• Interventions for morphea.1 passage
• Interventions for mycosis fungoides.1 passage
• Interventions for nausea and vomiting in early pregnancy.1 passage
• Interventions for necrotising pancreatitis.1 passage
• Interventions for necrotizing soft tissue infections in adults.1 passage
• Interventions for non-tubal ectopic pregnancy.1 passage
• Interventions for obtaining and maintaining employment in adults with severe mental illness, a network meta-analysis.1 passage
• Interventions for orbital lymphangioma.1 passage
• Interventions for pain with intrauterine device insertion.1 passage
• Interventions for palliative symptom control in COVID-19 patients.1 passage
• Interventions for paracetamol (acetaminophen) overdose.1 passage
• Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.1 passage
• Interventions for pityriasis rosea.1 passage
• Interventions for post-stroke fatigue.1 passage
• Interventions for preventing abuse in the elderly.1 passage
• Interventions for preventing and managing advanced liver disease in cystic fibrosis.2 passages
• Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.1 passage
• Interventions for preventing and treating incontinence-associated dermatitis in adults.1 passage
• Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).1 passage
• Interventions for preventing and treating low-back and pelvic pain during pregnancy.1 passage
• Interventions for preventing bone disease in kidney transplant recipients.1 passage
• Interventions for preventing delirium in hospitalised non-ICU patients.1 passage
• Interventions for preventing delirium in older people in institutional long-term care.1 passage
• Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome.1 passage
• Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.1 passage
• Interventions for preventing falls in older people in care facilities and hospitals.1 passage
• Interventions for preventing falls in people after stroke.1 passage
• Interventions for preventing falls in people with multiple sclerosis.1 passage
• Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.1 passage
• Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.1 passage
• Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.1 passage
• Interventions for preventing intensive care unit delirium in adults.1 passage
• Interventions for preventing mastitis after childbirth.1 passage
• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.1 passage
• Interventions for preventing obesity in children.1 passage
• Interventions for preventing occupational irritant hand dermatitis.1 passage
• Interventions for preventing ophthalmia neonatorum.1 passage
• Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors.1 passage
• Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy.1 passage
• Interventions for preventing osteoradionecrosis of the jaws in adults receiving head and neck radiotherapy.1 passage
• Interventions for preventing postpartum constipation.2 passages
• Interventions for preventing recurrent urinary tract infection during pregnancy.1 passage
• Interventions for preventing silent cerebral infarcts in people with sickle cell disease.2 passages
• Interventions for preventing the progression of autosomal dominant polycystic kidney disease.1 passage
• Interventions for preventing thrombosis in solid organ transplant recipients.1 passage
• Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries.1 passage
• Interventions for preventing unintended pregnancies among adolescents.1 passage
• Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.1 passage
• Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.1 passage
• Interventions for preventing weight gain after smoking cessation.1 passage
• Interventions for prevention of bullying in the workplace.1 passage
• Interventions for prevention of herpes simplex labialis (cold sores on the lips).1 passage
• Interventions for primary vesicoureteric reflux.1 passage
• Interventions for prodromal stage of psychosis.1 passage
• Interventions for promoting habitual exercise in people living with and beyond cancer.1 passage
• Interventions for promoting participation in shared decision-making for children and adolescents with cystic fibrosis.1 passage
• Interventions for promoting participation in shared decision-making for children with cancer.1 passage
• Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD).1 passage
• Interventions for promoting physical activity in people with neuromuscular disease.1 passage
• Interventions for promoting reintegration and reducing harmful behaviour and lifestyles in street-connected children and young people.1 passage
• Interventions for promoting the initiation of breastfeeding.1 passage
• Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.1 passage
• Interventions for psychotic symptoms concomitant with epilepsy.1 passage
• Interventions for raising breast cancer awareness in women.1 passage
• Interventions for recurrent corneal erosions.1 passage
• Interventions for reducing inflammation in familial Mediterranean fever.2 passages
• Interventions for reducing medication errors in children in hospital.1 passage
• Interventions for reducing sedentary behaviour in community-dwelling older adults.1 passage
• Interventions for reducing sedentary behaviour in people with stroke.1 passage
• Interventions for reducing wrong-site surgery and invasive clinical procedures.1 passage
• Interventions for renal vasculitis in adults.2 passages
• Interventions for replacing missing teeth: alveolar ridge preservation techniques for dental implant site development.2 passages
• Interventions for replacing missing teeth: attachment systems for implant overdentures in edentulous jaws.1 passage
• Interventions for rosacea.1 passage
• Interventions for self-harm in children and adolescents.2 passages
• Interventions for sexual dysfunction following stroke.1 passage
• Interventions for sexual dysfunction following treatments for cancer in women.1 passage
• Interventions for smokeless tobacco use cessation.1 passage
• Interventions for smoking cessation in people diagnosed with lung cancer.2 passages
• Interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese.1 passage
• Interventions for the cessation of non-nutritive sucking habits in children.1 passage
• Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.2 passages
• Interventions for the management of CMV-associated anterior segment inflammation.1 passage
• Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.1 passage
• Interventions for the management of abdominal pain in ulcerative colitis.1 passage
• Interventions for the management of external root resorption.1 passage
• Interventions for the management of fatigue in adults with a primary brain tumour.1 passage
• Interventions for the management of malignant pleural effusions: a network meta-analysis.2 passages
• Interventions for the management of obesity in people with bipolar disorder.1 passage
• Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.1 passage
• Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.1 passage
• Interventions for the prevention of recurrent erysipelas and cellulitis.1 passage
• Interventions for the reduction of prescribed opioid use in chronic non-cancer pain.1 passage
• Interventions for the treatment of Frey's syndrome.1 passage
• Interventions for the treatment of Paget's disease of the vulva.1 passage
• Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.1 passage
• Interventions for the treatment of keratocystic odontogenic tumours.1 passage
• Interventions for the treatment of metastatic extradural spinal cord compression in adults.1 passage
• Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.1 passage
• Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.1 passage
• Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.1 passage
• Interventions for tobacco cessation delivered by dental professionals.1 passage
• Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.1 passage
• Interventions for tobacco use cessation in people living with HIV and AIDS.1 passage
• Interventions for tophi in gout.1 passage
• Interventions for trachoma trichiasis.1 passage
• Interventions for treating acute high altitude illness.1 passage
• Interventions for treating ankle fractures in children.1 passage
• Interventions for treating anxiety after stroke.1 passage
• Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ).1 passage
• Interventions for treating brain arteriovenous malformations in adults.1 passage
• Interventions for treating burning mouth syndrome.1 passage
• Interventions for treating cavitated or dentine carious lesions.1 passage
• Interventions for treating collagenous colitis.1 passage
• Interventions for treating constipation in pregnancy.1 passage
• Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.1 passage
• Interventions for treating fractures of the distal femur in adults.1 passage
• Interventions for treating fractures of the patella in adults.2 passages
• Interventions for treating gas gangrene.1 passage
• Interventions for treating genital Chlamydia trachomatis infection in pregnancy.1 passage
• Interventions for treating hyperemesis gravidarum.1 passage
• Interventions for treating intrahepatic cholestasis in people with sickle cell disease.3 passages
• Interventions for treating iron deficiency anaemia in inflammatory bowel disease.1 passage
• Interventions for treating leg ulcers in people with sickle cell disease.1 passage
• Interventions for treating lymphocytic colitis.1 passage
• Interventions for treating neuropathic pain in people with sickle cell disease.1 passage
• Interventions for treating oral leukoplakia to prevent oral cancer.1 passage
• Interventions for treating oral lichen planus: corticosteroid therapies.1 passage
• Interventions for treating oro-antral communications and fistulae due to dental procedures.2 passages
• Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.1 passage
• Interventions for treating persistent pain in survivors of torture.1 passage
• Interventions for treating post-extraction bleeding.2 passages
• Interventions for treating proximal humeral fractures in adults.1 passage
• Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women.1 passage
• Interventions for treating simple bone cysts in the long bones of children.1 passage
• Interventions for treating traumatised ankylosed permanent front teeth.1 passage
• Interventions for treating traumatised permanent front teeth: avulsed (knocked out) and replanted.1 passage
• Interventions for treating tuberculous pericarditis.1 passage
• Interventions for treating urinary incontinence after stroke in adults.1 passage
• Interventions for treating wrist fractures in children.1 passage
• Interventions for ulceration and other skin changes caused by nerve damage in leprosy.1 passage
• Interventions for unexplained infertility: a systematic review and network meta-analysis.1 passage
• Interventions for varicose veins and leg oedema in pregnancy.1 passage
• Interventions for visual field defects in people with stroke.1 passage
• Interventions for vitiligo.1 passage
• Interventions for waterpipe smoking cessation.1 passage
• Interventions for weight loss in people with chronic kidney disease who are overweight or obese.1 passage
• Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.1 passage
• Interventions in outside-school hours childcare settings for promoting physical activity amongst schoolchildren aged 4 to 12 years.1 passage
• Interventions outside the workplace for reducing sedentary behaviour in adults under 60 years of age.1 passage
• Interventions targeted at women to encourage the uptake of cervical screening.1 passage
• Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.1 passage
• Interventions to enable communication for adult patients requiring an artificial airway with or without mechanical ventilator support.1 passage
• Interventions to enhance return-to-work for cancer patients.1 passage
• Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care.1 passage
• Interventions to help support caregivers of people with a brain or spinal cord tumour.1 passage
• Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries.1 passage
• Interventions to improve adherence to inhaled steroids for asthma.1 passage
• Interventions to improve adherence to lipid-lowering medication.1 passage
• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).1 passage
• Interventions to improve antibiotic prescribing practices for hospital inpatients.1 passage
• Interventions to improve disposal of child faeces for preventing diarrhoea and soil-transmitted helminth infection.1 passage
• Interventions to improve hand hygiene compliance in patient care.1 passage
• Interventions to improve hearing aid use in adult auditory rehabilitation.1 passage
• Interventions to improve inhaler technique for people with asthma.1 passage
• Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.1 passage
• Interventions to improve return to work in depressed people.1 passage
• Interventions to improve the appropriate use of polypharmacy for older people.1 passage
• Interventions to improve water quality for preventing diarrhoea.1 passage
• Interventions to increase adherence to medications for tobacco dependence.2 passages
• Interventions to increase attendance for diabetic retinopathy screening.1 passage
• Interventions to increase influenza vaccination rates of those 60 years and older in the community.1 passage
• Interventions to increase or decrease the length of primary care physicians' consultation.1 passage
• Interventions to increase patient and family involvement in escalation of care for acute life-threatening illness in community health and hospital settings.1 passage
• Interventions to increase the reporting of occupational diseases by physicians.1 passage
• Interventions to increase the use of electronic health information by healthcare practitioners to improve clinical practice and patient outcomes.1 passage
• Interventions to increase tuberculosis case detection at primary healthcare or community-level services.1 passage
• Interventions to optimise prescribing for older people in care homes.1 passage
• Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.1 passage
• Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants.1 passage
• Interventions to prevent injuries in construction workers.1 passage
• Interventions to prevent misconduct and promote integrity in research and publication.1 passage
• Interventions to prevent occupational noise-induced hearing loss.1 passage
• Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews.1 passage
• Interventions to promote patient utilisation of cardiac rehabilitation.1 passage
• Interventions to reduce Staphylococcus aureus in the management of eczema.1 passage
• Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.1 passage
• Interventions to reduce ambient particulate matter air pollution and their effect on health.1 passage
• Interventions to reduce body temperature to 35 ⁰C to 37 ⁰C in adults and children with traumatic brain injury.1 passage
• Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases.1 passage
• Interventions to reduce corruption in the health sector.1 passage
• Interventions to reduce harm from continued tobacco use.1 passage
• Interventions to reduce shoulder pain following gynaecological laparoscopic procedures.1 passage
• Interventions to reduce the time to diagnosis of brain tumours.1 passage
• Interventions to reduce tobacco use in people experiencing homelessness.1 passage
• Interventions to reduce waiting times for elective procedures.1 passage
• Interventions to slow progression of myopia in children.1 passage
• Interventions to support return to work for people with coronary heart disease.1 passage
• Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.1 passage
• Interventions using social networking sites to promote contraception in women of reproductive age.1 passage
• Interventions with pregnant women, new mothers and other primary caregivers for preventing early childhood caries.1 passage
• Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.1 passage
• Intra-articular corticosteroid for knee osteoarthritis.1 passage
• Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.1 passage
• Intra-uterine insemination for unexplained subfertility.2 passages
• Intracavity lavage and wound irrigation for prevention of surgical site infection.1 passage
• Intracystic bleomycin for cystic craniopharyngiomas in children.1 passage
• Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.1 passage
• Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour.1 passage
• Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.1 passage
• Intranasal corticosteroids for non-allergic rhinitis.1 passage
• Intranasal or transdermal nicotine for the treatment of postoperative pain.1 passage
• Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.1 passage
• Intraocular lens optic edge design for the prevention of posterior capsule opacification after cataract surgery.1 passage
• Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.1 passage
• Intraoperative imaging technology to maximise extent of resection for glioma.1 passage
• Intraoperative imaging technology to maximise extent of resection for glioma: a network meta-analysis.1 passage
• Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews.1 passage
• Intraoperative mild hypothermia for postoperative neurological deficits in people with intracranial aneurysm.1 passage
• Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery.1 passage
• Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in adults without acute lung injury.1 passage
• Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in patients without acute lung injury.1 passage
• Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fetal heart rate trace.1 passage
• Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.1 passage
• Intraperitoneal local anaesthetic instillation versus no intraperitoneal local anaesthetic instillation for laparoscopic cholecystectomy.1 passage
• Intrastromal corneal ring segments for treating keratoconus.1 passage
• Intrathecal baclofen for treating spasticity in children with cerebral palsy.1 passage
• Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.2 passages
• Intrauterine insemination versus intracervical insemination in donor sperm treatment.1 passage
• Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.1 passage
• Intravenous heparin during ruptured abdominal aortic aneurysmal repair.1 passage
• Intravenous immunoglobulin for presumed viral myocarditis in children and adults.2 passages
• Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.1 passage
• Intravenous immunoglobulin for suspected or proven infection in neonates.2 passages
• Intravenous immunoglobulin for the treatment of childhood encephalitis.1 passage
• Intravenous immunoglobulins for epilepsy.2 passages
• Intravenous in-line filters for preventing morbidity and mortality in neonates.1 passage
• Intravenous iron therapy for non-anaemic, iron-deficient adults.1 passage
• Intravenous magnesium sulfate for treating children with acute asthma in the emergency department.1 passage
• Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.1 passage
• Intravenous nutrients for preventing inadvertent perioperative hypothermia in adults.1 passage
• Intravenous thrombolytic treatment and endovascular thrombectomy for ischaemic wake-up stroke.1 passage
• Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery.1 passage
• Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour.1 passage
• Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.1 passage
• Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.1 passage
• Intravesical electromotive drug administration for non-muscle invasive bladder cancer.1 passage
• Intravesical gemcitabine for non-muscle invasive bladder cancer.1 passage
• Intravitreal steroids for macular edema in diabetes.1 passage
• Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.1 passage
• Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction.1 passage
• Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders.1 passage
• Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders.1 passage
• Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.1 passage
• Iodine supplementation for women during the preconception, pregnancy and postpartum period.1 passage
• Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.1 passage
• Iridotomy to slow progression of visual field loss in angle-closure glaucoma.1 passage
• Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer.1 passage
• Iron chelators for acute stroke.1 passage
• Iron for the treatment of restless legs syndrome.1 passage
• Iron therapy for pre-operative anaemia.1 passage
• Iron therapy for preoperative anaemia.1 passage
• Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury.1 passage
• Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units.1 passage
• Isoniazid for preventing tuberculosis in HIV-infected children.1 passage
• Ivabradine as adjuvant treatment for chronic heart failure.1 passage
• Ivermectin and permethrin for treating scabies.1 passage
• Ivermectin for preventing and treating COVID-19.1 passage
• Ivermectin treatment in humans for reducing malaria transmission.1 passage
• Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.1 passage
• Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis.1 passage
• Kangaroo mother care to reduce morbidity and mortality in low birthweight infants.1 passage
• Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.1 passage
• Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.1 passage
• Ketamine and other glutamate receptor modulators for depression in adults.1 passage
• Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.1 passage
• Ketamine as an adjuvant to opioids for cancer pain.1 passage
• Ketogenic diet and other dietary treatments for epilepsy.1 passage
• Ketogenic diets for drug-resistant epilepsy.2 passages
• Ketorolac for postoperative pain in children.1 passage
• Kinesio taping for rotator cuff disease.1 passage
• Knee orthoses for treating patellofemoral pain syndrome.1 passage
• L-acetylcarnitine for treating fragile X syndrome.1 passage
• L-carnitine for cognitive enhancement in people without cognitive impairment.1 passage
• L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.1 passage
• Lacosamide add-on therapy for focal epilepsy.1 passage
• Lacosamide add-on therapy for partial epilepsy.1 passage
• Lactational amenorrhoea method for family planning.1 passage
• Laetrile treatment for cancer.1 passage
• Lamotrigine add-on for drug-resistant partial epilepsy.1 passage
• Lamotrigine add-on therapy for drug-resistant focal epilepsy.1 passage
• Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures.1 passage
• Lamotrigine in the maintenance treatment of bipolar disorder.1 passage
• Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.2 passages
• Laparoendoscopic single-site donor nephrectomy (LESS-DN) versus standard laparoscopic donor nephrectomy.1 passage
• Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.1 passage
• Laparoscopic colposuspension for urinary incontinence in women.1 passage
• Laparoscopic entry techniques.2 passages
• Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults.1 passage
• Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome.1 passage
• Laparoscopic surgery for elective abdominal aortic aneurysm repair.1 passage
• Laparoscopic surgery for endometriosis.1 passage
• Laparoscopic versus open distal pancreatectomy for pancreatic cancer.1 passage
• Laparoscopic versus open gastrectomy for gastric cancer.1 passage
• Laparoscopic versus open resection for sigmoid diverticulitis.1 passage
• Laparoscopic versus open surgery for suspected appendicitis.1 passage
• Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer.1 passage
• Laparoscopic-endoscopic rendezvous versus preoperative endoscopic sphincterotomy in people undergoing laparoscopic cholecystectomy for stones in the gallbladder and bile duct.1 passage
• Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer.1 passage
• Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.1 passage
• Laparoscopy versus laparotomy for the management of early stage endometrial cancer.1 passage
• Larviciding to prevent malaria transmission.1 passage
• Laryngeal mask airway versus bag-mask ventilation or endotracheal intubation for neonatal resuscitation.1 passage
• Laser peripheral iridoplasty for chronic angle closure.1 passage
• Laser therapy for dentinal hypersensitivity.1 passage
• Laser therapy for retinopathy in sickle cell disease.1 passage
• Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.1 passage
• Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.1 passage
• Laser-assisted in-situ keratomileusis (LASIK) with a mechanical microkeratome compared to LASIK with a femtosecond laser for LASIK in adults with myopia or myopic astigmatism.1 passage
• Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.1 passage
• Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.1 passage
• Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.1 passage
• Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.1 passage
• Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.1 passage
• Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.2 passages
• Later school start times for supporting the education, health, and well-being of high school students.1 passage
• Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.1 passage
• Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV.1 passage
• Lateral pararectal versus transrectal stoma placement for prevention of parastomal herniation.1 passage
• Lateral positioning for critically ill adult patients.1 passage
• Latrepirdine for Alzheimer's disease.1 passage
• Laxatives for the management of constipation in people receiving palliative care.1 passage
• Lay-led and peer support interventions for adolescents with asthma.1 passage
• Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption.1 passage
• Lens extraction for chronic angle-closure glaucoma.1 passage
• Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion.1 passage
• Leukotriene inhibitors for bronchiolitis in infants and young children.1 passage
• Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.1 passage
• Leukotriene receptor antagonists for eczema.1 passage
• Levomepromazine for nausea and vomiting in palliative care.1 passage
• Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.2 passages
• Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.1 passage
• Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock.1 passage
• Lidocaine for preventing postoperative sore throat.1 passage
• Lidocaine for reducing propofol-induced pain on induction of anaesthesia in adults.1 passage
• Lifestyle changes for treating psoriasis.1 passage
• Lifestyle changes in women with polycystic ovary syndrome.1 passage
• Lifestyle interventions for the treatment of urinary incontinence in adults.1 passage
• Lifestyle interventions for the treatment of women with gestational diabetes.1 passage
• Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.1 passage
• Light therapy for preventing seasonal affective disorder.2 passages
• Limited versus full sternotomy for aortic valve replacement.1 passage
• Linezolid for drug-resistant pulmonary tuberculosis.1 passage
• Linezolid versus vancomycin for skin and soft tissue infections.1 passage
• Lipid emulsions for parenterally fed preterm infants.1 passage
• Lipid emulsions for parenterally fed term and late preterm infants.1 passage
• Lipid-based nutrient supplements for maternal, birth, and infant developmental outcomes.1 passage
• Lipid-lowering efficacy of atorvastatin.1 passage
• Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain.1 passage
• Liposomal bupivacaine peripheral nerve block for the management of postoperative pain.1 passage
• Lithium for acute mania.1 passage
• Lithium for schizophrenia.1 passage
• Local anaesthetic sympathetic blockade for complex regional pain syndrome.1 passage
• Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children.2 passages
• Local cooling for relieving pain from perineal trauma sustained during childbirth.1 passage
• Local oestrogen for vaginal atrophy in postmenopausal women.1 passage
• Local opinion leaders: effects on professional practice and healthcare outcomes.1 passage
• Local versus general anaesthesia for carotid endarterectomy.1 passage
• Localization techniques for guided surgical excision of non-palpable breast lesions.1 passage
• Long chain polyunsaturated fatty acid supplementation in infants born at term.1 passage
• Long-acting FSH versus daily FSH for women undergoing assisted reproduction.1 passage
• Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.1 passage
• Long-acting inhaled bronchodilators for cystic fibrosis.1 passage
• Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).1 passage
• Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.1 passage
• Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.1 passage
• Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma.1 passage
• Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.1 passage
• Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.1 passage
• Long-term antibiotics for preventing recurrent urinary tract infection in children.1 passage
• Long-term effects of weight-reducing diets in people with hypertension.2 passages
• Long-term effects of weight-reducing drugs in people with hypertension.2 passages
• Long-term hormone therapy for perimenopausal and postmenopausal women.1 passage
• Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.1 passage
• Longchain polyunsaturated fatty acid supplementation in preterm infants.1 passage
• Loop diuretics for patients receiving blood transfusions.1 passage
• Losigamone add-on therapy for focal epilepsy.2 passages
• Losigamone add-on therapy for partial epilepsy.1 passage
• Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.1 passage
• Low dialysate sodium levels for chronic haemodialysis.1 passage
• Low dose naltrexone for induction of remission in Crohn's disease.1 passage
• Low dose versus high dose stavudine for treating people with HIV infection.1 passage
• Low glycaemic index diets for the prevention of cardiovascular disease.1 passage
• Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.1 passage
• Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.1 passage
• Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.1 passage
• Low protein diets for non-diabetic adults with chronic kidney disease.2 passages
• Low vision rehabilitation for better quality of life in visually impaired adults.1 passage
• Low-dose oral misoprostol for induction of labour.1 passage
• Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.1 passage
• Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.1 passage
• Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth.1 passage
• Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease.1 passage
• Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.1 passage
• Lung recruitment manoeuvres for reducing mortality and respiratory morbidity in mechanically ventilated neonates.1 passage
• Lung volume reduction surgery for diffuse emphysema.1 passage
• Luteal phase support for assisted reproduction cycles.1 passage
• Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.1 passage
• Lymphadenectomy for the management of endometrial cancer.2 passages
• MVA85A vaccine to enhance BCG for preventing tuberculosis.1 passage
• Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.1 passage
• Macrolide antibiotics for bronchiectasis.1 passage
• Macrolides for chronic asthma.1 passage
• Macrolides for diffuse panbronchiolitis.1 passage
• Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults.1 passage
• Macrolides versus placebo for chronic asthma.1 passage
• Macular grid laser photocoagulation for branch retinal vein occlusion.1 passage
• Magnesium for skeletal muscle cramps.1 passage
• Magnesium for treating sickle cell disease.2 passages
• Magnesium sulphate for treating acute bronchiolitis in children up to two years of age.1 passage
• Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.1 passage
• Magnetic seizure therapy for treatment-resistant depression.1 passage
• Magnification devices for endodontic therapy.1 passage
• Mailuoning for acute ischaemic stroke.1 passage
• Maintenance agonist treatments for opiate-dependent pregnant women.1 passage
• Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.1 passage
• Maintenance treatment with antipsychotic drugs for schizophrenia.1 passage
• Malaria chemoprophylaxis in sickle cell disease.1 passage
• Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.1 passage
• Management for intussusception in children.1 passage
• Management of drainage for malignant ascites in gynaecological cancer.1 passage
• Management of gag reflex for patients undergoing dental treatment.2 passages
• Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.1 passage
• Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.1 passage
• Management strategies for pancreatic pseudocysts.1 passage
• Manipulation and mobilisation for neck pain contrasted against an inactive control or another active treatment.1 passage
• Manipulative interventions for reducing pulled elbow in young children.1 passage
• Manual lymphatic drainage for lymphedema following breast cancer treatment.1 passage
• Manual therapy and exercise for rotator cuff disease.1 passage
• Manually-generated reminders delivered on paper: effects on professional practice and patient outcomes.1 passage
• Marine-derived n-3 fatty acids therapy for stroke.1 passage
• Mass drug administration for malaria.1 passage
• Mass media interventions for preventing smoking in young people.1 passage
• Mass media interventions for smoking cessation in adults.1 passage
• Massage for low-back pain.1 passage
• Massage therapy for preventing pressure ulcers.1 passage
• Massage with or without aromatherapy for symptom relief in people with cancer.1 passage
• Massage, reflexology and other manual methods for pain management in labour.1 passage
• Materials for retrograde filling in root canal therapy.2 passages
• Maternal and foetal outcomes following natural vaginal versus caesarean section (c-section) delivery in women with bleeding disorders and carriers.3 passages
• Maternal position in the second stage of labour for women with epidural anaesthesia.1 passage
• Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood.1 passage
• Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.1 passage
• Maxillary distraction osteogenesis versus orthognathic surgery for cleft lip and palate patients.1 passage
• Means restriction for the prevention of suicide by jumping.1 passage
• Means restriction for the prevention of suicide on roads.1 passage
• Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.1 passage
• Mechanical and surgical interventions for treating primary postpartum haemorrhage.1 passage
• Mechanical assist devices for acute cardiogenic shock.1 passage
• Mechanical dilatation of the cervix during elective caeserean section before the onset of labour for reducing postoperative morbidity.1 passage
• Mechanical methods for induction of labour.1 passage
• Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.1 passage
• Mechanical versus manual chest compressions for cardiac arrest.1 passage
• Mechanically assisted walking training for walking, participation, and quality of life in children with cerebral palsy.1 passage
• Medical abortion offered in pharmacy versus clinic-based settings.1 passage
• Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.2 passages
• Medical and dietary interventions for preventing recurrent urinary stones in children.1 passage
• Medical and surgical abortion for women living with HIV.1 passage
• Medical and surgical interventions for the treatment of urinary stones in children.2 passages
• Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.1 passage
• Medical day hospital care for older people versus alternative forms of care.1 passage
• Medical interventions for acanthamoeba keratitis.1 passage
• Medical interventions for chronic rhinosinusitis in cystic fibrosis.1 passage
• Medical interventions for fungal keratitis.1 passage
• Medical interventions for high-grade vulval intraepithelial neoplasia.1 passage
• Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.1 passage
• Medical interventions for traumatic hyphema.1 passage
• Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.1 passage
• Medical treatment for botulism.1 passage
• Medical treatment for early fetal death (less than 24 weeks).1 passage
• Medical treatments for incomplete miscarriage.1 passage
• Medical versus surgical treatment for refractory or recurrent peptic ulcer.1 passage
• Medication review in hospitalised patients to reduce morbidity and mortality.1 passage
• Medications for daytime sleepiness in individuals with idiopathic hypersomnia.1 passage
• Meditation for adults with haematological malignancies.1 passage
• Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.1 passage
• Mefloquine for preventing malaria during travel to endemic areas.1 passage
• Mefloquine for preventing malaria in pregnant women.2 passages
• Melatonin and agomelatine for preventing seasonal affective disorder.2 passages
• Melatonin as add-on treatment for epilepsy.1 passage
• Melatonin for pre- and postoperative anxiety in adults.1 passage
• Melatonin for preoperative and postoperative anxiety in adults.1 passage
• Melatonin for the promotion of sleep in adults in the intensive care unit.1 passage
• Melatonin for women in pregnancy for neuroprotection of the fetus.1 passage
• Memantine for dementia.1 passage
• Membrane sweeping for induction of labour.1 passage
• Memory rehabilitation for people with multiple sclerosis.2 passages
• Mental practice for treating upper extremity deficits in individuals with hemiparesis after stroke.1 passage
• Mepolizumab versus placebo for asthma.1 passage
• Mesalamine (5-ASA) for the prevention of recurrent diverticulitis.1 passage
• Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.1 passage
• Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.1 passage
• Mesh fixation techniques in primary ventral or incisional hernia repair.1 passage
• Mesh fixation with glue versus suture for chronic pain and recurrence in Lichtenstein inguinal hernioplasty.1 passage
• Mesh versus non-mesh for inguinal and femoral hernia repair.1 passage
• Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies.2 passages
• Metal-free materials for fixed prosthodontic restorations.1 passage
• Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.1 passage
• Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome.1 passage
• Metformin for endometrial hyperplasia.1 passage
• Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.1 passage
• Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.1 passage
• Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.1 passage
• Metformin monotherapy for adults with type 2 diabetes mellitus.1 passage
• Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.1 passage
• Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.1 passage
• Methadone for cancer pain.1 passage
• Methadone for neuropathic pain in adults.1 passage
• Methods for assessing pre-induction cervical ripening.1 passage
• Methods for blood loss estimation after vaginal birth.1 passage
• Methods for managing miscarriage: a network meta-analysis.1 passage
• Methods of milk expression for lactating women.1 passage
• Methods of term labour induction for women with a previous caesarean section.1 passage
• Methods to decrease blood loss during liver resection: a network meta-analysis.1 passage
• Methotrexate for maintenance of remission in ulcerative colitis.1 passage
• Methotrexate for psoriatic arthritis.1 passage
• Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.1 passage
• Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.1 passage
• Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).1 passage
• Methylphenidate for children and adolescents with autism spectrum disorder.1 passage
• Metoclopramide for post-pyloric placement of naso-enteral feeding tubes.1 passage
• Micro-invasive interventions for managing proximal dental decay in primary and permanent teeth.1 passage
• Micronutrient supplementation in adults with HIV infection.1 passage
• Mid-urethral sling operations for stress urinary incontinence in women.2 passages
• Midazolam for sedation before procedures.1 passage
• Midwife-led continuity models versus other models of care for childbearing women.2 passages
• Milnacipran for neuropathic pain in adults.1 passage
• Milnacipran for pain in fibromyalgia in adults.1 passage
• Mind and body therapy for fibromyalgia.1 passage
• Mindfulness-based interventions for substance use disorders.1 passage
• Mindfulness-based psychological interventions for improving mental well-being in medical students and junior doctors.1 passage
• Mindfulness-based stress reduction for family carers of people with dementia.1 passage
• Mindfulness-based stress reduction for women diagnosed with breast cancer.1 passage
• Mini-Cog for the detection of dementia within a community setting.1 passage
• Mini-Cog for the detection of dementia within a primary care setting.1 passage
• Mini-Cog for the detection of dementia within a secondary care setting.1 passage
• Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting.1 passage
• Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting.1 passage
• Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.1 passage
• Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).1 passage
• Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations.1 passage
• Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).1 passage
• Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults.1 passage
• Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children.1 passage
• Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.1 passage
• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.1 passage
• Mirror therapy for improving motor function after stroke.1 passage
• Mirtazapine adjunct for people with schizophrenia.1 passage
• Mirtazapine for fibromyalgia in adults.1 passage
• Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.1 passage
• Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.1 passage
• Mixed exercise training for adults with fibromyalgia.1 passage
• Mobile bearing vs fixed bearing prostheses for posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and rheumatoid arthritis.1 passage
• Mobile clinics for women's and children's health.1 passage
• Mobile phone text messaging and app-based interventions for smoking cessation.1 passage
• Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease.1 passage
• Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.2 passages
• Mobile phone-based interventions for improving contraception use.1 passage
• Mobile phone-based interventions for smoking cessation.1 passage
• Mobile technologies to support healthcare provider to healthcare provider communication and management of care.1 passage
• Mobility management to prevent, reduce, or delay driving a car in teenagers.1 passage
• Modafinil for people with schizophrenia or related disorders.1 passage
• Modes of exercise training for intermittent claudication.1 passage
• Modifying the consistency of food and fluids for swallowing difficulties in dementia.1 passage
• Molecular assays for the diagnosis of sepsis in neonates.1 passage
• Molecular-targeted first-line therapy for advanced gastric cancer.1 passage
• Monitoring of gastric residual volume during enteral nutrition.1 passage
• Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).1 passage
• Monitoring strategies for clinical intervention studies.1 passage
• Monotherapy laser photocoagulation for diabetic macular oedema.1 passage
• Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.1 passage
• Montreal Cognitive Assessment for the detection of dementia.1 passage
• Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias.1 passage
• Morita therapy for anxiety disorders in adults.1 passage
• Morphine for chronic neuropathic pain in adults.1 passage
• Motivational interviewing for improving recovery after stroke.1 passage
• Motivational interviewing for smoking cessation.2 passages
• Motivational interviewing for the prevention of alcohol misuse in young adults.1 passage
• Motor control exercise for acute non-specific low back pain.1 passage
• Motor control exercise for chronic non-specific low-back pain.1 passage
• Motor imagery for gait rehabilitation after stroke.1 passage
• Motor neuroprosthesis for promoting recovery of function after stroke.1 passage
• Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer.1 passage
• Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.1 passage
• Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.2 passages
• Multi-disciplinary rehabilitation for acquired brain injury in adults of working age.1 passage
• Multi-domain interventions for the prevention of dementia and cognitive decline.1 passage
• Multi-nutrient fortification of human milk for preterm infants.1 passage
• Multi-professional simulation-based team training in obstetric emergencies for improving patient outcomes and trainees' performance.1 passage
• Multidisciplinary biopsychosocial rehabilitation for subacute low back pain.1 passage
• Multidisciplinary rehabilitation after primary brain tumour treatment.1 passage
• Multidisciplinary rehabilitation for older people with hip fractures.1 passage
• Multifactorial and multiple component interventions for preventing falls in older people living in the community.1 passage
• Multifocal versus monofocal intraocular lenses after cataract extraction.1 passage
• Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.1 passage
• Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women.1 passage
• Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.1 passage
• Multiple session early psychological interventions for the prevention of post-traumatic stress disorder.1 passage
• Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.1 passage
• Multiple-micronutrient supplementation for women during pregnancy.3 passages
• Muscle energy technique for non-specific low-back pain.1 passage
• Music for insomnia in adults.1 passage
• Music interventions for acquired brain injury.1 passage
• Music interventions for improving psychological and physical outcomes in cancer patients.1 passage
• Music interventions for improving psychological and physical outcomes in people with cancer.1 passage
• Music therapy for depression.1 passage
• Music therapy for people with schizophrenia and schizophrenia-like disorders.1 passage
• Music-based therapeutic interventions for people with dementia.2 passages
• Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.1 passage
• Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea.1 passage
• N-acetylcarnosine (NAC) drops for age-related cataract.1 passage
• N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.1 passage
• N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure.1 passage
• Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.1 passage
• Naloxone for opioid-exposed newborn infants.1 passage
• Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.1 passage
• Nasal decongestants in monotherapy for the common cold.1 passage
• Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers.1 passage
• Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.1 passage
• Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis.1 passage
• Natalizumab for induction of remission in Crohn's disease.1 passage
• Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure.1 passage
• Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters.1 passage
• Nebulised hypertonic saline for cystic fibrosis.1 passage
• Nebulised hypertonic saline solution for acute bronchiolitis in infants.1 passage
• Needle aspiration versus incision and drainage for the treatment of peritonsillar abscess.1 passage
• Needle aspiration versus intercostal tube drainage for pneumothorax in the newborn.2 passages
• Needle gauge and tip designs for preventing post-dural puncture headache (PDPH).1 passage
• Needle size for vaccination procedures in children and adolescents.2 passages
• Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.1 passage
• Negative pressure wound therapy for open traumatic wounds.1 passage
• Negative pressure wound therapy for surgical wounds healing by primary closure.2 passages
• Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus.1 passage
• Negative pressure wound therapy for treating leg ulcers.1 passage
• Negative pressure wound therapy for treating pressure ulcers.1 passage
• Negative pressure wound therapy for treating surgical wounds healing by secondary intention.1 passage
• Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.1 passage
• Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews.1 passage
• Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries.1 passage
• Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults.1 passage
• Nerve-sparing radical hysterectomy compared to standard radical hysterectomy for women with early stage cervical cancer (stage Ia2 to IIa).1 passage
• Neurally adjusted ventilatory assist compared to other forms of triggered ventilation for neonatal respiratory support.1 passage
• Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.1 passage
• Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome.1 passage
• Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.1 passage
• Neuromuscular electrical stimulation for the prevention of venous thromboembolism.1 passage
• Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease.1 passage
• Neuroprotection for treatment of glaucoma in adults.1 passage
• Neuropsychological and psychological interventions for people with newly diagnosed epilepsy.1 passage
• New generation antidepressants for depression in children and adolescents: a network meta-analysis.1 passage
• Newborn screening for galactosaemia.2 passages
• Newborn screening for homocystinuria.1 passage
• Niacin for primary and secondary prevention of cardiovascular events.1 passage
• Nicotine receptor partial agonists for smoking cessation.1 passage
• Nicotine replacement therapy versus control for smoking cessation.1 passage
• Nipple- and areola-sparing mastectomy for the treatment of breast cancer.1 passage
• Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery.1 passage
• Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke.1 passage
• Nitric oxide donors for cervical ripening and induction of labour.1 passage
• Nitric oxide donors for cervical ripening in first-trimester surgical abortion.1 passage
• Nitric oxide for respiratory failure in infants born at or near term.1 passage
• Nitroglycerin for management of retained placenta.1 passage
• Nitrous oxide-based techniques versus nitrous oxide-free techniques for general anaesthesia.1 passage
• Nitrous oxide-based versus nitrous oxide-free general anaesthesia and accidental awareness during general anaesthesia in surgical patients.1 passage
• Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).1 passage
• Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.1 passage
• Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.1 passage
• Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis.1 passage
• Non-clinical interventions for reducing unnecessary caesarean section.1 passage
• Non-contact tests for identifying people at risk of primary angle closure glaucoma.1 passage
• Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.1 passage
• Non-corticosteroid adjuvant therapies for acute bacterial meningitis.1 passage
• Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.1 passage
• Non-drug therapies for the secondary prevention of lower limb muscle cramps.1 passage
• Non-invasive brain stimulation techniques for chronic pain.1 passage
• Non-invasive diagnostic tests for Helicobacter pylori infection.1 passage
• Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea.1 passage
• Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema.1 passage
• Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients.2 passages
• Non-invasive respiratory support for the management of transient tachypnea of the newborn.1 passage
• Non-invasive ventilation for cystic fibrosis.1 passage
• Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.1 passage
• Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.1 passage
• Non-nutritive sucking for increasing physiologic stability and nutrition in preterm infants.1 passage
• Non-nutritive sweeteners for diabetes mellitus.1 passage
• Non-operative management versus operative management in high-grade blunt hepatic injury.1 passage
• Non-pharmacological care for opioid withdrawal in newborns.1 passage
• Non-pharmacological interventions for alleviating pain during orthodontic treatment.1 passage
• Non-pharmacological interventions for assisting the induction of anaesthesia in children.1 passage
• Non-pharmacological interventions for chronic pain in multiple sclerosis.1 passage
• Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.1 passage
• Non-pharmacological interventions for depression in adults and children with traumatic brain injury.1 passage
• Non-pharmacological interventions for people with epilepsy and intellectual disabilities.1 passage
• Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.1 passage
• Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.1 passage
• Non-pharmacological interventions for sleep promotion in the intensive care unit.1 passage
• Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury.1 passage
• Non-pharmacological interventions for stuttering in children six years and younger.1 passage
• Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.2 passages
• Non-pharmacological management of infant and young child procedural pain.1 passage
• Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.1 passage
• Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews.1 passage
• Non-speech oral motor treatment for children with developmental speech sound disorders.1 passage
• Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.1 passage
• Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).1 passage
• Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents.1 passage
• Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.1 passage
• Non-steroidal anti-inflammatory drugs (NSAIDs) for trigger finger.1 passage
• Non-steroidal anti-inflammatory drugs for acute gout.1 passage
• Non-steroidal anti-inflammatory drugs for acute low back pain.1 passage
• Non-steroidal anti-inflammatory drugs for chronic low back pain.1 passage
• Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.1 passage
• Non-steroidal anti-inflammatory drugs for sciatica.1 passage
• Non-steroidal anti-inflammatory drugs for the common cold.1 passage
• Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.1 passage
• Non-surgical adjunctive interventions for accelerating tooth movement in patients undergoing fixed orthodontic treatment.1 passage
• Non-surgical interventions for acute internal hordeolum.1 passage
• Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis.1 passage
• Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.1 passage
• Non-surgical versus surgical treatment for oesophageal cancer.1 passage
• Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis.1 passage
• Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery.1 passage
• Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic.1 passage
• Nonsteroidal anti-inflammatory drugs for assisted reproductive technology.1 passage
• Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.1 passage
• Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.1 passage
• Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.1 passage
• Normal saline versus lower-chloride solutions for kidney transplantation.1 passage
• Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache.1 passage
• Nortriptyline for neuropathic pain in adults.1 passage
• Nucleic acid and antigen detection tests for leptospirosis.1 passage
• Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection.1 passage
• Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.1 passage
• Nurses as substitutes for doctors in primary care.1 passage
• Nursing interventions for smoking cessation.1 passage
• Nut consumption for the primary prevention of cardiovascular disease.1 passage
• Nutrient-enriched formula versus standard formula for preterm infants following hospital discharge.1 passage
• Nutrient-enriched formula versus standard formula for preterm infants.1 passage
• Nutrition support in hospitalised adults at nutritional risk.1 passage
• Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews.1 passage
• Nutritional advice for improving outcomes in multiple pregnancies.1 passage
• Nutritional interventions for preventing stunting in children (birth to 59 months) living in urban slums in low- and middle-income countries (LMIC).1 passage
• Nutritional interventions for survivors of childhood cancer.1 passage
• Nutritional interventions for treating foot ulcers in people with diabetes.1 passage
• Nutritional labelling for healthier food or non-alcoholic drink purchasing and consumption.1 passage
• Nutritional supplementation for hip fracture aftercare in older people.1 passage
• Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.1 passage
• Nutritional supplements for patients being treated for active visceral leishmaniasis.1 passage
• Nutritional supplements for people being treated for active tuberculosis.1 passage
• Nutritional support for critically ill children.1 passage
• Nutritional support in children and young people with cancer undergoing chemotherapy.1 passage
• Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.1 passage
• Occlusion for stimulus deprivation amblyopia.1 passage
• Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia.1 passage
• Occupational therapy for adults with problems in activities of daily living after stroke.1 passage
• Ocriplasmin for symptomatic vitreomacular adhesion.1 passage
• Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.1 passage
• Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration.1 passage
• Omega 6 fatty acids for the primary prevention of cardiovascular disease.1 passage
• Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.1 passage
• Omega-3 fatty acid addition during pregnancy.1 passage
• Omega-3 fatty acid supplementation for cystic fibrosis.1 passage
• Omega-3 fatty acids for cystic fibrosis.1 passage
• Omega-3 fatty acids for depression in adults.2 passages
• Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.1 passage
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.3 passages
• Omega-3 fatty acids for the treatment of dementia.1 passage
• Omega-6 fats for the primary and secondary prevention of cardiovascular disease.1 passage
• Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.1 passage
• Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.1 passage
• Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.2 passages
• Oncoplastic breast-conserving surgery for women with primary breast cancer.1 passage
• One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.1 passage
• One-incision versus two-incision techniques for arthroscopically assisted anterior cruciate ligament reconstruction in adults.1 passage
• One-to-one oral hygiene advice provided in a dental setting for oral health.1 passage
• Online support groups for women with breast cancer.1 passage
• Open retropubic colposuspension for urinary incontinence in women.2 passages
• Open versus closed surgical exposure of canine teeth that are displaced in the roof of the mouth.1 passage
• Open versus laparoscopic pyloromyotomy for pyloric stenosis.1 passage
• Opioid agonist treatment for pharmaceutical opioid dependent people.1 passage
• Opioid antagonists with minimal sedation for opioid withdrawal.1 passage
• Opioid treatment for opioid withdrawal in newborn infants.1 passage
• Opioids for agitation in dementia.1 passage
• Opioids for cancer pain - an overview of Cochrane reviews.1 passage
• Opioids for cancer-related pain in children and adolescents.1 passage
• Opioids for chronic non-cancer pain in children and adolescents.1 passage
• Opioids for newborn infants receiving mechanical ventilation.1 passage
• Opioids for restless legs syndrome.1 passage
• Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.1 passage
• Optic nerve head and fibre layer imaging for diagnosing glaucoma.1 passage
• Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.1 passage
• Optical coherence tomography for diagnosing skin cancer in adults.1 passage
• Optical correction of refractive error for preventing and treating eye symptoms in computer users.1 passage
• Optical reading aids for children and young people with low vision.1 passage
• Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.1 passage
• Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.2 passages
• Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.2 passages
• Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.1 passage
• Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.1 passage
• Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.1 passage
• Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.1 passage
• Oral analgesia for relieving post-caesarean pain.1 passage
• Oral and intrauterine progestogens for atypical endometrial hyperplasia.1 passage
• Oral and sublingual immunotherapy for egg allergy.1 passage
• Oral anti-diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre-existing diabetes.1 passage
• Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes.1 passage
• Oral anti-pseudomonal antibiotics for cystic fibrosis.1 passage
• Oral antibiotics for chronic blepharitis.1 passage
• Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.2 passages
• Oral antifungal medication for toenail onychomycosis.1 passage
• Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts.1 passage
• Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children.1 passage
• Oral aspirin for treating venous leg ulcers.1 passage
• Oral budesonide for induction of remission in ulcerative colitis.1 passage
• Oral calorie supplements for cystic fibrosis.1 passage
• Oral care measures for preventing nursing home-acquired pneumonia.1 passage
• Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.1 passage
• Oral contraceptives for pain associated with endometriosis.1 passage
• Oral dextrose gel for the treatment of hypoglycaemia in newborn infants.1 passage
• Oral dextrose gel to prevent hypoglycaemia in at-risk neonates.1 passage
• Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis.1 passage
• Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.1 passage
• Oral fumaric acid esters for psoriasis.1 passage
• Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.1 passage
• Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.2 passages
• Oral hygiene interventions for people with intellectual disabilities.1 passage
• Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates.1 passage
• Oral iron supplements for children in malaria-endemic areas.1 passage
• Oral isotretinoin for acne.1 passage
• Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants.1 passage
• Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.1 passage
• Oral morphine for cancer pain.1 passage
• Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.2 passages
• Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period.2 passages
• Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.2 passages
• Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults.1 passage
• Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.1 passage
• Oral nonsteroidal anti-inflammatory drugs for neuropathic pain.1 passage
• Oral paracetamol (acetaminophen) for cancer pain.1 passage
• Oral protein calorie supplementation for children with chronic disease.1 passage
• Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis.1 passage
• Oral steroids for long-term use in cystic fibrosis.1 passage
• Oral tapentadol for cancer pain.1 passage
• Oral versus inhaled antibiotics for bronchiectasis.1 passage
• Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).1 passage
• Oral versus intravenous fluoropyrimidines for colorectal cancer.1 passage
• Oral vitamin B1 passage
• Oral water soluble contrast for malignant bowel obstruction.1 passage
• Oral zinc for the prevention of hyperbilirubinaemia in neonates.1 passage
• Oral zinc for treating diarrhoea in children.1 passage
• Organisation of health services for preventing and treating pressure ulcers.1 passage
• Organisational interventions for improving wellbeing and reducing work-related stress in teachers.1 passage
• Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates.1 passage
• Organised inpatient (stroke unit) care for stroke: network meta-analysis.1 passage
• Organising healthcare services for persons with an intellectual disability.1 passage
• Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants.1 passage
• Orotracheal intubation in infants performed with a stylet versus without a stylet.1 passage
• Orthodontic treatment for deep bite and retroclined upper front teeth in children.2 passages
• Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents.1 passage
• Oscillating devices for airway clearance in people with cystic fibrosis.2 passages
• Osmotic and stimulant laxatives for the management of childhood constipation.1 passage
• Osmotic therapies added to antibiotics for acute bacterial meningitis.1 passage
• Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.1 passage
• Outpatient versus inpatient treatment for acute pulmonary embolism.1 passage
• Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.1 passage
• Ovarian surgery for symptom relief in women with polycystic ovary syndrome.1 passage
• Over the counter (OTC) artificial tear drops for dry eye syndrome.1 passage
• Oxandrolone for growth hormone-treated girls aged up to 18 years with Turner syndrome.1 passage
• Oxcarbazepine add-on for drug-resistant focal epilepsy.1 passage
• Oxcarbazepine for neuropathic pain.1 passage
• Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.1 passage
• Oxycodone for cancer-related pain.2 passages
• Oxycodone for neuropathic pain in adults.1 passage
• Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy.1 passage
• Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a rapid review.1 passage
• Oxygen therapy for acute myocardial infarction.1 passage
• Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease.1 passage
• Oxytocin antagonists for assisted reproduction.1 passage
• Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.1 passage
• Ozone therapy for treating foot ulcers in people with diabetes.1 passage
• PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer.1 passage
• PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.2 passages
• PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.1 passage
• Padma 28 for intermittent claudication.1 passage
• Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.1 passage
• Pain relief for women undergoing oocyte retrieval for assisted reproduction.1 passage
• Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment.1 passage
• Pain relief in hysterosalpingography.1 passage
• Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.1 passage
• Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.1 passage
• Palliative care interventions for people with multiple sclerosis.1 passage
• Palliative care interventions in advanced dementia.2 passages
• Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.1 passage
• Palliative drug treatments for breathlessness in cystic fibrosis.2 passages
• Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.2 passages
• Palliative pharmacological sedation for terminally ill adults.1 passage
• Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.1 passage
• Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.1 passage
• Pancreatic enzyme replacement therapy for people with cystic fibrosis.2 passages
• Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy.1 passage
• Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults.1 passage
• Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents.1 passage
• Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.2 passages
• Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.1 passage
• Paracetamol (acetaminophen) for prevention or treatment of pain in newborns.2 passages
• Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children.1 passage
• Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults.1 passage
• Paracetamol for low back pain.1 passage
• Paracetamol versus placebo for knee and hip osteoarthritis.1 passage
• Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period.1 passage
• Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.1 passage
• Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast cancer surgery.1 passage
• Paravertebral block versus thoracic epidural for patients undergoing thoracotomy.1 passage
• Parent training interventions for parents with intellectual disability.1 passage
• Parent training programmes for managing infantile colic.1 passage
• Parent-infant psychotherapy for improving parental and infant mental health.1 passage
• Parent-mediated communication interventions for improving the communication skills of preschool children with non-progressive motor disorders.1 passage
• Parent-mediated interventions for promoting communication and language development in young children with Down syndrome.1 passage
• Parent-only interventions for childhood overweight or obesity in children aged 5 to 11 years.1 passage
• Parenteral anticoagulation in ambulatory patients with cancer.1 passage
• Parenteral fluid regimens for improving functional outcome in people with acute stroke.1 passage
• Parenteral opioids for maternal pain management in labour.1 passage
• Parenteral versus enteral fluid therapy for children hospitalised with bronchiolitis.1 passage
• Parenteral versus oral iron therapy for adults and children with chronic kidney disease.1 passage
• Parenting interventions for people with schizophrenia or related serious mental illness.1 passage
• Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.1 passage
• Pars plana vitrectomy combined with scleral buckle versus pars plana vitrectomy for giant retinal tear.1 passage
• Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments.1 passage
• Partial breast irradiation for early breast cancer.1 passage
• Partial breast irradiation versus whole breast radiotherapy for early breast cancer.1 passage
• Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.1 passage
• Participation in environmental enhancement and conservation activities for health and well-being in adults: a review of quantitative and qualitative evidence.1 passage
• Patches of different types for carotid patch angioplasty.1 passage
• Patching for corneal abrasion.1 passage
• Pathogen-reduced platelets for the prevention of bleeding.1 passage
• Patient and lay carer education for preventing pressure ulceration in at-risk populations.1 passage
• Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain.1 passage
• Patient education in the management of coronary heart disease.1 passage
• Patient reminder and recall interventions to improve immunization rates.1 passage
• Patient- and parent-initiated oral steroids for asthma exacerbations.1 passage
• Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.1 passage
• Patient-initiated appointment systems for adults with chronic conditions in secondary care.1 passage
• Patient-mediated interventions to improve professional practice.1 passage
• Pay for performance for hospitals.1 passage
• Paying for performance to improve the delivery of health interventions in low- and middle-income countries.1 passage
• Payment methods for healthcare providers working in outpatient healthcare settings.1 passage
• Payment methods for outpatient care facilities.1 passage
• Peer support for people with schizophrenia or other serious mental illness.1 passage
• Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.1 passage
• Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women.1 passage
• Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women.1 passage
• Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women.1 passage
• Pelvimetry for fetal cephalic presentations at or near term for deciding on mode of delivery.1 passage
• Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review.1 passage
• Penile rehabilitation for postprostatectomy erectile dysfunction.1 passage
• Pentasaccharides for the prevention of venous thromboembolism.1 passage
• Pentasaccharides for the treatment of deep vein thrombosis.1 passage
• Pentoxifylline for intermittent claudication.2 passages
• Pentoxifylline for the treatment of endometriosis-associated pain and infertility.1 passage
• Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates.1 passage
• Perceptions and experiences of labour companionship: a qualitative evidence synthesis.1 passage
• Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates.1 passage
• Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances.1 passage
• Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbances.1 passage
• Percutaneous ethanol injection for liver metastases.1 passage
• Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.1 passage
• Percutaneous pinning for treating distal radial fractures in adults.1 passage
• Percutaneous techniques versus surgical techniques for tracheostomy.1 passage
• Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis.1 passage
• Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke.1 passage
• Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.3 passages
• Peribulbar versus retrobulbar anaesthesia for cataract surgery.1 passage
• Perineal techniques during the second stage of labour for reducing perineal trauma.1 passage
• Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection.1 passage
• Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.1 passage
• Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis.1 passage
• Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.1 passage
• Perioperative alcohol cessation intervention for postoperative complications.1 passage
• Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.1 passage
• Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients.1 passage
• Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery.1 passage
• Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing cardiac surgery.1 passage
• Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery.1 passage
• Perioperative beta-blockers for preventing surgery-related mortality and morbidity.1 passage
• Perioperative dexmedetomidine for acute pain after abdominal surgery in adults.1 passage
• Perioperative enhanced recovery programmes for gynaecological cancer patients.1 passage
• Perioperative fluid volume optimization following proximal femoral fracture.1 passage
• Perioperative interventions in pelvic organ prolapse surgery.1 passage
• Perioperative intravenous ketamine for acute postoperative pain in adults.1 passage
• Perioperative local anaesthesia for reducing pain following septal surgery.1 passage
• Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.1 passage
• Perioperative nutrition for the treatment of bladder cancer by radical cystectomy.1 passage
• Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery.1 passage
• Perioperative systemic nonsteroidal anti-inflammatory drugs (NSAIDs) in women undergoing breast surgery.1 passage
• Perioperative transversus abdominis plane (TAP) blocks for analgesia after abdominal surgery.1 passage
• Peripheral iridotomy for pigmentary glaucoma.1 passage
• Peripheral nerve blocks for hip fractures in adults.1 passage
• Peripheral nerve blocks for hip fractures.1 passage
• Peritoneal dialysis for acute kidney injury.1 passage
• Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.1 passage
• Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.2 passages
• Perphenazine for schizophrenia.1 passage
• Person-directed, non-pharmacological interventions for sleepiness at work and sleep disturbances caused by shift work.1 passage
• Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.4 passages
• Personalised asthma action plans for adults with asthma.1 passage
• Personalised care planning for adults with chronic or long-term health conditions.1 passage
• Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations.1 passage
• Personally tailored activities for improving psychosocial outcomes for people with dementia in community settings.1 passage
• Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care.1 passage
• Pessaries (mechanical devices) for managing pelvic organ prolapse in women.1 passage
• Pharmaceutical interventions for emotionalism after stroke.1 passage
• Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.1 passage
• Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers.1 passage
• Pharmaceutical policies: effects of financial incentives for prescribers.1 passage
• Pharmacist services for non-hospitalised patients.1 passage
• Pharmacologic interventions for mydriasis in cataract surgery.1 passage
• Pharmacologic interventions for treating phantom limb pain.1 passage
• Pharmacological agents for adults with acute respiratory distress syndrome.1 passage
• Pharmacological agents for the prevention of vestibular migraine.1 passage
• Pharmacological and mechanical interventions for labour induction in outpatient settings.1 passage
• Pharmacological and non-pharmacological interventions for reducing rocuronium bromide induced pain on injection in children and adults.1 passage
• Pharmacological and non-pharmacological strategies for obese women with subfertility.1 passage
• Pharmacological and surgical interventions for the treatment of gastro-oesophageal reflux in adults and children with asthma.1 passage
• Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.1 passage
• Pharmacological interventions for acute hepatitis C infection.1 passage
• Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.1 passage
• Pharmacological interventions for acute pancreatitis.1 passage
• Pharmacological interventions for antisocial personality disorder.1 passage
• Pharmacological interventions for apathy in Alzheimer's disease.1 passage
• Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.1 passage
• Pharmacological interventions for clozapine-induced sinus tachycardia.1 passage
• Pharmacological interventions for cognitive decline in people with Down syndrome.1 passage
• Pharmacological interventions for drug-using offenders.1 passage
• Pharmacological interventions for epilepsy in people with intellectual disabilities.1 passage
• Pharmacological interventions for generalised itching (not caused by systemic disease or skin lesions) in pregnancy.1 passage
• Pharmacological interventions for heart failure in people with chronic kidney disease.1 passage
• Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.1 passage
• Pharmacological interventions for pain in children and adolescents with life-limiting conditions.1 passage
• Pharmacological interventions for pain relief during orthodontic treatment.1 passage
• Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.1 passage
• Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.2 passages
• Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.1 passage
• Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.1 passage
• Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.1 passage
• Pharmacological interventions for promoting smoking cessation during pregnancy.2 passages
• Pharmacological interventions for pruritus in adult palliative care patients.1 passage
• Pharmacological interventions for recurrent abdominal pain in childhood.1 passage
• Pharmacological interventions for self-harm in adults.1 passage
• Pharmacological interventions for the prevention of acute postoperative pain in adults following brain surgery.1 passage
• Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults.1 passage
• Pharmacological interventions for the treatment of delirium in critically ill adults.1 passage
• Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.1 passage
• Pharmacological interventions for those who have sexually offended or are at risk of offending.1 passage
• Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.1 passage
• Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy.1 passage
• Pharmacological interventions for treating intrahepatic cholestasis of pregnancy.1 passage
• Pharmacological interventions for treatment-resistant depression in adults.1 passage
• Pharmacological interventions for unilateral spatial neglect after stroke.1 passage
• Pharmacological interventions other than botulinum toxin for spasticity after stroke.1 passage
• Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.1 passage
• Pharmacological therapies for management of opium withdrawal.1 passage
• Pharmacological treatment for Buerger's disease.2 passages
• Pharmacological treatment for Kleine-Levin syndrome.1 passage
• Pharmacological treatment for antipsychotic-related constipation.1 passage
• Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.1 passage
• Pharmacological treatment for continuous spike-wave during slow wave sleep syndrome and Landau-Kleffner Syndrome.1 passage
• Pharmacological treatment for familial amyloid polyneuropathy.1 passage
• Pharmacological treatment for pain in Guillain-Barré syndrome.1 passage
• Pharmacological treatment for psychotic depression.2 passages
• Pharmacological treatment of depression in people with a primary brain tumour.1 passage
• Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.1 passage
• Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm.1 passage
• Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.2 passages
• Pharmacological treatments for Friedreich ataxia.1 passage
• Pharmacological treatments for fatigue associated with palliative care.1 passage
• Pharmacological treatments for preventing epilepsy following traumatic head injury.1 passage
• Pharmacological, psychological and non-invasive brain stimulation interventions for preventing depression after stroke.1 passage
• Pharmacological, psychological, and non-invasive brain stimulation interventions for treating depression after stroke.1 passage
• Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis.1 passage
• Pharmacotherapies for cannabis dependence.1 passage
• Pharmacotherapies for sleep disturbances in dementia.2 passages
• Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.1 passage
• Pharmacotherapy for anxiety and comorbid alcohol use disorders.1 passage
• Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.1 passage
• Pharmacotherapy for hypertension in adults 60 years or older.1 passage
• Pharmacotherapy for hypertension in adults aged 18 to 59 years.1 passage
• Pharmacotherapy for hypertension-induced left ventricular hypertrophy.1 passage
• Pharmacotherapy for hyperuricaemia in hypertensive patients.1 passage
• Pharmacotherapy for hyperuricemia in hypertensive patients.1 passage
• Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.1 passage
• Pharmacotherapy for social anxiety disorder (SAnD).1 passage
• Pharmacotherapy for trichotillomania.1 passage
• Pharmacy-based management for depression in adults.1 passage
• Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.1 passage
• Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review.1 passage
• Phlebotonics for venous insufficiency.2 passages
• Phonics training for English-speaking poor readers.1 passage
• Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).1 passage
• Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.1 passage
• Phosphodiesterase 5 inhibitors for pulmonary hypertension.1 passage
• Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.1 passage
• Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.1 passage
• Photobiomodulation for non-exudative age-related macular degeneration.1 passage
• Phototherapy for atopic eczema.1 passage
• Phototherapy for treating foot ulcers in people with diabetes.1 passage
• Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.1 passage
• Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction.1 passage
• Physical activity for women with breast cancer after adjuvant therapy.1 passage
• Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-advanced colorectal cancer.1 passage
• Physical activity interventions for people with congenital heart disease.1 passage
• Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.1 passage
• Physical exercise for people with cirrhosis.1 passage
• Physical exercise for the treatment of non-ulcerated chronic venous insufficiency.1 passage
• Physical exercise training for cystic fibrosis.2 passages
• Physical exercise training for type 3 spinal muscular atrophy.1 passage
• Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.1 passage
• Physical fitness training for stroke patients.2 passages
• Physical interventions to interrupt or reduce the spread of respiratory viruses.1 passage
• Physical rehabilitation for critical illness myopathy and neuropathy.1 passage
• Physical therapies for postural abnormalities in people with cystic fibrosis.1 passage
• Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer.1 passage
• Physiological track-and-trigger/early warning systems for use in maternity care.1 passage
• Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II.1 passage
• Phytomedicines (medicines derived from plants) for sickle cell disease.3 passages
• Pilates for low back pain.1 passage
• Pine bark (Pinus spp.) extract for treating chronic disorders.1 passage
• Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.1 passage
• Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa.2 passages
• Piracetam for reducing the incidence of painful sickle cell disease crises.1 passage
• Pit and fissure sealants for preventing dental decay in permanent teeth.1 passage
• Pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teeth of children and adolescents.2 passages
• Pitavastatin for lowering lipids.1 passage
• Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.1 passage
• Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.1 passage
• Planned birth at or near term for improving health outcomes for pregnant women with pre-existing diabetes and their infants.1 passage
• Planned caesarean section for term breech delivery.1 passage
• Planned caesarean section for women with a twin pregnancy.1 passage
• Planned caesarean section versus planned vaginal birth for severe pre-eclampsia.1 passage
• Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).1 passage
• Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.1 passage
• Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term.1 passage
• Planned early delivery versus expectant management for monoamniotic twins.1 passage
• Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.1 passage
• Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.1 passage
• Plasma exchange for Guillain-Barré syndrome.1 passage
• Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.1 passage
• Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.1 passage
• Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.1 passage
• Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation.1 passage
• Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.1 passage
• Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.1 passage
• Platinum-containing regimens for metastatic breast cancer.1 passage
• Platinum-containing regimens for triple-negative metastatic breast cancer.1 passage
• Platinum-induced hearing loss after treatment for childhood cancer.1 passage
• Plugs for containing faecal incontinence.1 passage
• Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments.2 passages
• Pneumococcal conjugate vaccines for preventing acute otitis media in children.2 passages
• Pneumococcal vaccination during pregnancy for preventing infant infection.1 passage
• Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.1 passage
• Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.1 passage
• Point-of-care ultrasonography for diagnosing thoracoabdominal injuries in patients with blunt trauma.1 passage
• Point-of-use fortification of foods with micronutrient powders containing iron in children of preschool and school-age.1 passage
• Policies for replacing long-term indwelling urinary catheters in adults.1 passage
• Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.1 passage
• Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.1 passage
• Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.1 passage
• Polymer-based oral rehydration solution for treating acute watery diarrhoea.1 passage
• Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.3 passages
• Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.1 passage
• Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.1 passage
• Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.2 passages
• Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco.1 passage
• Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.1 passage
• Position in the second stage of labour for women with epidural anaesthesia.1 passage
• Position in the second stage of labour for women without epidural anaesthesia.1 passage
• Positional therapy for obstructive sleep apnoea.1 passage
• Positioning and spinal bracing for pain relief in metastatic spinal cord compression in adults.1 passage
• Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure.1 passage
• Positive end-expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia.1 passage
• Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.2 passages
• Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.1 passage
• Positive pressure therapy for Ménière's disease or syndrome.1 passage
• Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.1 passage
• Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.1 passage
• Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome.1 passage
• Post-pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults.1 passage
• Posterior musculofascial reconstruction in robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.1 passage
• Postnatal corticosteroids for transient tachypnoea of the newborn.1 passage
• Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.1 passage
• Postoperative epidural analgesia versus systemic analgesia for thoraco-lumbar spine surgery in children.1 passage
• Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early-stage cervical cancer.1 passage
• Postoperative radiotherapy for non-small cell lung cancer.1 passage
• Posture and fluids for preventing post-dural puncture headache.1 passage
• Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.1 passage
• Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.2 passages
• Pre- and postsurgical medical therapy for endometriosis surgery.1 passage
• Pre-admission antibiotics for suspected cases of meningococcal disease.1 passage
• Pre-deployment programmes for building resilience in military and frontline emergency service personnel.1 passage
• Pre-employment examinations for preventing injury, disease and sick leave in workers.1 passage
• Pre-emptive and preventive NSAIDs for postoperative pain in adults undergoing all types of surgery.1 passage
• Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery.1 passage
• Pre-emptive correction for haemodialysis arteriovenous access stenosis.1 passage
• Pre-hospital versus in-hospital initiation of cooling for survival and neuroprotection after out-of-hospital cardiac arrest.1 passage
• Prebiotics for the prevention of hyperbilirubinaemia in neonates.1 passage
• Preconception care for diabetic women for improving maternal and infant health.1 passage
• Preconception lifestyle advice for people with infertility.1 passage
• Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.3 passages
• Preformed crowns for decayed primary molar teeth.1 passage
• Pregabalin add-on for drug-resistant focal epilepsy.1 passage
• Pregabalin for decreasing pancreatic pain in chronic pancreatitis.1 passage
• Pregabalin for essential tremor.1 passage
• Pregabalin for neuropathic pain in adults.1 passage
• Prehabilitation exercise therapy before elective abdominal aortic aneurysm repair.1 passage
• Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack.1 passage
• Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.1 passage
• Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.2 passages
• Prenatal education for congenital toxoplasmosis.1 passage
• Prenatal interventions for congenital diaphragmatic hernia for improving outcomes.1 passage
• Preoperative analgesics for additional pain relief in children and adolescents having dental treatment.1 passage
• Preoperative bathing or showering with skin antiseptics to prevent surgical site infection.1 passage
• Preoperative blood transfusions for sickle cell disease.2 passages
• Preoperative chemotherapy for resectable thoracic esophageal cancer.1 passage
• Preoperative exercise training for patients with non-small cell lung cancer.1 passage
• Preoperative hair removal to reduce surgical site infection.1 passage
• Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery.1 passage
• Preoperative medical therapy before surgery for uterine fibroids.1 passage
• Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma.1 passage
• Preoperative ripening of the cervix before operative hysteroscopy.1 passage
• Preoperative skin antiseptics for preventing surgical wound infections after clean surgery.1 passage
• Preoperative statin therapy for patients undergoing cardiac surgery.1 passage
• Preoperative vascular access evaluation for haemodialysis patients.1 passage
• Prescribed hypocaloric nutrition support for critically-ill adults.1 passage
• Present-centered therapy (PCT) for post-traumatic stress disorder (PTSD) in adults.1 passage
• Pressure modification or humidification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.1 passage
• Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).1 passage
• Presurgery exercise-based conditioning interventions (prehabilitation) in adults undergoing lower limb surgery for peripheral arterial disease.1 passage
• Preventing occupational stress in healthcare workers.1 passage
• Prevention of depression in adults with long-term physical conditions.1 passage
• Preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes.1 passage
• Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.1 passage
• Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.1 passage
• Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.1 passage
• Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.1 passage
• Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people.1 passage
• Primary care professionals providing non-urgent care in hospital emergency departments.1 passage
• Primary cryotherapy for localised or locally advanced prostate cancer.1 passage
• Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.1 passage
• Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.2 passages
• Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery.1 passage
• Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.1 passage
• Primary-level worker interventions for the care of people living with mental disorders and distress in low- and middle-income countries.1 passage
• Print-based self-help interventions for smoking cessation.1 passage
• Printed educational materials: effects on professional practice and healthcare outcomes.1 passage
• Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.1 passage
• ProSeal versus Classic laryngeal mask airway (LMA) for positive pressure ventilation in adults undergoing elective surgery.1 passage
• Probing for congenital nasolacrimal duct obstruction.1 passage
• Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well-being.1 passage
• Probiotics for induction of remission in Crohn's disease.1 passage
• Probiotics for induction of remission in ulcerative colitis.1 passage
• Probiotics for maintenance of remission in ulcerative colitis.1 passage
• Probiotics for people with cystic fibrosis.1 passage
• Probiotics for people with hepatic encephalopathy.1 passage
• Probiotics for preventing acute otitis media in children.1 passage
• Probiotics for preventing acute upper respiratory tract infections.1 passage
• Probiotics for preventing gestational diabetes.1 passage
• Probiotics for preventing urinary tract infection in people with neuropathic bladder.1 passage
• Probiotics for preventing urinary tract infections in adults and children.1 passage
• Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.1 passage
• Probiotics for the prevention of pediatric antibiotic-associated diarrhea.2 passages
• Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer.1 passage
• Probiotics for treating acute infectious diarrhoea.1 passage
• Probiotics for treating eczema.1 passage
• Probiotics for vulvovaginal candidiasis in non-pregnant women.1 passage
• Probiotics to prevent infantile colic.1 passage
• Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.1 passage
• Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.1 passage
• Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.2 passages
• Procarbazine, lomustine and vincristine for recurrent high-grade glioma.1 passage
• Processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cognitive dysfunction following non-cardiac and non-neurosurgical procedures in adults.1 passage
• Professional interventions for general practitioners on the management of musculoskeletal conditions.1 passage
• Professional, structural and organisational interventions in primary care for reducing medication errors.1 passage
• Progesterone for acute traumatic brain injury.1 passage
• Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.1 passage
• Progesterone receptor modulators for endometriosis.1 passage
• Progestin-only contraceptives: effects on weight.1 passage
• Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.2 passages
• Progestogen for treating threatened miscarriage.1 passage
• Progestogen-releasing intrauterine systems for heavy menstrual bleeding.1 passage
• Progestogens for preventing miscarriage: a network meta-analysis.1 passage
• Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).1 passage
• Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.1 passage
• Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.1 passage
• Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.1 passage
• Prokinetics for functional dyspepsia.1 passage
• Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults.1 passage
• Prolonged storage of packed red blood cells for blood transfusion.1 passage
• Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.3 passages
• Prone position for acute respiratory failure in adults.1 passage
• Prophylactic abdominal drainage for pancreatic surgery.3 passages
• Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.2 passages
• Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).1 passage
• Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.1 passage
• Prophylactic antibiotics for penetrating abdominal trauma.1 passage
• Prophylactic antibiotics for penetrating abdominal trauma: duration of use and antibiotic choice.1 passage
• Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.1 passage
• Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.2 passages
• Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.1 passage
• Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.1 passage
• Prophylactic anticoagulants for people hospitalised with COVID-19.1 passage
• Prophylactic barbiturate use for the prevention of morbidity and mortality following perinatal asphyxia.1 passage
• Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.1 passage
• Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass.1 passage
• Prophylactic drug management for febrile seizures in children.2 passages
• Prophylactic intravenous calcium therapy for exchange blood transfusion in the newborn.1 passage
• Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.2 passages
• Prophylactic lidocaine for myocardial infarction.1 passage
• Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.1 passage
• Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants.1 passage
• Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.1 passage
• Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.1 passage
• Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy.1 passage
• Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.1 passage
• Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.1 passage
• Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.1 passage
• Prophylactic platelet transfusions prior to surgery for people with a low platelet count.1 passage
• Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.1 passage
• Prophylactic use of ergot alkaloids in the third stage of labour.1 passage
• Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.1 passage
• Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy.1 passage
• Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates.1 passage
• Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.1 passage
• Propofol for the promotion of sleep in adults in the intensive care unit.1 passage
• Propofol versus thiopental sodium for the treatment of refractory status epilepticus.2 passages
• Prostacyclin for pulmonary arterial hypertension.1 passage
• Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.1 passage
• Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates.1 passage
• Prostanoids for critical limb ischaemia.1 passage
• Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.1 passage
• Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.1 passage
• Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.1 passage
• Prosthetic mesh placement for the prevention of parastomal herniation.1 passage
• Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation.2 passages
• Protease activity as a prognostic factor for wound healing in venous leg ulcers.1 passage
• Protease-modulating matrix treatments for healing venous leg ulcers.1 passage
• Protein hydrolysate versus standard formula for preterm infants.2 passages
• Protein substitute for children and adults with phenylketonuria.1 passage
• Protein supplementation of human milk for promoting growth in preterm infants.2 passages
• Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients.1 passage
• Protocol-directed sedation versus non-protocol-directed sedation in mechanically ventilated intensive care adults and children.1 passage
• Protocol-directed sedation versus non-protocol-directed sedation to reduce duration of mechanical ventilation in mechanically ventilated intensive care patients.1 passage
• Protocolized versus non-protocolized weaning for reducing the duration of invasive mechanical ventilation in newborn infants.1 passage
• Proton pump inhibitors for chronic obstructive pulmonary disease.1 passage
• Proton pump inhibitors for functional dyspepsia.2 passages
• Protons versus photons for the treatment of chordoma.1 passage
• Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication.1 passage
• Provision and uptake of routine antenatal services: a qualitative evidence synthesis.1 passage
• Provision of a surgeon's performance data for people considering elective surgery.1 passage
• Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults.1 passage
• Provision of respiratory support compared to no respiratory support before cord clamping for preterm infants.1 passage
• Psychoeducation (brief) for people with serious mental illness.1 passage
• Psychoeducation for siblings of people with severe mental illness.1 passage
• Psychological and educational interventions for subfertile men and women.1 passage
• Psychological and social interventions for the prevention of mental disorders in people living in low- and middle-income countries affected by humanitarian crises.1 passage
• Psychological interventions for acute pain after open heart surgery.1 passage
• Psychological interventions for antisocial personality disorder.1 passage
• Psychological interventions for co-occurring depression and substance use disorders.1 passage
• Psychological interventions for coronary heart disease.1 passage
• Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus.1 passage
• Psychological interventions for needle-related procedural pain and distress in children and adolescents.1 passage
• Psychological interventions for parents of children and adolescents with chronic illness.2 passages
• Psychological interventions for people with hemophilia.1 passage
• Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness.1 passage
• Psychological interventions for psychosis in adolescents.1 passage
• Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy.1 passage
• Psychological interventions for women with non-metastatic breast cancer.1 passage
• Psychological interventions to foster resilience in healthcare professionals.1 passage
• Psychological interventions to foster resilience in healthcare students.1 passage
• Psychological preparation and postoperative outcomes for adults undergoing surgery under general anaesthesia.1 passage
• Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents.2 passages
• Psychological therapies for anxiety and depression in children and adolescents with long-term physical conditions.1 passage
• Psychological therapies for children and adolescents exposed to trauma.1 passage
• Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.1 passage
• Psychological therapies for people with borderline personality disorder.1 passage
• Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.1 passage
• Psychological therapies for preventing seasonal affective disorder.2 passages
• Psychological therapies for sickle cell disease and pain.1 passage
• Psychological therapies for the management of chronic and recurrent pain in children and adolescents.1 passage
• Psychological therapies for the management of chronic neuropathic pain in adults.1 passage
• Psychological therapies for the management of chronic pain (excluding headache) in adults.1 passage
• Psychological therapies for the prevention of migraine in adults.1 passage
• Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease.1 passage
• Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.1 passage
• Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises.1 passage
• Psychological therapies for treatment-resistant depression in adults.1 passage
• Psychological therapies for women who experience intimate partner violence.1 passage
• Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults.1 passage
• Psychological treatments for people with epilepsy.1 passage
• Psychosocial group interventions to improve psychological well-being in adults living with HIV.1 passage
• Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.1 passage
• Psychosocial interventions for cannabis use disorder.1 passage
• Psychosocial interventions for conversion and dissociative disorders in adults.1 passage
• Psychosocial interventions for fatigue during cancer treatment with palliative intent.1 passage
• Psychosocial interventions for improving quality of life outcomes in adults undergoing strabismus surgery.1 passage
• Psychosocial interventions for informal caregivers of people living with cancer.1 passage
• Psychosocial interventions for people with both severe mental illness and substance misuse.1 passage
• Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.1 passage
• Psychosocial interventions for preventing and treating depression in dialysis patients.1 passage
• Psychosocial interventions for recurrent abdominal pain in childhood.1 passage
• Psychosocial interventions for self-harm in adults.2 passages
• Psychosocial interventions for smoking cessation in patients with coronary heart disease.1 passage
• Psychosocial interventions for supporting women to stop smoking in pregnancy.1 passage
• Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.1 passage
• Public health deworming programmes for soil-transmitted helminths in children living in endemic areas.1 passage
• Public stewardship of private for-profit healthcare providers in low- and middle-income countries.1 passage
• Puerarin for ischaemic stroke.1 passage
• Pulmonary artery perfusion versus no perfusion during cardiopulmonary bypass for open heart surgery in adults.1 passage
• Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.1 passage
• Pulmonary rehabilitation for chronic obstructive pulmonary disease.1 passage
• Pulmonary rehabilitation for interstitial lung disease.1 passage
• Pulp treatment for extensive decay in primary teeth.1 passage
• Pulse oximeters to self monitor oxygen saturation levels as part of a personalised asthma action plan for people with asthma.1 passage
• Pulse oximetry screening for critical congenital heart defects.1 passage
• Punctal occlusion for dry eye syndrome.1 passage
• Push versus gravity for intermittent bolus gavage tube feeding of preterm and low birth weight infants.1 passage
• Pushing/bearing down methods for the second stage of labour.2 passages
• Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma.1 passage
• Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.1 passage
• Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes.1 passage
• Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.1 passage
• Qigong for the primary prevention of cardiovascular disease.1 passage
• Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.1 passage
• Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.2 passages
• Quinine for muscle cramps.1 passage
• Racecadotril for acute diarrhoea in children.1 passage
• Radical multimodality therapy for malignant pleural mesothelioma.1 passage
• Radical prostatectomy versus deferred treatment for localised prostate cancer.1 passage
• Radiofrequency denervation for chronic low back pain.1 passage
• Radioiodine therapy versus antithyroid medications for Graves' disease.1 passage
• Radiotherapy for diffuse brainstem glioma in children and young adults.1 passage
• Radiotherapy for neovascular age-related macular degeneration.1 passage
• Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B.1 passage
• Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B.1 passage
• Random drug and alcohol testing for preventing injury in workers.1 passage
• Ranolazine for stable angina pectoris.1 passage
• Rapamycin and rapalogs for tuberous sclerosis complex.1 passage
• Rapid COJEC versus standard induction therapies for high-risk neuroblastoma.1 passage
• Rapid antigen detection test for group A streptococcus in children with pharyngitis.1 passage
• Rapid diagnostic tests for Plasmodium vivax malaria in endemic countries.1 passage
• Rapid diagnostic tests for plague.1 passage
• Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever.1 passage
• Rapid initiation of antiretroviral therapy for people living with HIV.1 passage
• Rapid point of care test for detecting urogenital Chlamydia trachomatis infection in nonpregnant women and men at reproductive age.1 passage
• Rapid versus slow withdrawal of antiepileptic drugs.1 passage
• Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection.1 passage
• Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.2 passages
• Re-feeding versus discarding gastric residuals to improve growth in preterm infants.1 passage
• Reactive air surfaces for preventing pressure ulcers.1 passage
• Reading aids for adults with low vision.1 passage
• Ready-to-use therapeutic food (RUTF) for home-based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age.1 passage
• Real-time video counselling for smoking cessation.1 passage
• Recall intervals for oral health in primary care patients.1 passage
• Recanalisation therapies for wake-up stroke.1 passage
• Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.1 passage
• Recombinant growth hormone therapy for X-linked hypophosphatemia in children.1 passage
• Recombinant growth hormone therapy for cystic fibrosis in children and young adults.3 passages
• Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis.1 passage
• Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.1 passage
• Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.1 passage
• Reconstructive surgery for treating pressure ulcers.1 passage
• Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation.1 passage
• Red blood cell transfusion for people undergoing hip fracture surgery.1 passage
• Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.1 passage
• Reducing medication errors for adults in hospital settings.1 passage
• Reduction in saturated fat intake for cardiovascular disease.3 passages
• Reduction of the number of fetuses for women with a multiple pregnancy.1 passage
• Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults.1 passage
• Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults.1 passage
• Regimens of fetal surveillance of suspected large-for-gestational-age fetuses for improving health outcomes.1 passage
• Regimens of ultrasound surveillance for twin pregnancies for improving outcomes.1 passage
• Regimens of vitamin D supplementation for women during pregnancy.1 passage
• Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy.1 passage
• Regional analgesia for improvement of long-term functional outcome after elective large joint replacement.1 passage
• Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.1 passage
• Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction.1 passage
• Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.2 passages
• Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.1 passage
• Rehabilitation following carpal tunnel release.1 passage
• Rehabilitation following surgery for flexor tendon injuries of the hand.1 passage
• Rehabilitation for distal radial fractures in adults.1 passage
• Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews.1 passage
• Reiki for depression and anxiety.1 passage
• Relapse prevention interventions for smoking cessation.2 passages
• Relaxation techniques for pain management in labour.1 passage
• Relief of pain due to uterine cramping/involution after birth.1 passage
• Remdesivir for the treatment of COVID-19.1 passage
• Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma.1 passage
• Reminiscence therapy for dementia.1 passage
• Remote ischaemic conditioning for preventing and treating ischaemic stroke.1 passage
• Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).1 passage
• Remote versus face-to-face check-ups for asthma.1 passage
• Remotely delivered information, training and support for informal caregivers of people with dementia.1 passage
• Renal denervation for resistant hypertension.2 passages
• Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.1 passage
• Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.1 passage
• Repeated lumbar or ventricular punctures in newborns with intraventricular haemorrhage.1 passage
• Repetitive peripheral magnetic stimulation for activities of daily living and functional ability in people after stroke.1 passage
• Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke.1 passage
• Repetitive task training for improving functional ability after stroke.1 passage
• Repositioning for pressure injury prevention in adults.1 passage
• Repositioning for treating pressure ulcers.1 passage
• Rescue high-frequency jet ventilation versus conventional ventilation for severe pulmonary dysfunction in preterm infants.1 passage
• Resorbable versus titanium plates for orthognathic surgery.1 passage
• Respiratory muscle training for cystic fibrosis.2 passages
• Respiratory muscle training for multiple sclerosis.1 passage
• Respiratory muscle training in children and adults with neuromuscular disease.1 passage
• Responsive versus scheduled feeding for preterm infants.2 passages
• Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome.1 passage
• Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.1 passage
• Resveratrol for adults with type 2 diabetes mellitus.1 passage
• Retention procedures for stabilising tooth position after treatment with orthodontic braces.1 passage
• Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.1 passage
• Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.1 passage
• Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies.1 passage
• Retroperitoneal versus transperitoneal approach for elective open abdominal aortic aneurysm repair.1 passage
• Return-to-work coordination programmes for improving return to work in workers on sick leave.1 passage
• Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.1 passage
• Revascularisation of the left subclavian artery for thoracic endovascular aortic repair.1 passage
• Ribavirin for treating Crimean Congo haemorrhagic fever.1 passage
• Rigid dressings versus soft dressings for transtibial amputations.1 passage
• Rinse-free hand wash for reducing absenteeism among preschool and school children.1 passage
• Risk assessment tools for the prevention of pressure ulcers.1 passage
• Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.1 passage
• Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.1 passage
• Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease.1 passage
• Risk scoring for the primary prevention of cardiovascular disease.1 passage
• Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.1 passage
• Risk-reducing mastectomy for the prevention of primary breast cancer.1 passage
• Risk-reducing medications for primary breast cancer: a network meta-analysis.1 passage
• Risk-scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes.1 passage
• Risperidone (depot) for schizophrenia.1 passage
• Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).1 passage
• Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.1 passage
• Risperidone versus placebo for schizophrenia.1 passage
• Rituximab for eradicating inhibitors in people with acquired haemophilia A.2 passages
• Rituximab for people with multiple sclerosis.1 passage
• Rituximab for rheumatoid arthritis.1 passage
• Rituximab for treating inhibitors in people with inherited severe hemophilia.3 passages
• Rivastigmine for Alzheimer's disease.1 passage
• Robot-assisted surgery in gynaecology.1 passage
• Robotic versus open radical cystectomy for bladder cancer in adults.1 passage
• Rocuronium versus succinylcholine for rapid sequence induction intubation.1 passage
• Rooming-in for new mother and infant versus separate care for increasing the duration of breastfeeding.1 passage
• Root coverage procedures for treating localised and multiple recession-type defects.1 passage
• Roselle for hypertension in adults.1 passage
• Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection.1 passage
• Routes of administration of antibiotic prophylaxis for preventing infection after caesarean section.1 passage
• Routine Health Information System (RHIS) improvements for strengthened health system management.1 passage
• Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity.1 passage
• Routine blood cultures in the management of pyelonephritis in pregnancy for improving outcomes.1 passage
• Routine intracranial pressure monitoring in acute coma.1 passage
• Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.1 passage
• Routine laboratory testing to determine if a patient has COVID-19.1 passage
• Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants.1 passage
• Routine oro/nasopharyngeal suction versus no suction at birth.1 passage
• Routine preoperative medical testing for cataract surgery.1 passage
• Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice.1 passage
• Routine scale and polish for periodontal health in adults.1 passage
• Routine ultrasound for fetal assessment before 24 weeks' gestation.1 passage
• Routine ultrasound in late pregnancy (after 24 weeks' gestation).1 passage
• Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults.1 passage
• Routine vitamin A supplementation for the prevention of blindness due to measles infection in children.1 passage
• Roux-en-Y versus Billroth-I reconstruction after distal gastrectomy for gastric cancer.1 passage
• Rubber dam isolation for restorative treatment in dental patients.1 passage
• Rufinamide add-on therapy for drug-resistant epilepsy.1 passage
• Rufinamide add-on therapy for refractory epilepsy.1 passage
• Rutosides for prevention of post-thrombotic syndrome.2 passages
• Rutosides for treatment of post-thrombotic syndrome.2 passages
• S-adenosyl methionine (SAMe) for depression in adults.1 passage
• Sacral nerve stimulation for faecal incontinence and constipation in adults.1 passage
• Safety of topical corticosteroids in pregnancy.1 passage
• Salbutamol for transient tachypnea of the newborn.2 passages
• Saline irrigation for allergic rhinitis.1 passage
• Saline irrigation for chronic rhinosinusitis.1 passage
• Saline irrigation for the management of skin extravasation injury in neonates.1 passage
• Saline nasal irrigation for acute upper respiratory tract infections.1 passage
• Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.1 passage
• Sapropterin dihydrochloride for phenylketonuria.1 passage
• Scalpel versus electrosurgery for major abdominal incisions.1 passage
• Schedules for home visits in the early postpartum period.2 passages
• School dental screening programmes for oral health.2 passages
• School-based education programmes for the prevention of child sexual abuse.1 passage
• School-based education programmes for the prevention of unintentional injuries in children and young people.1 passage
• School-based interventions for improving contraceptive use in adolescents.1 passage
• School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents.1 passage
• School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.1 passage
• School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review.1 passage
• Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.1 passage
• Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.1 passage
• Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health.1 passage
• Screening for aspiration risk associated with dysphagia in acute stroke.1 passage
• Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.1 passage
• Screening for nasopharyngeal cancer.1 passage
• Screening for reducing morbidity and mortality in malignant melanoma.1 passage
• Screening for type 2 diabetes mellitus.1 passage
• Screening hysteroscopy in subfertile women and women undergoing assisted reproduction.1 passage
• Screening strategies for hypertension.1 passage
• Screening tests for active pulmonary tuberculosis in children.1 passage
• Screening with urinary dipsticks for reducing morbidity and mortality.1 passage
• Screening women for intimate partner violence in healthcare settings.1 passage
• Sealing procedures for preterm prelabour rupture of membranes.1 passage
• Search strategies to identify observational studies in MEDLINE and Embase.1 passage
• Second-generation antidepressants for preventing seasonal affective disorder in adults.2 passages
• Second-generation antidepressants for treatment of seasonal affective disorder.1 passage
• Second-line systemic therapy for metastatic colorectal cancer.1 passage
• Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.1 passage
• Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.1 passage
• Sedation of children undergoing dental treatment.1 passage
• Sedation versus general anaesthesia for provision of dental treatment to patients younger than 18 years.1 passage
• Sedatives for opioid withdrawal in newborn infants.1 passage
• Selective noradrenaline reuptake inhibitors for schizophrenia.1 passage
• Selective oestrogen receptor modulators (SERMs) for endometriosis.1 passage
• Selective progesterone receptor modulators (SPRMs) for uterine fibroids.1 passage
• Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.1 passage
• Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.1 passage
• Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.1 passage
• Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.2 passages
• Selective serotonin reuptake inhibitors for fibromyalgia syndrome.1 passage
• Selective versus routine use of episiotomy for vaginal birth.1 passage
• Selenium for preventing cancer.1 passage
• Selenium supplementation for critically ill adults.1 passage
• Self management interventions for type 2 diabetes in adult people with severe mental illness.1 passage
• Self management programmes for quality of life in people with stroke.1 passage
• Self-administered versus provider-administered medical abortion.1 passage
• Self-certification versus physician certification of sick leave for reducing sickness absence and associated costs.1 passage
• Self-management for bronchiectasis.1 passage
• Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.1 passage
• Self-monitoring and self-management of oral anticoagulation.1 passage
• Semen preparation techniques for intrauterine insemination.1 passage
• Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation.1 passage
• Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.1 passage
• Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.1 passage
• Septum resection for women of reproductive age with a septate uterus.1 passage
• Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.1 passage
• Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.1 passage
• Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.1 passage
• Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.1 passage
• Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis.1 passage
• Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.1 passage
• Serum or plasma ferritin concentration as an index of iron deficiency and overload.1 passage
• Setting and techniques for monitoring blood pressure during pregnancy.1 passage
• Severe fatigue after treatment for childhood cancer.1 passage
• Sexual counselling for sexual problems in patients with cardiovascular disease.1 passage
• Shared care across the interface between primary and specialty care in management of long term conditions.1 passage
• Shared decision-making for people with asthma.1 passage
• Shock wave therapy for rotator cuff disease with or without calcification.1 passage
• Short versus long feeding interval for bolus feedings in very preterm infants.1 passage
• Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients.1 passage
• Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.1 passage
• Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.1 passage
• Short-course oral steroids alone for chronic rhinosinusitis.1 passage
• Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.1 passage
• Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.2 passages
• Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients.1 passage
• Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.1 passage
• Short-term and long-term effects of tibolone in postmenopausal women.1 passage
• Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.1 passage
• Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy.1 passage
• Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.1 passage
• Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.1 passage
• Sildenafil for pulmonary hypertension in neonates.1 passage
• Silicone gel sheeting for treating hypertrophic scars.1 passage
• Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.1 passage
• Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients.1 passage
• Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults.1 passage
• Simulated presence therapy for dementia.2 passages
• Singing as an adjunct therapy for children and adults with cystic fibrosis.1 passage
• Singing for adults with chronic obstructive pulmonary disease (COPD).1 passage
• Single crowns versus conventional fillings for the restoration of root-filled teeth.1 passage
• Single dose dipyrone (metamizole) for acute postoperative pain in adults.1 passage
• Single dose intra-articular morphine for pain control after knee arthroscopy.1 passage
• Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain.1 passage
• Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews.1 passage
• Single dose oral diclofenac for acute postoperative pain in adults.1 passage
• Single dose oral ibuprofen plus caffeine for acute postoperative pain in adults.1 passage
• Single dose oral ibuprofen plus codeine for acute postoperative pain in adults.1 passage
• Single dose oral ketoprofen or dexketoprofen for acute postoperative pain in adults.1 passage
• Single herbal medicine for diabetic retinopathy.1 passage
• Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.1 passage
• Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.2 passages
• Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.2 passages
• Single versus multiple visits for endodontic treatment of permanent teeth.1 passage
• Single-dose intravenous diclofenac for acute postoperative pain in adults.1 passage
• Single-dose intravenous ibuprofen for acute postoperative pain in adults.1 passage
• Single-dose intravenous ketorolac for acute postoperative pain in adults.1 passage
• Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma.1 passage
• Single-incision sling operations for urinary incontinence in women.1 passage
• Sinonasal debridement versus no debridement for the postoperative care of patients undergoing endoscopic sinus surgery.1 passage
• Siponimod for multiple sclerosis.1 passage
• Six-month therapy for abdominal tuberculosis.1 passage
• Skin antisepsis for reducing central venous catheter-related infections.1 passage
• Skin care interventions in infants for preventing eczema and food allergy.1 passage
• Skin grafting and tissue replacement for treating foot ulcers in people with diabetes.1 passage
• Skin preparation for preventing infection following caesarean section.2 passages
• Skin preparation with alcohol versus alcohol followed by any antiseptic for preventing bacteraemia or contamination of blood for transfusion.1 passage
• Skin-to-skin care for procedural pain in neonates.1 passage
• Sleep positioning systems for children with cerebral palsy.1 passage
• Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus.1 passage
• Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.3 passages
• Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity.2 passages
• Slow-release fluoride devices for the control of dental decay.1 passage
• Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma.1 passage
• Smectite for acute infectious diarrhoea in children.1 passage
• Smoking cessation advice for people with serious mental illness.1 passage
• Smoking cessation for improving mental health.1 passage
• Smoking cessation for people with chronic obstructive pulmonary disease.1 passage
• Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.1 passage
• Smoking cessation interventions for pulmonary tuberculosis treatment outcomes.1 passage
• Smoking reduction interventions for smoking cessation.1 passage
• Snake antivenom for snake venom induced consumption coagulopathy.1 passage
• Social norms information for alcohol misuse in university and college students.2 passages
• Social skills programmes for schizophrenia.1 passage
• Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.1 passage
• Sodium channel blockers for neuroprotection in multiple sclerosis.1 passage
• Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.1 passage
• Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.1 passage
• Sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants.2 passages
• Sound therapy (using amplification devices and/or sound generators) for tinnitus.1 passage
• Souvenaid for Alzheimer's disease.1 passage
• Specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant outcomes.1 passage
• Specialised early intervention teams (extended time) for recent-onset psychosis.1 passage
• Specialised early intervention teams for recent-onset psychosis.1 passage
• Specialist breast care nurses for support of women with breast cancer.1 passage
• Specialist teams for neonatal transport to neonatal intensive care units for prevention of morbidity and mortality.1 passage
• Specific allergen immunotherapy for the treatment of atopic eczema.1 passage
• Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children.1 passage
• Spectral entropy monitoring for adults and children undergoing general anaesthesia.1 passage
• Speech and language therapy for aphasia following stroke.1 passage
• Speech and language therapy for management of chronic cough.1 passage
• Speech therapy for children with dysarthria acquired before three years of age.1 passage
• Sphincterotomy for biliary sphincter of Oddi dysfunction.1 passage
• Spinal cord stimulation for cancer-related pain in adults.1 passage
• Splenectomy for people with thalassaemia major or intermedia.2 passages
• Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease.2 passages
• Standard (head-down tilt) versus modified (without head-down tilt) postural drainage in infants and young children with cystic fibrosis.1 passage
• Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.3 passages
• Standardised formal resuscitation training programmes for reducing mortality and morbidity in newborn infants.1 passage
• Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomy.1 passage
• Statins for age-related macular degeneration.2 passages
• Statins for asthma.1 passage
• Statins for children with familial hypercholesterolemia.2 passages
• Statins for the prevention of dementia.1 passage
• Statins versus placebo for people with chronic obstructive pulmonary disease.1 passage
• Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.1 passage
• Stem cell therapy for dilated cardiomyopathy.1 passage
• Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).1 passage
• Stem cell transplantation for ischemic stroke.1 passage
• Stem cell treatment for acute myocardial infarction.1 passage
• Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants.1 passage
• Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants.1 passage
• Stent graft types for endovascular repair of abdominal aortic aneurysms.1 passage
• Stent graft types for endovascular repair of thoracic aortic aneurysms.1 passage
• Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction.1 passage
• Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy.1 passage
• Stepping down the dose of inhaled corticosteroids for adults with asthma.1 passage
• Steroid avoidance or withdrawal for kidney transplant recipients.1 passage
• Steroid-eluting sinus stents for improving symptoms in chronic rhinosinusitis patients undergoing functional endoscopic sinus surgery.1 passage
• Steroidal contraceptives and bone fractures in women: evidence from observational studies.1 passage
• Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.1 passage
• Steroids for symptom control in infectious mononucleosis.1 passage
• Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting.1 passage
• Stiripentol add-on therapy for drug-resistant focal epilepsy.1 passage
• Stiripentol add-on therapy for focal refractory epilepsy.1 passage
• Stiripentol for focal refractory epilepsy.1 passage
• Stopping enteral feeds for prevention of transfusion-associated necrotising enterocolitis in preterm infants.1 passage
• Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.1 passage
• Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids.1 passage
• Strategies for detecting colon cancer in patients with inflammatory bowel disease.1 passage
• Strategies for enhancing the implementation of school-based policies or practices targeting risk factors for chronic disease.1 passage
• Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy.2 passages
• Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth.1 passage
• Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.1 passage
• Strategies for the discontinuation of humidified high flow nasal cannula (HHFNC) in preterm infants.1 passage
• Strategies for the removal of short-term indwelling urethral catheters in adults.1 passage
• Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.1 passage
• Strategies to improve recruitment to randomised trials.1 passage
• Strategies to improve retention in randomised trials.1 passage
• Strategies to improve smoking cessation rates in primary care.1 passage
• Strategies to improve the implementation of healthy eating, physical activity and obesity prevention policies, practices or programmes within childcare services.2 passages
• Strategies to improve the implementation of workplace-based policies or practices targeting tobacco, alcohol, diet, physical activity and obesity.1 passage
• Strategies to increase the ownership and use of insecticide-treated bednets to prevent malaria.1 passage
• Strength training and aerobic exercise training for muscle disease.1 passage
• Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.1 passage
• Structured telephone support or non-invasive telemonitoring for patients with heart failure.1 passage
• Sub-Tenon's anaesthesia versus topical anaesthesia for cataract surgery.1 passage
• Subacromial decompression surgery for rotator cuff disease.1 passage
• Subconjunctival draining minimally-invasive glaucoma devices for medically uncontrolled glaucoma.1 passage
• Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.1 passage
• Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.1 passage
• Subcuticular sutures for skin closure in non-obstetric surgery.1 passage
• Subfascial endoscopic perforator surgery (SEPS) for treating venous leg ulcers.1 passage
• Subintimal angioplasty for lower limb arterial chronic total occlusions.1 passage
• Sublingual immunotherapy for asthma.2 passages
• Subpial transection surgery for epilepsy.2 passages
• Subsidising artemisinin-based combination therapy in the private retail sector.1 passage
• Sucrose for analgesia in newborn infants undergoing painful procedures.1 passage
• Sulodexide for treating venous leg ulcers.1 passage
• Sulthiame add-on therapy for epilepsy.2 passages
• Sulthiame monotherapy for epilepsy.1 passage
• Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.1 passage
• Sun protection for preventing basal cell and squamous cell skin cancers.1 passage
• Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates.1 passage
• Supervised dosing with a long-acting opioid medication in the management of opioid dependence.1 passage
• Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.1 passage
• Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic obstructive pulmonary disease.1 passage
• Supplemental oxygen for caesarean section during regional anaesthesia.1 passage
• Supplemental perioperative intravenous crystalloids for postoperative nausea and vomiting.1 passage
• Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development.1 passage
• Supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby.1 passage
• Support during pregnancy for women at increased risk of low birthweight babies.1 passage
• Support for healthy breastfeeding mothers with healthy term babies.1 passage
• Support surfaces for pressure ulcer prevention.1 passage
• Support surfaces for treating pressure ulcers.1 passage
• Supportive interventions for enhancing dietary intake in malnourished or nutritionally at-risk adults.1 passage
• Supportive periodontal therapy (SPT) for maintaining the dentition in adults treated for periodontitis.1 passage
• Supportive therapy for schizophrenia.1 passage
• Surfactant for pulmonary haemorrhage in neonates.1 passage
• Surfactant therapy for bronchiolitis in critically ill infants.1 passage
• Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.1 passage
• Surgery for Dupuytren's contracture of the fingers.1 passage
• Surgery for cataracts in people with age-related macular degeneration.1 passage
• Surgery for complete (full-thickness) rectal prolapse in adults.1 passage
• Surgery for deep venous incompetence.1 passage
• Surgery for deep venous insufficiency.1 passage
• Surgery for epilepsy.2 passages
• Surgery for idiopathic epiretinal membrane.1 passage
• Surgery for limited-stage small-cell lung cancer.1 passage
• Surgery for nonarteritic anterior ischemic optic neuropathy.1 passage
• Surgery for patellar tendinopathy (jumper's knee).1 passage
• Surgery for postvitrectomy cataract.1 passage
• Surgery for rotator cuff tears.1 passage
• Surgery for scoliosis in Duchenne muscular dystrophy.1 passage
• Surgery for small asymptomatic abdominal aortic aneurysms.2 passages
• Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.1 passage
• Surgery for the treatment of obesity in children and adolescents.1 passage
• Surgery for thumb (trapeziometacarpal joint) osteoarthritis.1 passage
• Surgery for trigger finger.1 passage
• Surgery for tubal infertility.1 passage
• Surgery for women with anterior compartment prolapse.1 passage
• Surgery for women with apical vaginal prolapse.1 passage
• Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.1 passage
• Surgery for women with posterior compartment prolapse.1 passage
• Surgery versus medical therapy for heavy menstrual bleeding.1 passage
• Surgery versus non-surgical management for unilateral ureteric-pelvic junction obstruction in newborns and infants less than two years of age.1 passage
• Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.1 passage
• Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis.1 passage
• Surgery versus thrombolysis for initial management of acute limb ischaemia.1 passage
• Surgical adjunctive procedures for accelerating orthodontic treatment.1 passage
• Surgical and medical interventions for abdominal aortic graft infections.1 passage
• Surgical and radiological interventions for treating symptomatic extracranial cervical artery dissection.1 passage
• Surgical approach to hysterectomy for benign gynaecological disease.1 passage
• Surgical fixation methods for tibial plateau fractures.1 passage
• Surgical hand antisepsis to reduce surgical site infection.1 passage
• Surgical interventions for infantile nystagmus syndrome.1 passage
• Surgical interventions for lamellar macular holes.1 passage
• Surgical interventions for primary congenital glaucoma.2 passages
• Surgical interventions for symptomatic mild to moderate knee osteoarthritis.1 passage
• Surgical interventions for the early management of Bell's palsy.1 passage
• Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment.1 passage
• Surgical interventions for treating acute fractures or non-union of the middle third of the clavicle.1 passage
• Surgical interventions for treating distal tibial metaphyseal fractures in adults.1 passage
• Surgical interventions for vertical strabismus in superior oblique palsy.1 passage
• Surgical options for lumbar spinal stenosis.1 passage
• Surgical or radiological treatment for varicoceles in subfertile men.1 passage
• Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.1 passage
• Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.1 passage
• Surgical removal versus retention for the management of asymptomatic disease-free impacted wisdom teeth.2 passages
• Surgical techniques for the removal of mandibular wisdom teeth.1 passage
• Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.1 passage
• Surgical treatment of fibroids for subfertility.1 passage
• Surgical versus conservative interventions for treating acromioclavicular dislocation of the shoulder in adults.1 passage
• Surgical versus conservative interventions for treating anterior cruciate ligament injuries.1 passage
• Surgical versus conservative interventions for treating fractures of the middle third of the clavicle.1 passage
• Surgical versus non-surgical interventions for treating patellar dislocation.1 passage
• Surgical versus non-surgical interventions in people with adolescent idiopathic scoliosis.1 passage
• Surgical versus non-surgical management for pleural empyema.1 passage
• Surgical versus non-surgical management of abdominal injury.1 passage
• Surgical versus non-surgical treatment for lumbar spinal stenosis.1 passage
• Surgical versus nonsurgical interventions for flail chest.1 passage
• Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer.1 passage
• Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes.3 passages
• Swallowing therapy for dysphagia in acute and subacute stroke.1 passage
• Sweet tasting solutions for reduction of needle-related procedural pain in children aged one to 16 years.1 passage
• Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth.1 passage
• Symptom screening for active tuberculosis in pregnant women living with HIV.1 passage
• Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.1 passage
• Synchronized mechanical ventilation for respiratory support in newborn infants.1 passage
• System change interventions for smoking cessation.1 passage
• Systematic screening and assessment of psychosocial well-being and care needs of people with cancer.1 passage
• Systematic screening for the detection of atrial fibrillation.1 passage
• Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease.1 passage
• Systemic administration of local anesthetic agents to relieve neuropathic pain.1 passage
• Systemic and topical antibiotics for chronic rhinosinusitis.1 passage
• Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults.1 passage
• Systemic antibiotics for treating diabetic foot infections.1 passage
• Systemic antibiotics for treating malignant wounds.1 passage
• Systemic antifungal therapy for tinea capitis in children.1 passage
• Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.1 passage
• Systemic corticosteroids for acute otitis media in children.1 passage
• Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.1 passage
• Systemic corticosteroids for the treatment of COVID-19.1 passage
• Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years.1 passage
• Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.3 passages
• Systemic treatment for blepharokeratoconjunctivitis in children.1 passage
• Systemic treatments for eczema: a network meta-analysis.1 passage
• Systemic treatments for metastatic cutaneous melanoma.1 passage
• TNF-alpha inhibitors for ankylosing spondylitis.1 passage
• TNF-α blockers for the treatment of Kawasaki disease in children.1 passage
• Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.2 passages
• Tai Chi for chronic obstructive pulmonary disease (COPD).1 passage
• Tai Chi for rheumatoid arthritis.1 passage
• Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.1 passage
• Tailored interventions to address determinants of practice.1 passage
• Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.1 passage
• Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.1 passage
• Tapentadol for chronic musculoskeletal pain in adults.1 passage
• Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.1 passage
• Targeted client communication via mobile devices for improving maternal, neonatal, and child health.1 passage
• Targeted client communication via mobile devices for improving sexual and reproductive health.1 passage
• Targeted mass media interventions promoting healthy behaviours to reduce risk of non-communicable diseases in adult, ethnic minorities.1 passage
• Targeted therapy for metastatic renal cell carcinoma.1 passage
• Task-oriented interventions for children with developmental co-ordination disorder.1 passage
• Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.1 passage
• Taxane-containing regimens for metastatic breast cancer.1 passage
• Taxanes for adjuvant treatment of early breast cancer.1 passage
• Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes.1 passage
• Taxation of unprocessed sugar or sugar-added foods for reducing their consumption and preventing obesity or other adverse health outcomes.1 passage
• Tea tree oil for Demodex blepharitis.1 passage
• Techniques for assisting difficult delivery at caesarean section.1 passage
• Techniques for preventing hypotension during spinal anaesthesia for caesarean section.1 passage
• Techniques for the interruption of tubal patency for female sterilisation.2 passages
• Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.2 passages
• Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury.1 passage
• Teledermatology for diagnosing skin cancer in adults.1 passage
• Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).1 passage
• Telephone counselling for smoking cessation.1 passage
• Telephone interventions for symptom management in adults with cancer.1 passage
• Telephone interventions, delivered by healthcare professionals, for providing education and psychosocial support for informal caregivers of adults with diagnosed illnesses.1 passage
• Telerehabilitation for chronic respiratory disease.1 passage
• Telerehabilitation for people with low vision.2 passages
• Telerehabilitation for persons with multiple sclerosis.1 passage
• Telerehabilitation services for stroke.1 passage
• Temperature of embryo culture for assisted reproduction.1 passage
• Teriflunomide for multiple sclerosis.1 passage
• Terlipressin versus other vasoactive drugs for hepatorenal syndrome.1 passage
• Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.1 passage
• Tests for detecting strabismus in children aged 1 to 6 years in the community.1 passage
• Tests to detect and inform the diagnosis of root caries.1 passage
• The Neonatal Behavioral Assessment Scale (NBAS) and Newborn Behavioral Observations (NBO) system for supporting caregivers and improving outcomes in caregivers and their infants.1 passage
• The effect of time spent in rehabilitation on activity limitation and impairment after stroke.1 passage
• The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.1 passage
• The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.1 passage
• The effects of high perioperative inspiratory oxygen fraction for adult surgical patients.1 passage
• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.1 passage
• The effects of interactive training of healthcare providers on the management of life-threatening emergencies in hospital.1 passage
• The impact of biological interventions for ulcerative colitis on health-related quality of life.1 passage
• The impact of surgical therapies for inflammatory bowel disease on female fertility.1 passage
• The role of high-frequency oscillations in epilepsy surgery planning.1 passage
• The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents.1 passage
• The use of propofol for procedural sedation in emergency departments.1 passage
• The use of ultrasound guidance for perioperative neuraxial and peripheral nerve blocks in children.2 passages
• Theory-based interventions for contraception.1 passage
• Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.1 passage
• Therapeutic touch for healing acute wounds.1 passage
• Therapeutic ultrasound for chronic low back pain.1 passage
• Therapeutic ultrasound for venous leg ulcers.1 passage
• Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.2 passages
• This Cochrane Review is closed: deciding what constitutes enough research and where next for pulmonary rehabilitation in COPD.1 passage
• Thoracic endovascular repair (TEVAR) versus open surgery for blunt traumatic thoracic aortic injury.2 passages
• Thoracic imaging tests for the diagnosis of COVID-19.3 passages
• Thoracic stent graft versus surgery for thoracic aneurysm.1 passage
• Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions.1 passage
• Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding.1 passage
• Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding.1 passage
• Thrombolysis for acute deep vein thrombosis.1 passage
• Thrombolysis for acute upper extremity deep vein thrombosis.1 passage
• Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb.1 passage
• Thrombolytic therapy for pulmonary embolism.3 passages
• Thrombopoietin mimetics for patients with myelodysplastic syndromes.1 passage
• Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.1 passage
• Thyroid surgery for Graves' disease and Graves' ophthalmopathy.1 passage
• Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism.1 passage
• Tiagabine add-on therapy for drug-resistant focal epilepsy.1 passage
• Time course for blood pressure lowering of beta-blockers with partial agonist activity.1 passage
• Time-lapse systems for embryo incubation and assessment in assisted reproduction.3 passages
• Time-limited home-care reablement services for maintaining and improving the functional independence of older adults.1 passage
• Timed intercourse for couples trying to conceive.1 passage
• Timing of dornase alfa inhalation for cystic fibrosis.3 passages
• Timing of hypertonic saline inhalation for cystic fibrosis.1 passage
• Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis.1 passage
• Timing of renal replacement therapy initiation for acute kidney injury.1 passage
• Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.1 passage
• Tobacco cessation interventions for young people.1 passage
• Tobacco packaging design for reducing tobacco use.1 passage
• Tocilizumab for giant cell arteritis.1 passage
• Tocilizumab for thyroid eye disease.1 passage
• Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.1 passage
• Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA).1 passage
• Tonsillectomy or adenotonsillectomy versus non-surgical management for obstructive sleep-disordered breathing in children.1 passage
• Tonsillectomy versus tonsillotomy for obstructive sleep-disordered breathing in children.1 passage
• Tools developed and disseminated by guideline producers to promote the uptake of their guidelines.1 passage
• Topical NSAIDs for acute musculoskeletal pain in adults.1 passage
• Topical NSAIDs for chronic musculoskeletal pain in adults.1 passage
• Topical anaesthesia for needle-related pain in newborn infants.1 passage
• Topical anaesthetics for pain control during repair of dermal laceration.1 passage
• Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews.1 passage
• Topical and device-based treatments for fungal infections of the toenails.1 passage
• Topical and systemic antifungal therapy for chronic rhinosinusitis.1 passage
• Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation.1 passage
• Topical antibiotics for chronic suppurative otitis media.1 passage
• Topical antibiotics for preventing surgical site infection in wounds healing by primary intention.1 passage
• Topical antifungals for seborrhoeic dermatitis.1 passage
• Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.1 passage
• Topical antimicrobial agents for treating foot ulcers in people with diabetes.1 passage
• Topical antiseptics for chronic suppurative otitis media.1 passage
• Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.1 passage
• Topical azole treatments for otomycosis.1 passage
• Topical benzoyl peroxide for acne.1 passage
• Topical capsaicin (high concentration) for chronic neuropathic pain in adults.1 passage
• Topical clonidine for neuropathic pain.1 passage
• Topical cyclosporine A therapy for dry eye syndrome.1 passage
• Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.1 passage
• Topical emollient for preventing infection in preterm infants.2 passages
• Topical medication instillation techniques for glaucoma.1 passage
• Topical microbicides for preventing sexually transmitted infections.1 passage
• Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.1 passage
• Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema.1 passage
• Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions.1 passage
• Topical phenytoin for treating pressure ulcers.1 passage
• Topical tacrolimus for atopic dermatitis.1 passage
• Topical treatment for facial burns.1 passage
• Topical treatments for blepharokeratoconjunctivitis in children.1 passage
• Topical treatments for scalp psoriasis.1 passage
• Topical versus systemic antibiotics for chronic suppurative otitis media.1 passage
• Topiramate add-on therapy for drug-resistant focal epilepsy.1 passage
• Topiramate for essential tremor.1 passage
• Topiramate for juvenile myoclonic epilepsy.2 passages
• Topiramate monotherapy for juvenile myoclonic epilepsy.2 passages
• Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.2 passages
• Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification.1 passage
• Total intravenous anaesthesia versus inhalational anaesthesia for adults undergoing transabdominal robotic assisted laparoscopic surgery.1 passage
• Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults.1 passage
• Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.1 passage
• Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.1 passage
• Tourniquet use for knee replacement surgery.1 passage
• Tracheal suction at birth in non-vigorous neonates born through meconium-stained amniotic fluid.1 passage
• Tracking health commodity inventory and notifying stock levels via mobile devices: a mixed methods systematic review.1 passage
• Traditional Chinese herbal medicine for vascular dementia.1 passage
• Traditional suburethral sling operations for urinary incontinence in women.2 passages
• Training and supportive programs for palliative care volunteers in community settings.1 passage
• Training healthcare providers to respond to intimate partner violence against women.1 passage
• Training interventions for improving telephone consultation skills in clinicians.1 passage
• Tramadol for neuropathic pain in adults.1 passage
• Tramadol for osteoarthritis.1 passage
• Tramadol for postoperative pain treatment in children.1 passage
• Tramadol with or without paracetamol (acetaminophen) for cancer pain.1 passage
• Tranexamic acid for patients with nasal haemorrhage (epistaxis).1 passage
• Tranexamic acid for preventing postpartum haemorrhage.1 passage
• Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps.1 passage
• Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.1 passage
• Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk.1 passage
• Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults.1 passage
• Transcranial Doppler sonography for detecting stenosis or occlusion of intracranial arteries in people with acute ischaemic stroke.1 passage
• Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease.1 passage
• Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke.2 passages
• Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke.1 passage
• Transcranial direct current stimulation (tDCS) for improving aphasia in patients with aphasia after stroke.1 passage
• Transcranial magnetic stimulation (TMS) for schizophrenia.1 passage
• Transcranial magnetic stimulation for the treatment of epilepsy.2 passages
• Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality.1 passage
• Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain.1 passage
• Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews.1 passage
• Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults.1 passage
• Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults.1 passage
• Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.1 passage
• Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults.1 passage
• Transcutaneous electrical nerve stimulation for acute pain.1 passage
• Transcutaneous electrical stimulation (TES) for treatment of constipation in children.2 passages
• Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus.1 passage
• Transfusion of fresher versus older red blood cells for all conditions.1 passage
• Transfusion of red blood cells stored for shorter versus longer duration for all conditions.1 passage
• Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.1 passage
• Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.1 passage
• Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical patients: a network meta-analysis.1 passage
• Transillumination and optical coherence tomography for the detection and diagnosis of enamel caries.1 passage
• Transition of care for adolescents from paediatric services to adult health services.1 passage
• Transmyocardial laser revascularization versus medical therapy for refractory angina.1 passage
• Transperitoneal versus retroperitoneal approach for elective open abdominal aortic aneurysm repair.1 passage
• Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults.1 passage
• Transplacental versus direct fetal corticosteroid treatment for accelerating fetal lung maturation where there is a risk of preterm birth.1 passage
• Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease.1 passage
• Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.1 passage
• Transurethral radiofrequency collagen denaturation for the treatment of women with urinary incontinence.1 passage
• Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse.1 passage
• Transverse versus vertical groin incision for femoral artery approach.1 passage
• Travel-related control measures to contain the COVID-19 pandemic: a rapid review.1 passage
• Treadmill interventions in children under six years of age at risk of neuromotor delay.1 passage
• Treadmill training and body weight support for walking after stroke.1 passage
• Treadmill training for patients with Parkinson's disease.2 passages
• Treating periodontal disease for preventing adverse birth outcomes in pregnant women.1 passage
• Treating progressive disseminated histoplasmosis in people living with HIV.1 passage
• Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.3 passages
• Treatment for Barrett's oesophagus.1 passage
• Treatment for HIV-associated cryptococcal meningitis.1 passage
• Treatment for IgG and IgA paraproteinaemic neuropathy.1 passage
• Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.1 passage
• Treatment for avascular necrosis of bone in people with sickle cell disease.2 passages
• Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.1 passage
• Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.2 passages
• Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.1 passage
• Treatment for dysphagia (swallowing difficulties) in hereditary ataxia.1 passage
• Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis.1 passage
• Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.1 passage
• Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.1 passage
• Treatment for osteoporosis in people with ß-thalassaemia.1 passage
• Treatment for postpolio syndrome.1 passage
• Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.1 passage
• Treatment for superficial infusion thrombophlebitis of the upper extremity.1 passage
• Treatment for superficial thrombophlebitis of the leg.1 passage
• Treatment for telangiectasias and reticular veins.1 passage
• Treatment for ulnar neuropathy at the elbow.1 passage
• Treatment for women with postpartum iron deficiency anaemia.1 passage
• Treatment of dental and orthodontic complications in thalassaemia.1 passage
• Treatment of dental complications in sickle cell disease.2 passages
• Treatment of distal deep vein thrombosis.1 passage
• Treatment of epilepsy for people with Alzheimer's disease.3 passages
• Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease.1 passage
• Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.1 passage
• Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.1 passage
• Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.1 passage
• Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.1 passage
• Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.1 passage
• Treatments for breast abscesses in breastfeeding women.1 passage
• Treatments for breast engorgement during lactation.2 passages
• Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.1 passage
• Treatments for delusional disorder.1 passage
• Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.1 passage
• Treatments for priapism in boys and men with sickle cell disease.2 passages
• Treatments for primary delusional infestation.1 passage
• Treatments for seizures in catamenial (menstrual-related) epilepsy.2 passages
• Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).2 passages
• Treatments for unruptured intracranial aneurysms.1 passage
• Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.1 passage
• Triage tools for detecting cervical spine injury in pediatric trauma patients.1 passage
• Tricyclic and related drugs for nocturnal enuresis in children.1 passage
• Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia.1 passage
• Trihexyphenidyl for dystonia in cerebral palsy.1 passage
• Trocar types in laparoscopy.1 passage
• Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).1 passage
• Tubal flushing for subfertility.2 passages
• Tumour bed boost radiotherapy for women after breast-conserving surgery.1 passage
• Type I interferons for induction of remission in ulcerative colitis.1 passage
• Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.1 passage
• Types of materials for frontalis sling surgery for congenital ptosis.1 passage
• Tyrosine supplementation for phenylketonuria.1 passage
• Ultrasonography for confirmation of gastric tube placement.1 passage
• Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.1 passage
• Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair.1 passage
• Ultrasound for diagnosis of birth weight discordance in twin pregnancies.1 passage
• Ultrasound for fetal assessment in early pregnancy.1 passage
• Ultrasound guidance for arterial (other than femoral) catheterisation in adults.1 passage
• Ultrasound guidance for upper and lower limb blocks.1 passage
• Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization.1 passage
• Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization.1 passage
• Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women.1 passage
• Ultrasound versus liver function tests for diagnosis of common bile duct stones.1 passage
• Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.1 passage
• Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women.2 passages
• Umbilical vein injection for management of retained placenta.1 passage
• Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).1 passage
• Unconditional cash transfers for assistance in humanitarian disasters: effect on use of health services and health outcomes in low- and middle-income countries.1 passage
• Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries.1 passage
• Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.1 passage
• Universal screening for SARS-CoV-2 infection: a rapid review.1 passage
• Upper limb exercise training for COPD.1 passage
• Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.1 passage
• Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi.1 passage
• Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalised adults.1 passage
• Urethral injection therapy for urinary incontinence in women.1 passage
• Urgent-start peritoneal dialysis versus conventional-start peritoneal dialysis for people with chronic kidney disease.1 passage
• Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.1 passage
• Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease.1 passage
• Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women.1 passage
• Urinary biomarkers for the non-invasive diagnosis of endometriosis.1 passage
• Urine tests for Down's syndrome screening.1 passage
• Ursodeoxycholic acid for cystic fibrosis-related liver disease.1 passage
• Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.1 passage
• Use of biochemical tests of placental function for improving pregnancy outcome.1 passage
• Use of endoanal ultrasound for reducing the risk of complications related to anal sphincter injury after vaginal birth.1 passage
• Use of hyaluronidase as an adjunct to local anaesthetic eye blocks to reduce intraoperative pain in adults.1 passage
• Use of plastic adhesive drapes during surgery for preventing surgical site infection.1 passage
• Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.2 passages
• Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia.1 passage
• Uterine distension media for outpatient hysteroscopy.1 passage
• Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.1 passage
• Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.2 passages
• Vaccines for measles, mumps, rubella, and varicella in children.2 passages
• Vaccines for preventing herpes zoster in older adults.2 passages
• Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.1 passage
• Vaccines for preventing influenza in healthy adults.1 passage
• Vaccines for preventing influenza in healthy children.1 passage
• Vaccines for preventing influenza in the elderly.1 passage
• Vaccines for preventing invasive salmonella infections in people with sickle cell disease.2 passages
• Vaccines for preventing rotavirus diarrhoea: vaccines in use.3 passages
• Vaccines for preventing typhoid fever.1 passage
• Vaccines for the common cold.1 passage
• Vaccines for women for preventing neonatal tetanus.1 passage
• Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections.2 passages
• Vagus nerve stimulation for partial seizures.1 passage
• Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.1 passage
• Valproate for acute mania.1 passage
• Valproate for schizophrenia.1 passage
• Valproate preparations for agitation in dementia.1 passage
• Vapocoolants (cold spray) for pain treatment during intravenous cannulation.1 passage
• Vascular access specialist teams for device insertion and prevention of failure.1 passage
• Vascular closure devices for femoral arterial puncture site haemostasis.1 passage
• Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.1 passage
• Vasodilators for primary Raynaud's phenomenon.1 passage
• Vasodilators for women undergoing fertility treatment.1 passage
• Vasopressors for hypotensive shock.1 passage
• Vector and reservoir control for preventing leishmaniasis.1 passage
• Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases.1 passage
• Vena caval filters for the prevention of pulmonary embolism.1 passage
• Venlafaxine for neuropathic pain in adults.1 passage
• Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports.1 passage
• Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.1 passage
• Ventriculo-peritoneal shunting devices for hydrocephalus.1 passage
• Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.1 passage
• Very early versus delayed mobilisation after stroke.1 passage
• Vestibular rehabilitation for unilateral peripheral vestibular dysfunction.1 passage
• Video calls for reducing social isolation and loneliness in older people: a rapid review.1 passage
• Video feedback for parental sensitivity and attachment security in children under five years.1 passage
• Video games for people with schizophrenia.1 passage
• Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation.1 passage
• Videolaryngoscopy versus direct laryngoscopy for tracheal intubation in children (excluding neonates).1 passage
• Videolaryngoscopy versus direct laryngoscopy for tracheal intubation in neonates.2 passages
• Vigabatrin add-on therapy for drug-resistant focal epilepsy.1 passage
• Vigabatrin versus carbamazepine monotherapy for epilepsy.1 passage
• Virtual reality distraction for acute pain in children.1 passage
• Virtual reality for rehabilitation in Parkinson's disease.1 passage
• Virtual reality for stroke rehabilitation.2 passages
• Virtual reality simulation training for health professions trainees in gastrointestinal endoscopy.1 passage
• Virtual reality training for improving the skills needed for performing surgery of the ear, nose or throat.1 passage
• Vision screening for correctable visual acuity deficits in school-age children and adolescents.1 passage
• Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.1 passage
• Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults.1 passage
• Visual inspection for diagnosing cutaneous melanoma in adults.1 passage
• Visual or visual-tactile examination to detect and inform the diagnosis of enamel caries.1 passage
• Vitamin A and beta (β)-carotene supplementation for cystic fibrosis.1 passage
• Vitamin A and fish oils for preventing the progression of retinitis pigmentosa.1 passage
• Vitamin A supplementation during pregnancy for maternal and newborn outcomes.1 passage
• Vitamin A supplementation for postpartum women.1 passage
• Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.1 passage
• Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants.1 passage
• Vitamin A supplements for reducing mother-to-child HIV transmission.1 passage
• Vitamin B and its derivatives for diabetic kidney disease.1 passage
• Vitamin C supplementation for prevention and treatment of pneumonia.2 passages
• Vitamin C supplementation for the primary prevention of cardiovascular disease.1 passage
• Vitamin C supplementation in pregnancy.1 passage
• Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia.1 passage
• Vitamin D for the management of multiple sclerosis.1 passage
• Vitamin D for the treatment of chronic painful conditions in adults.1 passage
• Vitamin D supplementation for chronic liver diseases in adults.2 passages
• Vitamin D supplementation for preventing infections in children under five years of age.1 passage
• Vitamin D supplementation for sickle cell disease.2 passages
• Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health.1 passage
• Vitamin D supplementation for the treatment of COVID-19: a living systematic review.1 passage
• Vitamin D supplementation for women during pregnancy.2 passages
• Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in children.1 passage
• Vitamin E for Alzheimer's dementia and mild cognitive impairment.1 passage
• Vitamin E for antipsychotic-induced tardive dyskinesia.1 passage
• Vitamin E supplementation in people with cystic fibrosis.2 passages
• Vitamin E supplementation in pregnancy.1 passage
• Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.1 passage
• Vitamin K for the primary prevention of cardiovascular disease.1 passage
• Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases.1 passage
• Vitamin K supplementation for cystic fibrosis.3 passages
• Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.1 passage
• Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.1 passage
• Vitamin supplementation for preventing miscarriage.1 passage
• Vitrectomy for idiopathic macular hole.1 passage
• Vocational rehabilitation for enhancing return-to-work in workers with traumatic upper limb injuries.1 passage
• Volume expanders for the prevention of ovarian hyperstimulation syndrome.1 passage
• Volume-targeted versus pressure-limited ventilation in neonates.1 passage
• Vortioxetine for depression in adults.1 passage
• Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis.1 passage
• WITHDRAWN. Antiviral treatment for Bell's palsy (idiopathic facial paralysis).1 passage
• WITHDRAWN: Acupuncture for neck disorders.1 passage
• WITHDRAWN: Angioplasty (versus non surgical management) for intermittent claudication.1 passage
• WITHDRAWN: Anticonvulsants for fibromyalgia.1 passage
• WITHDRAWN: Antistreptococcal interventions for guttate and chronic plaque psoriasis.1 passage
• WITHDRAWN: Celecoxib for rheumatoid arthritis.1 passage
• WITHDRAWN: Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.1 passage
• WITHDRAWN: Community-based population-level interventions for promoting child oral health.1 passage
• WITHDRAWN: Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission.1 passage
• WITHDRAWN: Day care for pre-school children.1 passage
• WITHDRAWN: Dental fillings for the treatment of caries in the primary dentition.1 passage
• WITHDRAWN: Drugs for preventing postoperative nausea and vomiting.1 passage
• WITHDRAWN: Ear drops for the removal of ear wax.1 passage
• WITHDRAWN: Electrical cardioversion for atrial fibrillation and flutter.1 passage
• WITHDRAWN: Exercise for dysmenorrhoea.1 passage
• WITHDRAWN: Extraction of primary (baby) teeth for unerupted palatally displaced permanent canine teeth in children.1 passage
• WITHDRAWN: Grommets (ventilation tubes) for recurrent acute otitis media in children.1 passage
• WITHDRAWN: Hand and ultrasonic instrumentation for orthograde root canal treatment of permanent teeth.1 passage
• WITHDRAWN: Hypnosis for children undergoing dental treatment.1 passage
• WITHDRAWN: Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.1 passage
• WITHDRAWN: Intermittent catheterisation for long-term bladder management.1 passage
• WITHDRAWN: Interventions for ear discharge associated with grommets (ventilation tubes).1 passage
• WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness.1 passage
• WITHDRAWN: Interventions for replacing missing teeth: 1- versus 2-stage implant placement.1 passage
• WITHDRAWN: Interventions for replacing missing teeth: different types of dental implants.1 passage
• WITHDRAWN: Interventions for replacing missing teeth: partially absent dentition.1 passage
• WITHDRAWN: Interventions for skin changes caused by nerve damage in leprosy.1 passage
• WITHDRAWN: Interventions for treating obesity in children.1 passage
• WITHDRAWN: Iodine supplementation for preventing iodine deficiency disorders in children.1 passage
• WITHDRAWN: Nursing record systems: effects on nursing practice and healthcare outcomes.1 passage
• WITHDRAWN: Nutrition support for bone marrow transplant patients.1 passage
• WITHDRAWN: Occlusal interventions for periodontitis in adults.1 passage
• WITHDRAWN: Operative caries management in adults and children.1 passage
• WITHDRAWN: Oxcarbazepine add-on for drug-resistant partial epilepsy.1 passage
• WITHDRAWN: Ozone therapy for the treatment of dental caries.1 passage
• WITHDRAWN: Peripheral nerve blocks for postoperative pain after major knee surgery.1 passage
• WITHDRAWN: Pharmacological cardioversion for atrial fibrillation and flutter.1 passage
• WITHDRAWN: Propranolol for migraine prophylaxis.1 passage
• WITHDRAWN: Psychotherapy for depression among incurable cancer patients.1 passage
• WITHDRAWN: Pulp management for caries in adults: maintaining pulp vitality.1 passage
• WITHDRAWN: Radioisotopes for metastatic bone pain.1 passage
• WITHDRAWN: Reduction versus abrupt cessation in smokers who want to quit.1 passage
• WITHDRAWN: Resorbable versus titanium plates for facial fractures.1 passage
• WITHDRAWN: Root canal posts for the restoration of root filled teeth.1 passage
• WITHDRAWN: Surgery for thumb (trapeziometacarpal joint) osteoarthritis.1 passage
• WITHDRAWN: Systemic treatments for metastatic cutaneous melanoma.1 passage
• WITHDRAWN: Techniques to ascertain correct endotracheal tube placement in neonates.1 passage
• WITHDRAWN: Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis.1 passage
• WITHDRAWN: Traditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndrome.1 passage
• WITHDRAWN: Transcendental meditation for the primary prevention of cardiovascular disease.1 passage
• WITHDRAWN: Transcutaneous electrical stimulation (TES) for treatment of constipation in children.1 passage
• WITHDRAWN: Treatments for adults with prominent lower front teeth.1 passage
• WITHDRAWN: Trimetazidine for stable angina.1 passage
• Walk-in clinics versus physician offices and emergency rooms for urgent care and chronic disease management.1 passage
• Walking for hypertension.1 passage
• Warfarin initiation nomograms for venous thromboembolism.1 passage
• Warming of intravenous and irrigation fluids for preventing inadvertent perioperative hypothermia.1 passage
• Washed versus unwashed red blood cells for transfusion for the prevention of morbidity and mortality in preterm infants.1 passage
• Washout policies in long-term indwelling urinary catheterisation in adults.1 passage
• Water fluoridation for the prevention of dental caries.1 passage
• Water for preventing urinary stones.1 passage
• Water infusion versus air insufflation for colonoscopy.1 passage
• Water precautions for prevention of infection in children with ventilation tubes (grommets).1 passage
• Wavefront excimer laser refractive surgery for adults with refractive errors.1 passage
• Welfare-to-work interventions and their effects on the mental and physical health of lone parents and their children.1 passage
• Wendan decoction (Traditional Chinese medicine) for schizophrenia.1 passage
• Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations.1 passage
• Wheat flour fortification with iron for reducing anaemia and improving iron status in populations.1 passage
• Whole body vibration exercise training for fibromyalgia.1 passage
• Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.1 passage
• Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.1 passage
• Whole grain cereals for the primary or secondary prevention of cardiovascular disease.1 passage
• Whole-body cryotherapy (extreme cold air exposure) for preventing and treating muscle soreness after exercise in adults.1 passage
• Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children.1 passage
• Withdrawal of antihypertensive drugs in older people.1 passage
• Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.1 passage
• Work-break schedules for preventing musculoskeletal symptoms and disorders in healthy workers.1 passage
• Workplace interventions for increasing standing or walking for decreasing musculoskeletal symptoms in sedentary workers.1 passage
• Workplace interventions for reducing sitting at work.4 passages
• Workplace interventions for treatment of occupational asthma.1 passage
• Workplace interventions to prevent work disability in workers on sick leave.1 passage
• Workplace lighting for improving alertness and mood in daytime workers.1 passage
• Workplace pedometer interventions for increasing physical activity.1 passage
• Wound cleansing for treating venous leg ulcers.1 passage
• Wound drainage after plastic and reconstructive surgery of the breast.1 passage
• Wound drainage for lower limb arterial surgery.1 passage
• Wound-care teams for preventing and treating pressure ulcers.1 passage
• Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care.1 passage
• Xenon as an adjuvant to therapeutic hypothermia in near-term and term newborns with hypoxic-ischaemic encephalopathy.1 passage
• Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.1 passage
• Xpert1 passage
• Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.1 passage
• Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.1 passage
• Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.1 passage
• Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.1 passage
• Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.1 passage
• Xylitol for preventing acute otitis media in children up to 12 years of age.1 passage
• Xylitol-containing products for preventing dental caries in children and adults.1 passage
• Yoga as part of a package of care versus non-standard care for schizophrenia.1 passage
• Yoga as part of a package of care versus standard care for schizophrenia.1 passage
• Yoga for asthma.1 passage
• Yoga for epilepsy.2 passages
• Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer.1 passage
• Yoga for secondary prevention of coronary heart disease.1 passage
• Yoga for stroke rehabilitation.1 passage
• Yoga for treating urinary incontinence in women.1 passage
• Yoga treatment for chronic non-specific low back pain.1 passage
• Yoga versus non-standard care for schizophrenia.1 passage
• Yoga versus standard care for schizophrenia.1 passage
• Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.3 passages
• Zinc supplementation for improving pregnancy and infant outcome.2 passages
• Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.1 passage
• Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance.1 passage
• Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age.1 passage
• Zinc supplementation for the treatment of measles in children.2 passages
• Zinc supplementation for tinnitus.1 passage
• Zonisamide add-on therapy for focal epilepsy.2 passages
• Zonisamide for essential tremor.1 passage
• Zonisamide for neuropathic pain in adults.1 passage
• Zuclopenthixol dihydrochloride for schizophrenia.1 passage
• Zuclopenthixol versus placebo for schizophrenia.1 passage
• eHealth interventions for people with chronic kidney disease.1 passage
• mHealth education interventions in heart failure.1 passage
• ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).1 passage
• ​Primary closure versus delayed or no closure for traumatic wounds due to mammalian bite.1 passage